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This bulletin presents key findings at a local level  
from the third drug prevalence survey of households  
in both Ireland and Northern Ireland. The survey 
sampled a representative number of people aged 
between 15 and 64 during late 2010 and early 2011. 
The survey was carried out according to standards set 
by the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). This bulletin presents results 
relating to drug prevalence on a lifetime, last year 
(recent) and last month (current) basis for illegal and 
other drugs including alcohol and tobacco for each 
Regional Drug Task Force Area (former Health Board 
areas) in Ireland, and Health and Social Care Trust 
(HSCT) in Northern Ireland.
Key findings:  
RDTF and HSCT areas
n	 Cannabis was the most commonly used 
illegal drug in all RDTF and HSCT areas. 
Generally, prevalence rates for other 
illegal drugs were considerably lower 
than the rates for cannabis use in all 
RDTF and HSCT areas.
n	 The profile of illegal drug users was 
similar across RDTF and HSCT areas: 
in general, men were more likely than 
women, and young adults were more 
likely than older adults, to use any illegal 
drugs.
n	 Compared to the survey reports of 
changes over time in 2006/7, in this 
survey there is less evidence of increases 
in the use of any illegal drugs in many 
of RDTF and HSCT areas. Examining the 
results over time shows that in many 
areas the use of any illegal drugs has 
stabilised or declined.
n	 The regional variation in the prevalence 
of recent use of any illegal drugs was 
greater in Ireland. Recent use of an 
illegal drug in Ireland was highest in the 
Northern RDTF (11%) and lowest in 
the North West RDTF (3%). In Northern 
Ireland recent use of any illegal drugs 
was highest in BHSCT (11%) and lowest 
in SHSCT and NHSCT (both 5%).
n	 The regional variation in the prevalence 
of last year sedatives/tranquillisers was 
greater in Ireland. The region with the 
highest rate (10%; NERDTF) was almost 
2.5 times larger than the lowest (4%; 
NWRDTF). In the North the highest rate 
(13%; BHSCT) was about 1.5 times 
larger than the lowest (9% WHSCT) rate.
n	 The regional variation for last year Anti-
depressants use was greater in Ireland. 
The highest (7%; NERDTF) was about 
2.5 times the lowest (3%; NRDTF) rate. 
In the North of Ireland, the highest rate 
(13%; BHSCT) was marginally greater 
than the lowest (11% WHSCT and 11% 
SHSCT).
n	 The regional variation for last year other 
opiates was greater in Northern Ireland. 
The ratio between highest (10%; 
BHSCT) and lowest (3%; WHSCT) was 
over 3 times. In the RDTFs the highest 
(38%; WRDTF) is almost two times 
greater than the lowest (19%; NWRDTF).
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Northern Ireland Key Findings by 
Health and Social Care Trust (HSCT)
n	 In 2010/11 use of any illegal drug was highest in the BHSCT. 
Adults (15-64 yrs) in the BHSCT reported lifetime (41%), 
recent (11%) and current (6%) use of an illegal drug.
n	 The highest last year prevalence rate for any illegal drugs 
(BHSCT – 11%) was more than double that of the lowest 
rate (SHSCT and NHSCT – both 5%) among all adults.
n	 Prevalence rates tended to be higher across all time periods 
in the BHSCT area than in other HSCTs.
n	 Cannabis was the drug most frequently used in all HSCTs for 
all time periods.
n	 In relation to recent use, the highest prevalence of cocaine 
powder was in the BHSCT while the lowest prevalence was 
in the SHSCT.
n	 Generally, prevalence rates for other illegal drugs were 
considerably lower than the rates for cannabis use in all 
HSCTs.
n	 The profile of illegal drug users was similar across HSCT 
areas: in general, men were more likely than women, and 
young adults were more likely than older adults, to use any 
illegal drugs.
n	 A higher proportion of respondents in the BHSCT (27%) 
reported lifetime usage of sedatives and/or tranquillisers than 
any other HSCT; the lowest proportion being found in the 
WHSCT (15%).
n	 The highest proportions of respondents who had ever used 
anti-depressants were in the SEHSCT and BHSCT (both 
24%); the highest proportions for recent use of these drugs 
were in the same HSCTs (both 13%).
n	 Significant differences are not available for the BHSCT or 
the SEHSCT due to restructuring in the HSCTs in Northern 
Ireland.
n	 With regards to all adults (15-64 yrs) and all prevalence 
periods, there were no significant differences for the all illegal 
drugs category between 2006/7 and 2010/11 in the NHSCT, 
SHSCT or the WHSCT.
n	 Since the last survey, there was a significant decrease in last 
month cannabis usage for all adults (15-64 yrs) in the SHSCT 
(-2.5 percentage points) and a significant increase in the 
WHSCT (+2.3 percentage points). There was not a significant 
difference for use of this drug in the NHSCT for this time 
period.
n	 No significant changes in lifetime, last year or last month 
use of cocaine were recorded in the NHSCT, SHSCT and the 
WHSCT between 2006/7 and 2010/11.
n	 Since 2006/7, there was an increase of 3.9 percentage 
points for last year prevalence for sedatives and/or 
tranquillisers in the SHSCT. There were no significance 
differences for all adults (15-64 yrs) in the NHSCT or the 
WHSCT.
n	 With regards to anti-depressants, there was a significant 
difference (+5.7 percentage points) between 2006/7 and 
2010/11 in the NHSCT for older adults (35-64 yrs) for last 
year prevalence. In the WHSCT, for last year prevalence, there 
was no significant difference for this time period. In relation 
to last year usage, in the SHSCT, there was a significant 
increase (+7.8 percentage points) for older adults (35-64 
yrs) and a significant decrease (-6.1 percentage points) for 
young adults (15-34 yrs) in this time period.
n	 In the NHSCT, there was a significant lifetime change in 
relation to other opiates between 2006/7 and 2010/11  
(-6.8 percentage points) for all adults (15-64 yrs). This trend 
was also true in the WHSCT (-4.3 percentage points). There 
were no significant lifetime changes in the SHSCT for all 
adults (15-64 yrs).
n	 Between 2006/7 and 2010/11, there were significant 
differences for lifetime prevalence for all adults (15-64 yrs) 
in relation to methadone (15-64 yrs) in the NHSCT (+1.2 
percentage points) and the WHSCT (+1.5 percentage 
points).
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Ireland Key Findings by Regional 
Drug Task Force (RDTF) Areas
n	 The results from 2010/11 survey show that the prevalence 
of illegal drugs varies across RDFT areas. Lifetime use of any 
illegal drug in Ireland was highest in the East Coast RDTF 
area (38%) and lowest in North West (17%). Recent use of 
an illegal drug was highest in the South West RDTF (11%) 
and lowest in the North West RDTF (3%). Current use of an 
illegal drug was also highest in the South West (6%) and 
lowest in the North West (1%).
n	 In all RDTF areas cannabis was the most frequently used 
illegal drug in the year prior to the survey. After cannabis, 
new psychoactive substances and cocaine (including crack) 
were the most frequently reported illegal drugs for recent use 
across all areas.
n	 Recent use of other opiates was highest in the Western 
(38%) and Southern (35%) areas and lowest in the North 
Western (19%) area. Of the other prescription/over-the-
counter medicines surveyed, recent use of sedatives and/or 
tranquillisers and recent use of anti-depressants was highest 
in the North East (10% and 7%) and lowest in the North 
West (4% and 3%).
n	 Recent tobacco use was highest in the Northern RDTF area 
(39%) followed by the South West (37%) and lowest in 
the Mid-Western and Western areas (28% in both). In the 
remaining areas last year tobacco prevalence was between 
29% (EC) and 33%(SE).
n	 Compared to illegal drugs, there is little variation in the level 
of last year alcohol prevalence between regions, ranging from 
82% in the North West and Mid-West to 88% in the East 
Coast. Last month alcohol prevalence ranges from 66% (NE 
and SE) to 77% (EC).
n	 The 2010/11 results show that the gender pattern of recent 
drug use is similar in all RDTF regions. Men are more likely 
to consume illegal drugs, alcohol and tobacco while women 
are more likely than men to consume prescription/over-the-
counter medicines.
n	 With regard to the difference in use of illegal drugs between 
men and women there is no evidence of a narrowing of the 
gap in any of the regional drug task force areas.
n	 The profile of illegal drug users was similar across RDTF 
areas: in general young adults (15-34 yrs) were more likely 
than older adults (34-65 yrs), to use an illegal drug.
n	 Younger adults are more likely than older adults to use 
tobacco in all regions except the South East where the  
recent use for younger and older adults is very similar.
n	 Last year alcohol prevalence was higher among younger than 
older adults in many regions (MRDTF, NERDTF, NWRDTF, 
SWRDTF and WRDTF). Levels were very similar in the other 
regions. The one exception was the Northern RDTF where 
prevalence was higher among older adults. Last month 
alcohol prevalence was higher among younger adults in 
many regions. The exceptions were the East Coast, Northern 
and South East RDTF areas where prevalence is slightly 
higher for older adults.
n	 Comparing 2010/11 results with earlier surveys shows an 
overall decline in recent cannabis use in many areas. This 
has occurred in two ways: The first is a gradual and steady 
decline of last year cannabis prevalence in the North East 
and the South East areas in each of the earlier surveys. The 
second pattern in the East Coast and Northern areas entails 
an increase in prevalence between 2002/3 and 2006/7 
followed by a reduction in 2010/11. This suggests last year 
cannabis use may have peaked around 2006/7 in these two 
regions.
n	 Comparisons over time also show increases in recent 
cannabis use found in some regions. For example a gradual 
and steady increase in last year cannabis prevalence was 
found in each survey for the Western RDTF area. While 
increases were also found in the Midlands and Mid-Western 
regions between 2002/3 and 2006/7, these were followed 
by little change in 2010/11 rates indicating a possible 
stabilisation in recent cannabis use in these two regions.
n	 Taken together the former two points show that the 
difference in recent cannabis use between RDTF areas  
has narrowed over time.
n	 The results show that over time recent cocaine (including 
crack) increased in most RDTFs between 2002/3 and 
2006/7, followed by a decline in 2010/11. This suggests 
recent cocaine use may have peaked around 2006/7 in 
these areas. There are two exceptions to this. One is in 
the South West RDTF where the decline recorded between 
2002/3 and 2006/7 was followed by an increase in the 
2010/11 results. The other exception is in the North West 
where there has been little change since the last survey.
n	 Since the 2006/7 survey there has been a small increase in 
last year alcohol prevalence in the East Coast and Midlands 
areas and a small decrease in the Northern area. Relatively 
larger increases in last year alcohol prevalence were found 
for the South East, Western, North West and Southern areas. 
There was hardly any change in last year alcohol prevalence 
in the remaining areas.
n	 Since earlier surveys regional differences in last year alcohol 
prevalence has narrowed.
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1 Since January 2005 the Health Boards in Ireland have been restructured and merged under one authority, the Health Service Executive. For the purpose of 
facilitating comparisons between the 2002/3, 2006/7 and the current survey, it was decided to continue to weight the data by the former Health Board areas  
as these correspond with the Regional Drug Task Force structures.
2 The composition of the population in Ireland has changed substantially since Census 2006. Given that Census 2011 information was not available when weights 
were calculated, it was decided to weight the data using 2010 population estimates. For the purpose of constructing post-stratification weights, Regional Authority 
areas were used to define regions instead of Health Board/RDTF.
3 Since the 2006/7 Survey the Health and Social Services Boards have been restructured into Health and Social Care Trusts. In the 2010/11 survey the data have 
been weighted by the 5 Health and Social Care Trust areas, while in the previous two surveys the data were weighted by the 4 Health and Social Services 
Boards that existed at the time.
Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Public Health 
Information & Research Branch (PHIRB) within the Department 
of Health, Social Services and Public Safety (DHSSPS) in 
Northern Ireland.
The main focus of the survey was to obtain prevalence rates for 
key illegal drugs, such as cannabis, ecstasy, cocaine and heroin 
on a lifetime (ever used), last year (recent use), and last month 
(current use) basis. Similar prevalence questions were also 
asked of alcohol, tobacco, and other drugs (e.g. tranquillisers); 
attitudinal and demographic information was also sought from 
respondents.
Methodology
The questionnaire and methodology for this general population 
survey were based on best practice guidelines drawn up by the 
EMCDDA. The questionnaires were administered through face-
to-face interviews with respondents aged between 15 and 64 
years and who are normally resident in households in Ireland 
and Northern Ireland. Thus persons outside these age ranges, or 
who do not normally live in private households, have not been 
included in the survey (for example prisons, nursing homes etc.).
Fieldwork for the survey was carried out between October  
2010 and May 2011 and the final achieved sample comprised 
7,669 respondents (5,134 in Ireland and 2,535 in Northern 
Ireland). The response rate for the survey was 60% in Ireland 
and 67% in Northern Ireland. Areas based sampling was applied 
in Ireland. The first stage involved stratifying by Health Board in 
Ireland1. The achieved sample was weighted by gender, age and 
region2 in Ireland and by gender, age and Health and Social Care 
Trust area in Northern Ireland3 to maximise its representativeness 
of the general population. The effects of stratification, clustering 
and weighing have been incorporated in the interval estimates 
(i.e. intervals are design effect adjusted). Details of the 
methodology have been summarised in a paper published 
on the websites of the NACD (http://www.nacd.ie/) and the 
DHSSPS (http://www.dhsspsni.gov.uk/) and a comprehensive 
technical report containing copies of the questionnaires used in 
both jurisdictions will be published separately.
Interviews were conducted using computer-assisted personal 
interviewing (CAPI). These techniques allow interviews to be 
conducted more efficiently and more accurately than other 
techniques such as pen-and-paper completion.
Please note:
n Prevalence rates for ‘any illegal drugs’ refers to the reported 
use of one or more of the following: amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic 
mushrooms, poppers or solvents.
n	 In terms of comparisons between the surveys, tests of 
statistical significance for differences between the prevalence 
of Other Opiates are not reported. As a result of measurement 
changes between 2006/7 and 2010/11, the Other Opiates 
category is not comparable between the surveys. The 
measurement of Other Opiates in Ireland in 2002/3 included 
9 drugs: Opium, Temgesic®, Diconal®, Napps, MSTs®, 
Pethidine, DF118®, (Dihydrocodeine), Buprenorphine and 
Morphine. In 2006/7 the category ‘Other Opiates’ was 
extended to be consistent with Northern Ireland and included: 
Codeine, Feminax, Kapake, Diffs, Dikes, Peach, Fentanyl 
(Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, 
Oxynorm®), and Buprenorphine (Subutex®). In 2010/11 
the category ‘Other Opiates’ also asked specifically about 
substances containing codeine such as Maxilief, Migraleve, 
Nurofen Plus, Codeine Phosp, Panadeine, Paracetamol/
Caffeine/Codeine and Doxylamine, Paracodin, Paramol, 
Solpadeine, Solpadol, Syndol, Tylex, Uniflu Plus, Veganin Plus.
n	 In the Republic of Ireland the measurement of New 
Psychoactive Substances included herbal smoking mixtures/
incense, Party Pills or Herbal Highs, Bath salts, Plant feeders or 
Other Powders, Kratom (Krypton), Salvia, Magic mint, Divine 
mint or Sally D and Other New Psychoactive substances 
mentioned by the respondent.
n	 In Northern Ireland, the category Legal Highs includes 
Party Pills, Herbal Highs, Party Powders, Kratom and Salvia 
Divinorum, it does not include Mephedrone as it is asked 
about separately. Questions on legal highs were first asked in 
2010/11.
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What is Prevalence?
The term prevalence refers to the proportion of a 
population who have used a drug over a particular time 
period. In general population surveys, prevalence is 
measured by asking respondents in a representative sample 
drawn from the population to recall their use of drugs. The 
three most widely used recall periods are: lifetime (ever 
used a drug), last year (used a drug in the last twelve 
months), and last month (used a drug in the last 30 
days). Provided that a sample is representative of the total 
population, prevalence information obtained from a sample 
can be used to infer prevalence in the population.
Lifetime prevalence refers to the proportion of the sample 
that reported ever having used the named drug at the 
time they were surveyed. A person who records lifetime 
prevalence may or may not be currently using the drug. 
Lifetime prevalence should not be interpreted as meaning 
that people have necessarily used a drug over a long period 
of time or that they will use the drug in future.
Last year prevalence refers to the proportion of the sample 
that reported using a named drug in the year prior to the 
survey. Last year prevalence is often referred to as recent use.
Last month prevalence refers to the proportion of the 
sample that reported using a named drug in the 30 day 
period prior to the survey. Last month prevalence is often 
referred to as current use. A proportion of those reporting 
current use may be occasional (or first-time) users who 
happen to have used in the period leading up to the survey 
– it should therefore be appreciated that current use is not 
synonymous with regular use.
As with other European surveys, people over the age of 64 
are excluded from this survey, as they grew up in an era 
when both the use and availability of illegal drugs were very 
limited. Therefore surveys with older people have, to date, 
shown very low rates of use even on a lifetime basis. This 
situation will change over time as the younger population 
grows older. Hence lifetime prevalence rates are likely to 
increase for a considerable period of time. When examining 
the data and comparing results over time, last year use is 
the best reflection of changes as it refers to recent use. Last 
month use is equally valuable as it refers to current use.
Understanding the Results  
of this Bulletin
Results (revised) from the first (October 2003, revised June 
2005) and second Drug Prevalence Surveys (January 2008) 
were published in Bulletin 1 and gave lifetime, last year, and last 
month prevalence rates for key drugs for the Island of Ireland, 
Ireland and Northern Ireland.
The tables for this bulletin report drug prevalence rates for 
2002/3, 2006/7 and 2010/11. Results are given for all 
respondents, and are also presented by gender and age. The 
results from comparing 2010/11 survey results with the 2006/7 
and 2002/3 survey results are presented in the tables in this 
bulletin. Only 2010/11 and 2006/7 comparisons are discussed 
in the accompanying text.
The figures for Ireland in 2002/3 and 2006/7 reported in 
this bulletin may differ slightly from figures report in earlier 
publications. These differences are due to applying new 
estimation procedures which were necessary to ensure the 
comparability between 2002/3, 2006/7 and 2010/11 drug 
prevalence survey data.
All prevalence rates presented in the accompanying tables 
are rounded to one decimal place and are rounded to whole 
numbers in the text. Where it provides for a better understanding 
of the situation figures in the text are sometimes reported at one 
decimal place (e.g. small/low figures).
As in all sample surveys, the greater the sample size the more 
statistically reliable are the results. Some of the differences in 
prevalence rates in the tables will be attributable to natural 
sample variations. Details confidence intervals for all of the 
figures contained in this bulletin can be found on the websites  
of the NACD and DHSSPS.
Invalid responses have been excluded from all analyses. 
Percentages may not always sum to 100 due to either the effect of 
rounding or where respondents could give more than one answer.
When the figure 0.0% appears it does not mean that no-one in the 
population has used the drug, rather it means that in this category 
no respondent reported use. The confidence intervals will provide a 
range of likely prevalence rates for all categories of drug use.
The Island of Ireland data was derived from the combined data 
from Northern Ireland and Ireland.
Statistical significance tests (Newcombe-Wilson Hybrid) have been 
used for this bulletin and changes that are found to be statistically 
significant are reported. When considering the results it should be 
borne in mind that statistical significance does not imply that the 
change is of practical importance. This importance is reflected in 
an evaluation of effect size, which is a substantive issue.
The tests of statistical significance are used to establish the 
degree of confidence with which we can infer that the observed 
changes in drug prevalence between 2010/11 and 2006/7 and 
between 2010/11 and 2002/3 are not due to sampling error. 
A significance level of 5% has been specified which means that 
the likelihood that sampling error accounts for the observed 
change is less than 5%.
A general population drug prevalence survey has some 
limitations. As mentioned above, some groups with high  
drug use prevalence are not covered by this type of survey 
(for example the homeless, those in prison). Drug prevalence 
questions are considered to be sensitive and therefore people 
may refuse to participate or under-report their drug use. 
Moreover, for some groups the numbers included in the sample 
are too small for reliable prevalence estimations. General 
population prevalence estimates are therefore supplemented by 
other methods (e.g. capture-recapture for problem drug use and 
surveys targeting special populations (e.g. prisoners, students, 
early school leavers).
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Northern Ireland – Results by Health and Social Care Trust
Prevalence rates for Northern Ireland are given in Tables 1–7.
Map 1: Northern Ireland – Health and Social Care Trust Areas
 
NHSCT
SHSCT
WHSCT
SEHCT
BHSCT
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Belfast Health and Social Care Trust (BHSCT) 
– Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey are presented in Table 2.1 and 
show that more than two fifths (41%) of respondents reported 
having taken illegal drugs at least once.
Drug Type
Cannabis was the most commonly used illegal drug, with 
approximately one third (34%) of respondents reporting ever 
having taken it. Among other illegal drugs, lifetime prevalence 
was highest for poppers (17%), ecstasy (16%), cocaine powder 
(14%), amphetamines (12%), magic mushrooms (10%), LSD 
(9%) and solvents (8%). Smaller proportions of respondents 
reported having taken crack and mephedrone (each 3%), 
heroin and methadone (each 1%).
Over one quarter (27%) of all adult respondents reported 
lifetime use of sedative and/or tranquillisers while 24% of 
respondents reported lifetime use of anti-depressants and 
23% of respondents reported other opiates. Four percent of 
respondents reported using legal highs and 2% of respondents 
reported using anabolic steroids.
Ninety percent of adults reported lifetime prevalence of alcohol 
and 55% of respondents reported lifetime prevalence of tobacco.
Gender
Lifetime use of any illegal drug was higher among men (46%) 
than women (35%). Comparing men and women for each 
of the illegal drugs separately, the largest difference was for 
cannabis (40% vs 28%). Other main distinctions between male 
and female respondents were for the following drugs: cocaine 
(20% vs 9%), magic mushrooms (14% vs 5%), amphetamines 
(17% vs 8%), ecstasy (20% vs 12%) and LSD (12% vs 6%).
Women were more likely than men to report lifetime usage of 
sedatives and/or tranquillisers (31% vs 23%), anti-depressants 
(28% vs 19%) and other opiates (24% vs 22%).
Age
Lifetime prevalence of any illegal drug was 49% for young 
adults compared with 33% for older adults.
Forty percent of young adults (15-34 yrs) had lifetime 
prevalence of cannabis compared with 29% of older adults  
(35-64 yrs).
Of the other drugs asked in the survey, the most commonly 
reported substances that young adults (15-34 yrs) used were: 
poppers (22%), ecstasy (21%), cocaine powder (19%), 
sedatives and/or tranquillisers (18%), anti-depressants (15%), 
amphetamines (14%), solvents (9%), and mephedrone and 
legal highs (each 6%).
In relation to older adults (35-64 yrs), the most commonly 
reported drugs used were: sedatives and/or tranquillisers (34%) 
and anti-depressants (31%). Other drugs that were reported 
for this age category were: poppers (13%), ecstasy (12%), 
amphetamines (11%), LSD (10%), and cocaine powder and 
magic mushrooms (each 9%).
Belfast Health and Social Care Trust (BHSCT) 
– Last Year Prevalence (Recent Use)
Table 2.2 shows that the overall prevalence rates for last year 
use of any illegal drugs was 11% for BHSCT.
Drug Type
In the year prior to the survey, cannabis was the most reported 
illegal drug (9%). This was followed by cocaine (3%), 
amphetamines, mephedrone, poppers and ecstasy (each 2%).
The same proportion of respondents reported using sedatives 
and/or tranquillisers and anti-depressants (each 13%) the 
previous year. A tenth of respondents (10%) had used other 
opiates.
There was no reported use of magic mushrooms or solvents.
Gender
The proportion of males who used illegal drugs was higher than 
females (15% vs 8%). Males were more than twice as likely  
as females to use cannabis (12% vs 5%).
There was a higher prevalence among males compared 
with females for the all illegal drugs category; however, the 
proportion of males and females who used illegal drugs was 
similar for most illegal drug categories. In relation to the most 
commonly reported drugs these were: cocaine powder (4% 
vs 2%), mephedrone (3% vs 1%), and amphetamines (3% 
vs 1%). While 1% of males reported using heroin, no females 
reported doing so.
A higher proportion of females compared with males reported 
using anti-depressants (15% vs 12%) and sedatives and/
or tranquillisers (15% vs 12%). Similar proportions of males 
(11%) and females (10%) reported using other opiates.
Age
In the year prior to the survey, the proportion of young adults 
(15-34 yrs) who used illegal drugs was over three times (18% 
vs 5%) that of older adults (35-64 yrs). In particular, this was 
true for cannabis (14% vs 4%).
While the proportion of respondents was similar for many of the 
other illegal drug categories, there was a higher proportion of 
young adults (15-34 yrs) who used some drugs compared with 
older adults (35-64 yrs). In particular, these were: poppers (3% 
vs 0.4%), mephedrone (3% vs 1%) and cocaine (4% vs 2%).
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Conversely, older adults were over three times more likely to use 
sedatives and/or tranquillisers than younger adults (19% vs 6%) 
and over two times more likely to use anti-depressants (18% vs 
8%). Similar proportions of young adults and older adults had 
taken other opiates during the past year (11% vs 10%).
Belfast Health and Social Care Trust (BHSCT) 
– Last Month Prevalence (Current Use)
Table 2.3 shows that the overall prevalence rates for last month 
use of any illegal drugs was 6% for BHSCT.
Drug Type
In the month prior to the survey, cannabis (5%) was the most 
reported illegal drug. After cannabis, the most frequently reported 
illegal drugs used were: cocaine, anabolic steroids, ecstasy and 
amphetamines (each 1%).
Over one tenth (11%) of respondents reported use of  
anti-depressants in the last month, while 9% of respondents 
reported use of sedatives and/or tranquillisers and 5% reported 
use of other opiates.
There was no reported use of heroin, magic mushrooms, 
solvents, mephedrone or legal highs.
Gender
The last month prevalence rate for any illegal drugs was 9% 
among men and 4% among women. Males were over three 
times more likely to use cannabis compared with females  
(7% vs 2%). Larger proportions of male respondents compared 
with female respondents reported use of most other drugs, 
for instance, cocaine powder (2% vs 0.6%) and anabolic 
steroids (1% vs 0.3%). While 1% of males reported using 
amphetamines, no females reported using these drugs.
However, while females reported using poppers (0.6%) and 
crack (0.3%), no male respondents reported using these drugs.
Last month use was higher for women than men for anti-
depressants (12% vs 9%), and sedatives and/or tranquillisers 
(10% vs 8%).
Age
Young adults (15-34 yrs) were more likely than older adults  
(35-64 yrs) to have taken any illegal drug (10% vs 3%) during 
the last month. In particular, 7% of young adults had taken 
cannabis compared with 2% of older adults. However, this 
pattern was not true for all categories of illegal drugs. Older 
adults were more likely than young adults to have taken cocaine 
powder (2% vs 0.7%), amphetamines (0.8% vs 0.4%), ecstasy 
(0.8% vs 0.7%), LSD (0.4 vs 0%) and crack (0.3% vs 0%).
Older adults (35-64 yrs) were over seven times more likely 
than young adults (15-34 yrs) to have used sedatives and/or 
tranquillisers (15% vs 2%) and over four times more likely to 
have used anti-depressants (17% vs 4%).
Belfast Health and Social Care Trust (BHSCT) 
– Comparison 2006/7–2010/11
The BHSCT was established since the last survey and therefore it 
is not possible to make statistical comparisons for this time period.
Northern Health and Social Care Trust 
(NHSCT) – Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey are presented in Table 3.1  
and show that over one fifth (22%) of respondents had used  
an illegal drug at least once.
Drug type
Cannabis was the most reported illegal drug with almost one 
fifth of respondents (19%) reporting having ever used this drug. 
This was followed by amphetamines, ecstasy and poppers (each 
6%), cocaine and LSD (each 5%), magic mushrooms (4%), 
solvents (3%), mephedrone, anabolic steroids and legal highs 
(each 2%), and methadone (1%). Less than 1% of respondents 
reported lifetime prevalence of crack (0.7%) and heroin (0.2%).
Over one fifth (23%) of respondents had used anti-depressants, 
20% of respondents had used sedatives and/or tranquillisers 
and 13% had used other opiates, at least once.
Gender
Males were more likely than females to report lifetime 
prevalence of illegal drugs (25% v 19%). Comparing male  
and female use for each of the illegal drugs separately, a higher 
proportion of males compared with females had taken cannabis 
at least once (23% vs 15%). Males were over three times 
more likely to have taken LSD than females (7% vs 2%). The 
prevalence rates for the majority of other illegal drugs were 
similar for males and females.
In contrast, more females than males stated lifetime prevalence 
for the following drugs: anti-depressants (32% vs 13%), 
sedatives and/or tranquillisers (25% vs 14%), and other opiates 
(16% vs 11%).
Age
Young adults (15-34 yrs) were twice as likely as older adults 
(35-64 yrs) to have used illegal drugs at least once (32% vs 
16%). This was also true for cannabis use (28% vs 13%). 
Young adults were also more likely than older adults to have 
used the following drugs: poppers (12% vs 3%), ecstasy  
(11% vs 3%), amphetamines (10% vs 4%), cocaine powder 
(9% vs 1%) and magic mushrooms (7% vs 2%).
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Older adults (35-64 yrs) were more likely than younger adults 
(15-34 yrs) to have taken anti-depressants (28% vs 15%), 
sedatives and/or tranquillisers (25% vs 12%) and other opiates 
(16% vs 10%).
No young adults (15-34 yrs) reported lifetime use of heroin 
compared with 0.3% of older adults (35-64 yrs). On the other 
hand, no older adults reported use of legal highs compared with 
5% of young adults.
Northern Health and Social Care Trust 
(NHSCT) – Last Year Prevalence (Recent Use)
Table 3.2 shows the overall prevalence rate for last year for illegal 
drugs was 5% in the NHSCT.
Drug type
Cannabis was the most frequently used drug in the past year 
(3%). This was followed by cocaine powder, amphetamines  
and ecstasy (each 1%).
No respondents reported having used heroin, crack, LSD,  
or solvents in the year prior to the survey being carried out.
Twelve percent of respondents reported using anti-depressants, 
10% reported use of sedatives and/or tranquillisers and 5% 
reported use of other opiates.
Gender
Males were twice as likely as females to have used illegal 
drugs recently (6% vs 3%). In relation to individual drugs, the 
proportions taken by males and females were similar. However, 
while there was last year prevalence reported by males for the 
following drugs there was no female prevalence – mephedrone 
(2%), methadone (1%), magic mushrooms and poppers (each 
0.3%).
Females were over three times more likely than males to have 
used anti-depressants (19% vs 6%) and twice as likely to have 
used sedatives and/or tranquillisers (14% vs 7%) in the past 
year. There were similar last year prevalence rates for other 
opiates for females and males (6% vs 4%).
Age
Young adults (15-34 yrs) were over twice as likely as older adults 
(35-64 yrs) to have used an illegal drug in the past year (7% 
vs 3%). In relation to cannabis, young adults were five times 
more likely to have used this drug compared with older adults 
(5% vs 1%). Although there was low usage recorded for cocaine 
and ecstasy, younger adults were more likely to have used 
these drugs than older adults (each 2% vs 0.3%). Over 1% 
of younger adults reported taking mephedrone compared with 
0.3% of older adults.
While no young adults reported having taken magic mushrooms 
and poppers, a small proportion of older adults reported having 
taken these drugs (each 0.3%). Conversely, while no older 
adults had taken legal highs, 1% of younger adults reported 
having taken these drugs.
Older adults compared with young adults reported higher last 
year prevalence for anti-depressants (15% vs 7%) and sedatives 
and/or tranquillisers (14% vs 5%). The same proportions of 
young and older adults had used other opiates (5%).
Northern Health and Social Care Trust 
(NHSCT) – Last Month Prevalence  
(Current Use)
Table 3.3 shows that the overall prevalence rates for last month 
usage of any illegal drugs was 2% for NHSCT.
Drug use
With the exception of cannabis which had a prevalence rate of 
1%, all other illegal drug categories had a prevalence rate of 
less than 1%. No respondents reported having taken heroin, 
methadone, crack, LSD, magic mushrooms, solvents, poppers, 
mephedrone or legal highs during the last month.
A tenth of respondents (10%) reported current use of anti-
depressants and 7% of respondents reported current use of 
sedatives and/or tranquillisers. Two percent of respondents 
reported using other opiates during the last month.
Gender
Males were three times more likely to take any illegal drug than 
females (3% vs 1%). Two percent of males reported taking 
cannabis compared with 0.3% of females. Less than 1% of 
male respondents had taken ecstasy or cocaine (0.7% each) 
compared with no females. The proportions of males and 
females were similar for all other illegal drug categories for last 
month drug prevalence.
Females were three times more likely to take anti-depressants 
(15% vs 5%) than males during the last month. A higher 
proportion of females than males had also taken sedatives and/
or tranquillisers (9% vs 5%) and other opiates (4% vs 1%).
Age
Young adults were three times as likely as older adults to have 
taken drugs in the month prior to the survey being completed 
(3% vs 1%).
While there was no recorded use by older adults (35-64 yrs), 
there was recorded use by younger adults (15-34 yrs) for the 
following drugs in the last month – cocaine powder and ecstasy 
(each 0.9%). In contrast, older adults reported using anabolic 
steroids (0.6%) while there was no reported use by young 
adults.
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Similar proportions of young adults compared with older adults 
had taken amphetamines during the past month (0.8% vs 0.6%).
A higher proportion of older adults than young adults reported 
current use of anti-depressants (12% vs 6%). This was also true 
in relation to sedatives and/or tranquillisers (10% vs 3%).
Northern Health and Social Care Trust 
(NHSCT) – Comparison 2006/7–2010/11
Any illegal drugs
There were no significant changes recorded in relation to 
lifetime, last year or last month use of any illegal drugs among 
adults between 2006/7 and 2010/11.
There were also no significant changes in relation to gender  
or age for any of the time periods.
Cannabis
In relation to last year prevalence, there was a significant 
decrease with regards to cannabis use for all adults (-3.5 
percentage points) from 2006/7 to 2010/11.
There were no significant changes in relation to lifetime or last 
month usage.
Cocaine
No significant changes in lifetime, last year or last month use  
of cocaine since 2006/7 were recorded.
Sedatives, tranquillisers and anti-depressants
With regards to anti-depressants, there was a significant increase 
of 5.7 percentage points for last year prevalence between 
2006/7 and 2010/11 for older adults (35-64 yrs). There were 
no significant changes for all adults in relation to lifetime or 
last month prevalence for anti-depressants for this time period. 
However, there was a significant increase (+7.6 percentage 
points) for last year usage for females (15-64 yrs).
Since 2006/7, there were no significant changes in lifetime,  
last year or last month use of sedatives and/or tranquillisers.
Other opiates
There were significant lifetime changes in relation to other 
opiates between 2006/7 and 2010/11. For lifetime prevalence 
for all adults (15-64 yrs) there was a decrease of 6.8 percentage 
points. This trend was also true for older adults (35-64 yrs) for 
lifetime prevalence for this time period (-7.3 percentage points).
In relation to all females (15-64 yrs) for lifetime usage, there 
was a significant decrease of -9.4 percentage points.
There were no significant changes in relation to last year or last 
month usage for other opiates.
Other significant changes
There was a statistically significant change of +1.2 percentage 
points in lifetime use of methadone for all adults (15-64 yrs).
For older adults (35-64), there was a significant increase in the 
lifetime use of solvents (+2.2 percentage points).
South Eastern Health and Social Care Trust 
(SEHSCT) – Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey are presented in Table 4.1 and 
show that almost one third (31%) of respondents had used an 
illegal drug at least once.
Drug use
The main drug which respondents had used at least once was 
cannabis (27%). Other illegal drugs used were: poppers (12%), 
ecstasy (11%), magic mushrooms (8%), LSD and cocaine (each 
7%), amphetamines (6%), solvents (4%), legal highs (3%), 
mephedrone (2%), crack (0.8%) and methadone (0.5%). No 
respondents reported taking heroin.
Almost one quarter of respondents reported using anti-depressants 
(24%) and the same proportion reported using sedatives and/
or tranquillisers (24%). The proportion of respondents who had 
lifetime prevalence for other opiates was 22%.
Gender
Males were more likely than females to have lifetime prevalence 
of any illegal drug (36% vs 27%). Cannabis was the drug that 
was used most frequently and a higher proportion of males than 
females reported having used this drug (32% vs 23%). Males 
were also over four times more likely than females to have taken 
magic mushrooms (13% vs 3%) at least once.
A higher proportion of males than females were more likely to 
have taken the following drugs – poppers (15% vs 9%), LSD 
(10% vs 5%), cocaine powder (9% vs 5%), amphetamines 
(8% vs 4%) and legal highs (5% vs 2%). While males reported 
the use of mephedrone (5%), no females reported the use of 
this drug.
A similar proportion of females and males reported having taken 
solvents (5% vs 4%).
Females were more likely than males to have used the following 
drugs at least once – anti-depressants (32% vs 16%) and 
sedatives and/or tranquillisers (26% vs 22%). The same 
proportion of males and females (22%) reported lifetime 
prevalence of other opiates.
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Age
A higher proportion of young adults (15-34 yrs) than older adults 
(35-64 yrs) had lifetime prevalence of illegal drugs (42% vs 
24%). This was true for a high proportion of drug categories – 
cannabis (37% vs 21%), poppers (19% vs 7%), ecstasy (19% 
vs 6%), cocaine (12% vs 4%), magic mushrooms (11% vs 
6%), amphetamines (9% vs 4%) and solvents (6% vs 3%).
In particular, young adults (15-34 yrs) were seven times more 
likely than older adults (35-64 yrs) to have taken legal highs 
(7% vs 1%). While young adults had taken mephedrone (6%) 
and methadone (1%), older adults did not report having taken 
these drugs.
The same proportion of young (15-34 yrs) and older adults  
(35-64 yrs) had taken LSD (7%).
In terms of lifetime prevalence, older adults were more likely 
than young adults to have taken anti-depressants (29% vs 
17%), sedatives and/or tranquillisers (27% vs 19%), and other 
opiates (26% vs 17%).
South Eastern Health and Social Care Trust 
(SEHSCT) – Last Year Prevalence  
(Recent Use)
Table 4.2 shows the overall prevalence rate for last year for illegal 
drugs was 6% in the SEHSCT.
Drug Use
In the year prior to the survey being carried out, cannabis was 
the main drug that people reported using (5%). A smaller 
proportion of respondents reported using the following drugs – 
cocaine powder (2%), and amphetamines and anabolic steroids 
(each 1%). The remaining illegal drugs had a prevalence rate of 
less than 1% – mephedrone (0.7%), LSD, magic mushrooms 
and poppers (each 0.6%), crack (0.5%), methadone (0.3%) 
and solvents (0.2%).
Thirteen percent of respondents had taken anti-depressants, 
while 11% had taken sedatives and/or tranquillisers and 9%  
had taken other opiates during the last year.
Gender
Males were over three times more likely to take illegal drugs 
than females (10% vs 3%). This was true in the vast majority of 
illegal drug categories. In relation to cannabis, when males were 
compared with females they were four times more likely to have 
taken the drug (8% vs 2%).
It was noted that while there was male drug prevalence in 
relation to several of the illegal drug categories, there was 
no female drug prevalence. These drugs were: ecstasy, LSD, 
poppers, solvents and mephedrone. Conversely, there was 
female prevalence and no male prevalence for methadone.
Females were more likely than males to report recent use of 
anti-depressants (16% vs 10%), while the proportion of females 
and males taking other opiates was similar (9% vs 8%). The 
same proportion of males and females had used sedatives and/
or tranquillisers (11%).
Age
Young adults (15-34 yrs) were seven times more likely (14% vs 
2%) to have taken illegal drugs than older adults (35-64 yrs). A 
higher proportion of young respondents had used illegal drugs 
than older adults in all illegal drug categories. In particular, young 
adults were eleven times more likely than older adults to have 
used cannabis (11% vs 1%).
In a high proportion of drug categories, while there was reported 
use by young adults (15-34 yrs) there was no reported use 
by older adults (35-64 yrs) – methadone, ecstasy, LSD, magic 
mushrooms, solvents, poppers, mephedrone and legal highs.
A higher proportion of older adults (15-34 yrs) compared with 
young adults (35-64 yrs) had taken anti-depressants (15% vs 
9%), sedatives and/or tranquillisers (12% vs 9%) and other 
opiates (10% vs 7%).
South Eastern Health and Social Care Trust 
(SEHSCT) – Last Month Prevalence  
(Current Use)
Table 4.3 shows that the overall prevalence rates for last month 
use of any illegal drugs was 4% for SEHSCT.
Drug Use
Four percent of respondents had used cannabis in the month 
prior to the survey being carried out. There was a prevalence 
rate of less than 1% for all other illegal drug categories, of which 
cocaine powder (0.8%) had the highest rate.
Over one in ten respondents (11%) had used anti-depressants, 
9% had used sedatives and/or tranquillisers and 5% had used 
other opiates during the last month.
There was no reported use for the following drugs in the month 
preceding the survey – heroin, methadone, crack, ecstasy, LSD, 
magic mushrooms, poppers or mephedrone.
Gender
Males were seven times more likely than females to have used 
an illegal drug (7% vs 1%). In all illegal drug categories, the 
proportion of males having used the drug was higher than for 
females.
While there was reported drug use for males in relation to 
cocaine powder, amphetamines and solvents, there was no 
reported use for females.
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More females than males reported current use of anti-
depressants (14% vs 9%), while similar proportions of males 
and females reported current use of sedatives and anti-
depressants (9% vs 8%). The same proportion of males and 
females (5%) used other opiates during the previous month.
Age
Young adults (15-34 yrs) were eight times more likely than older 
adults (35-64 yrs) to have used illegal drugs (8% vs 1%). This 
was also true of cannabis (8% vs 1%). While there were lesser 
prevalence levels of the following drugs, young adults were 
also more likely to have used these drugs than older adults – 
cocaine powder, solvents, anabolic steroids and legal highs. On 
the other hand, while there was reported older adult usage of 
amphetamines (0.3%), there was no reported young adult usage.
In terms of lifetime prevalence, older adults (35-64 yrs) were 
more likely than young adults (15-34 yrs) to have taken anti-
depressants (14% vs 8%), sedatives and/or tranquillisers (10% 
vs 7%) and other opiates (7% vs 3%).
South Eastern Health and Social Care Trust 
(SEHSCT) – Comparison 2006/7–2010/11
The SEHSCT was established since the last survey and therefore 
it is not possible to make statistical comparisons for this time 
period.
Southern Health and Social Care Trust 
(SHSCT) – Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey are presented in Table 5.1 and 
show that almost one quarter (23%) of respondents had used 
an illegal drug at least once.
Drug use
Over one fifth (21%) of those surveyed had used cannabis at 
least once. This was followed by ecstasy (5%), poppers (4%), 
magic mushrooms, amphetamines, and cocaine powder (each 
3%), LSD and solvents (each 2%). The remaining illegal drug 
categories had a prevalence rate of 1% or less.
Lifetime prevalence was 20% for anti-depressants, 17% for 
sedatives and/or tranquillisers and 11% for other opiates.
Gender
Over one quarter of males (29%) had lifetime prevalence 
for illegal drugs compared with 17% of females. More males 
than females reported lifetime prevalence of most illegal drug 
categories. In particular, 26% of males and 16% of females 
reported lifetime use of cannabis.
There were also variations between the proportion of males and 
females in relation to drugs where there were lesser prevalence 
levels. These were for: magic mushrooms (6% vs 1%), ecstasy 
(8% vs 3%) and cocaine powder (4% vs 1%). While there was 
a lifetime drug prevalence rate of 0.4% for crack for males, no 
females had used the drug.
More female respondents than male respondents had used 
anti-depressants (24% vs 16%), sedatives and/or tranquillisers 
(20% vs 15%), and other opiates (13% vs 9%).
Age
Young adults (15-34 yrs) were almost twice as likely (31% vs 
17%) to report the usage of illegal drugs than older adults (35-
64 yrs). This was true for all almost all illegal drug categories, the 
exception being magic mushrooms, where 4% of older adults 
reported lifetime usage compared with 3% of young adults.
Young adults (15-34 yrs) who reported lifetime prevalence of 
cocaine were five times more likely (5% vs 1%) to have used 
the drug than older adults (35-64 yrs). Similarly, young adults 
were over four times as likely to have used ecstasy as older 
adults (9% vs 2%).
While 2% of young adults (15-34 yrs) had used methadone at 
least once, no older adults (35-64 yrs) had used this drug.
A higher proportion of older adults (15-34 yrs) than young adults 
(35-64 yrs) had used anti-depressants (29% vs 8%), sedatives and/
or tranquillisers (24% vs 9%), and other opiates (13% vs 8%).
Southern Health and Social Care Trust 
(SHSCT) – Last Year Prevalence (Recent Use)
Table 5.2 shows the overall prevalence rate for last year for illegal 
drugs was 5% in the SHSCT.
Any drugs
Four percent of respondents reported recent use of cannabis. In 
all the remaining drug categories, the prevalence rate was under 
1%. In particular, there was no reported use of the following 
drugs – heroin, crack, LSD, magic mushrooms or solvents.
Lifetime prevalence was 11% for anti-depressants, 11% for 
sedatives and/or tranquillisers and 5% for other opiates.
Gender
Seven percent of males reported last year prevalence for illegal 
drugs compared with 3% of females. In relation to cannabis, 
this represented 5% of males compared with 2% of females. 
In relation to other illegal drug categories, there was a higher 
proportion of male respondents who had used illegal drugs 
within the last year compared with female respondents. In 
particular, while male respondents had used cocaine powder 
(0.4%) and ecstasy (0.6%), no female respondents had used 
these drugs in the past year.
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A higher proportion of females had used anabolic steroids within 
the past year than males (1% vs 0.4%).
There were similar levels of use for males and females for anti-
depressants (10% vs 12%) and sedatives and/or tranquillisers 
(10% vs 12%) and other opiates (4% vs 6%).
Age
Young adults (15-34 yrs) were over four times more likely (9% 
vs 2%) to have taken illegal drugs compared with older adults 
(35-64 yrs). In relation to cannabis, young adults were six times 
more likely to use this drug than older adults (6% vs 1%). Young 
respondents had used legal highs (2%) and methadone (1%); 
no older adults reported using these drugs. Conversely, older 
adults reported using cocaine (0.4%) in the past year, while no 
younger adults reported using these drugs. The proportions of 
young and older adults who used other illegal drugs were similar 
for this timeframe.
Older adults (35-64 yrs) were more likely than young adults  
(15-34 yrs) to have used anti-depressants (17% vs 4%), 
sedatives and/or tranquillisers (15% vs 5%) and other opiates 
(7% vs 2%).
Southern Health and Social Care Trust 
(SHSCT) – Last Month Prevalence  
(Current Use)
Last month prevalence for illegal drugs was 1% in the SHSCT 
(Table 5.3).
Any drugs
Cannabis (1%) was the main illegal drug that respondents 
reported using. This was followed by mephedrone and legal 
highs (each 0.3%), and poppers (0.2%). There was no other 
reported drug usage for any of the other illegal drug categories.
Less than 1% of respondents had used anabolic steroids (0.3%).
One in ten respondents (10%) had used anti-depressants, while 
8% of respondents had used sedatives and/or tranquillisers and 
3% had used other opiates during the last month.
Gender
Over twice as many males compared with females had 
used illegal drugs during the previous month (2% vs 0.7%). 
Similar proportions of males and females had used cannabis 
(1% vs 0.7%). While there was reported usage by males of 
mephedrone and legal highs (each 0.6%), and poppers (0.4%), 
there was no reported female usage.
A similar proportion of males and females had used anabolic 
steroids (0.4% vs 0.3%).
The same proportion of males and females had used sedatives 
and/or tranquillisers (each 8%), while a similar proportion of  
males and females had used anti-depressants (10% vs 11%). 
Females were twice as likely as males to have used other opiates 
(4% vs 2%).
Age
Young adults (15-34 yrs) were more likely than older adults 
(35-64 yrs) to have used an illegal drug (2% vs 1%). A similar 
proportion of males and females used cannabis during the 
previous month (each 1%). Young adults reported use of 
poppers (0.5%), and mephedrone and legal highs (each 0.7%), 
while older adult respondents did not.
Older adults (35-64 yrs) reported usage of anabolic steroids 
(0.6%) while young adults (15-34 yrs) did not.
In the past month, older adults (35-64 yrs) were over eight 
times more likely (17% vs 2%) to have taken anti-depressants 
than younger adults (15-34 yrs) and six times more likely  
to have used sedatives and/or tranquillisers (12% vs 2%).  
A higher proportion of older adults (35-64 yrs) than young 
adults (15-34 yrs) had also used other opiates (4% vs 2%).
Southern Health and Social Care Trust 
(SHSCT) – Comparison 2006/7–2010/11
Any illegal drugs
There were no significant changes recorded for lifetime, last 
year or last month use of illegal drugs among adults (15-64 yrs) 
between 2006/7 and 2010/11. However, there was a significant 
change in relation to last month usage of illegal drugs for all 
adults (-2.6 percentage points). This trend was also true for 
young adults (15-34 yrs) where there was a change of  
-6.9 percentage points between these years.
The proportion of males (15-64 yrs) who had used illegal drugs 
during the past month decreased by 4.0 percentage points 
between 2006/7 and 2010/11.
Cannabis
There were no significant changes in relation to lifetime 
prevalence of cannabis between 2006/7 and 2010/11.
In relation to last year prevalence, there was a significant change 
when all adults were compared between 2006/7 and 2010/11 
(-3.6 percentage points). When all male respondents of this 
age group were compared for these years, there was also a 
significant change for recent drug use (-5.1 percentage points).
There was a significant decrease in relation to last year use of 
cannabis for young respondents (15-34 yrs) between 2006/7 
and 2010/11 (-6.6 percentage points).
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With regards to last month usage of cannabis, there was a 
significant decrease of 2.5 percentage points for all adults  
(15-64 yrs), between 2006/07 and 2010/11. There was also 
a significant decrease (-3.8 percentage points) for males of this 
age group for last month prevalence.
Current usage for young adults (15-34 yrs) decreased 6.7 
percentage points between 2006/7 and 2010/11.
Cocaine
No significant changes in lifetime, last year or last month use  
of cocaine since 2006/7 were recorded.
Sedatives, tranquillisers and anti-depressants
With regards to sedatives and/or tranquillisers, there were no 
significant changes in relation to lifetime prevalence of these 
drugs between 2006/7 and 2010/11.
There were significant changes in relation to last year prevalence 
for sedatives and/or tranquillisers. For all adults (15-64 yrs), 
there was an increase of 3.9 percentage points between  
2006/7 and 2010/11. In particular, this was true of older adults  
(35-64 yrs), where there was an increase of 5.6 percentage 
points between these time frames.
In relation to males (15-64 yrs) and last year usage of sedatives 
and/or tranquillisers, the difference in proportions between 
2006/7 and 2010/11 was +5.0 percentage points. This trend 
was also found in relation to last month prevalence for males 
(15-64 yrs) and usage of sedatives and/or tranquillisers where 
there was an increase of 5.1 percentage points.
There was a significant increase (+5.1 percentage points) for 
older adults (35-64 yrs) in relation to an increase in last month 
prevalence rates for sedatives and/or tranquillisers.
Between 2006/7 and 2010/11, there was a significant change 
(+7.5 percentage points) for older adults (35-64 yrs) who had 
lifetime prevalence for anti-depressant usage. This was also found 
for last year usage (+7.8 percentage points) and last month usage 
(+9.5 percentage points) for this age group and time period.
Conversely, the proportion of young adults (15-34 yrs) who had 
used anti-depressants showed a decrease for last year usage 
(-6.1 percentage points) and last month usage (-6.0 percentage 
points) between 2006/7 and 2010/11.
In relation to last month anti-depressant usage by all adult males 
(15-64 yrs), there was a significant increase of 6.0 percentage 
points between 2006/7 and 2010/11.
Other opiates
There were no significant changes in relation to lifetime, last year 
or last month prevalence of other opiates between 2006/7 and 
2010/11.
Other significant changes
There were no significant changes for lifetime, last year or last 
month usage for any of the other drug categories between 
2006/7 and 2010/11.
Western Health and Social Care Trust 
(WHSCT) – Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey are presented in Table 6.1  
and show that over one fifth (21%) of respondents had used  
an illegal drug at least once.
Any drugs
A fifth of respondents (20%) reported taking cannabis. This 
was followed by ecstasy (6%), poppers and cocaine powder 
(each 5%), magic mushrooms and amphetamines (each 4%), 
solvents 3%, LSD, legal highs, mephedrone and methadone 
(each 2%). Less than 1% of respondents had used heroin 
(0.3%) and no respondents had used crack.
Almost one fifth of respondents (19%) had used anti-
depressants, while 15% of respondents had used sedatives and/
or tranquillisers and 9% of respondents had used other opiates.
Gender
Twice as many males as females had used an illegal drug at least 
once (28% vs 14%). Over one quarter of male respondents 
(27%) had used cannabis compared with 14% of female 
respondents. Females were twice as likely as males to have 
taken solvents (4% vs 2%). With the exception of these, there 
was a higher prevalence of males than females for the remaining 
drug categories. While 5% of males had used legal highs, there 
was no reported use by females of these drugs.
Less than 1% of males had used anabolic steroids (0.7%);  
there were no female respondents who had used these drugs.
Females were more likely than males to have used anti-
depressants (24% vs 14%), sedatives and/or tranquillisers  
(18% vs 13%) and other opiates (11% vs 7%).
Age
Young adults (15-34 yrs) were more than twice as likely as 
older adults (35-64 yrs) to have lifetime prevalence of illegal 
drugs (31% vs 13%). In the majority of drug categories, young 
males were more likely than older adults to have used illegal 
drugs. Twenty nine percent of young adults had used cannabis 
compared with 13% of older adults.
The most common illegal drugs used by young adults (15-34 
yrs) were ecstasy (12%), cocaine powder and poppers (each 
9%), magic mushrooms (8%), and amphetamines (7%). 
These drugs also represented the highest proportions for older 
adults (35-64 yrs), each of these drugs representing 2% of 
respondents. Six percent of young respondents had taken 
solvents compared with 1% of older adults.
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No young adults (15-34 yrs) had taken heroin while 0.5% of 
older adults (35-64 yrs) reported doing so. Older adults also 
reported the use of anabolic steroids (0.6%), whereas no young 
adults reported using these drugs.
A higher proportion of older respondents (15-34 yrs) than 
young respondents (35-64 yrs) took anti-depressants (23% 
vs 13%) and sedatives and/or tranquillisers (19% vs 10%). 
Similar proportions of young adult respondents and older adult 
respondents had taken other opiates (10% vs 8%).
Western Health and Social Care Trust 
(WHSCT) – Last Year Prevalence (Recent Use)
Table 6.2 shows that the last year prevalence rate for illegal 
drugs was 7% in the WHSCT.
Any drugs
Six percent of respondents reported recent use of cannabis. 
Smaller proportions of adults had taken other illegal drugs. 
Respondents reported using ecstasy (2%) and mephedrone  
and cocaine powder (each 1%).
Less than 1% of those surveyed had taken poppers (0.8%)  
and solvents and methadone (each 0.3%).
No respondents had used the following drugs in the past year – 
heroin, crack, LSD or magic mushrooms.
Less than 1% of respondents had used anabolic steroids 
(0.4%).
Over one tenth (11%) of respondents had taken anti-
depressants and 9% had taken sedatives and/or tranquillisers. A 
smaller proportion of respondents had taken other opiates (3%).
Gender
Males were over three times more likely to have taken an illegal 
drug in the past year than females (10% vs 3%). In relation to 
cannabis, males were more than five times more likely to use this 
drug than females (10% vs 2%). Ecstasy and solvents were the 
only other illegal drugs that females had used in the past year.
Less than 1% of male respondents (0.7%) had used anabolic 
steroids whereas no females had used these drugs.
Thirteen percent of female respondents had used anti-
depressants compared with 8% of male respondents and 
11% of females and 8% of males had taken sedatives and/or 
tranquillisers. The proportions of males and females who had 
taken other opiates were similar (2% vs 3%).
Age
Young adults (15-34 yrs) were six times more likely than older 
adults (35-64 yrs) to have taken an illegal drug in the past year 
(12% vs 2%). Regarding all illegal drugs categories, young adults 
were more likely than older adults to have used drugs.
While young adults (15-34 yrs) had taken mephedrone and legal 
highs (each 3%), amphetamines (1%) and methadone (0.8%), 
older adults (35-64 yrs) did not report the use of these drugs.
Conversely, older adults (35-64 yrs) reported having taken 
anabolic steroids (0.6%), while young adults (15-34 yrs) did  
not report last year prevalence for these drugs.
A higher proportion of older adults (35-64 yrs) compared with 
young adults (15-34 yrs) reported taking anti-depressants (13% 
vs 8%) and sedatives and/or tranquillisers (12% vs 7%). The 
same proportion of young and older adults had used other 
opiates (3%).
Western Health and Social Care Trust 
(WHSCT) – Last Month Prevalence  
(Current Use)
Last month prevalence for illegal drugs was 3% in the WHSCT 
(Table 6.3).
Any drugs
Three percent of respondents reported use of cannabis in 
the last month. Usage of other illegal drug categories was 
less than 1% – ecstasy (0.5%) and cocaine powder (0.2%). 
No respondents had used the following drugs: heroin, crack, 
methadone, amphetamines, LSD, magic mushrooms, solvents, 
poppers, mephedrone or legal highs.
A small proportion of respondents had used anabolic steroids 
(0.2%).
Nine percent of respondents had used anti-depressants and 
8% of respondents had used sedatives and/or tranquillisers. A 
smaller proportion of respondents had used other opiates (2%).
Gender
Males were approximately six times more likely than females to 
have used illegal drugs in the last month (6% vs 1%). The same 
proportion of males to females had used cannabis (6% vs 1%). 
No female respondents had used any other illegal drug type. The 
remaining usage for males was under 1% – ecstasy (0.9%) and 
cocaine (0.5%).
A similar proportion of males had used anabolic steroids (0.4%). 
No females had used these drugs.
Higher proportions of females than males had used anti-
depressants (12% vs 7%) and sedatives and/or tranquillisers 
(9% vs 6%). More males than females had used other opiates 
(2% vs 1%).
Age
Young adults (15-34 yrs) were more likely than older adults  
(35-64 yrs) to have used any illegal drugs (6% vs 1%); the 
same proportions having used cannabis.
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Young adults (15-34 yrs) had used ecstasy (1%) and cocaine 
powder (0.5%), while older adults (35-64 yrs) had not.
Older adults (35-64 yrs) had used anabolic steroids (0.4%) 
while young adults (15-34 yrs) had not.
Higher proportions of older adults (35-64 yrs) than young 
adults (15-34 yrs) had used anti-depressants (12% vs 5%) and 
sedatives and/or tranquillisers (9% vs 6%). The same proportion 
of young and older adults had used other opiates (2%).
Western Health and Social Care Trust 
(WHSCT) – Comparison 2006/7–2010/11
Any illegal drugs
There were no significant changes recorded for lifetime, last year 
or last month usage of any illegal drugs among adults between 
2006/7 and 2010/11.
There were also no significant changes in relation to gender or 
age for any of the time periods.
Cannabis
There were no significant changes for lifetime or last year 
prevalence of cannabis between 2006/7 and 2010/11. 
However, there was a significant change in last month prevalence 
for this drug. In relation to all adults (15-64 yrs), there was an 
increase of 2.3 percentage points for current use of cannabis. 
For those adults aged 15-34 years, there was an increase of 5.2 
percentage points in relation to usage of this drug.
Adult males (15-64 yrs) were significantly more likely to have 
taken cannabis during the last month in 2010/11 compared with 
2006/7 (+4.2 percentage points).
Cocaine
No significant changes in lifetime, last year or last month use  
of cocaine was recorded between 2006/7 and 2010/11.
Sedatives, tranquillisers and anti-depressants
There was a significant change (-6.3 percentage points) for older 
adults aged 35-64 years, in relation to lifetime usage of sedatives 
and/or tranquillisers between 2006/7 and 2010/11. There were 
no gender differences for this period.
There were no significant changes for last year prevalence for 
sedatives and/or tranquillisers between 2006/7 and 2010/11.
In relation to last month prevalence, there was a significant 
change (+4.2 percentage points) for young adults (15-34 yrs) 
since 2006/7. There were no gender differences for this period.
There were no significant changes recorded for lifetime, last year 
or last month use of anti-depressants among adults (15-64 yrs) 
between 2006/7 and 2010/11.
Other opiates
There was a significant change (-4.3 percentage points) for 
adults aged 15-64 years, in relation to lifetime usage of other 
opiates since 2006/7. In particular, this related to older adults 
(35-64 yrs) where there was a significant change of -9.4 
percentage points.
Similarly, in relation to usage of other opiates and last year 
prevalence of this drug category, there was a significant decrease 
of 2.9 percentage points for all adults, between 2006/7 and 
2010/11. For adults aged 35-64 years, the significant change 
was -5.1 percentage points.
In relation to last month prevalence, there was a significant 
change (-3.1 percentage points) for adults aged 35-64 years 
between 2006/7 and 2010/11.
There were no significant changes in relation to gender for 
lifetime, last year or last month prevalence of other opiates 
between 2006/7 and 2010/11.
Other significant changes
There was a significant change (+1.5 percentage points) in 
relation to lifetime usage of methadone for all adults (15-64 yrs) 
between 2006/7 and 2010/11. This was also true for males 
during this time period (+3.0 percentage points).
There were no significant changes in last year or last month  
use of other adults since 2006/7.
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Ireland – Results by Regional Drug Task Force Area (RDTF)
Prevalence rates for Ireland are given in Tables 8–18.
Map 2: Ireland – Regional Drug Task Force Areas
NWRDTF
MWRDTF
MRDTF
WRDTF
NERDTF
NRDTF
SERDTF
SRDTF
ECRDTF
SWRDTF
Drug use in Ireland and Northern Ireland 2010/11 Drug Prevalence Survey: Regional Drug Task Force (Ireland)  
and Health and Social Care Trust (Northern Ireland) Results
Drug use in Ireland and Northern Ireland 2010/11 Drug Prevalence Survey: Regional Drug Task Force (Ireland)  
and Health and Social Care Trust (Northern Ireland) Results
17National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) 2012
East Coast Regional Drug Task Force – 
Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey show that 38% of the 
population aged 15-64 years in the East Regional Drug Task 
Force region have used an illegal drug in their lifetime.
Drug Type
Cannabis use was the most common illegal drug ever used 
and 36% reported using the drug in their lifetime. Among 
other illegal drugs, lifetime prevalence was highest for magic 
mushrooms (11%), cocaine (including crack) (10%), ecstasy 
(9%), LSD and amphetamines (each 7%), poppers (5%), 
solvents (3%) and heroin (2%). Less than 1% reported having 
ever used methadone and crack.
Just over one third of all adult respondents reported ever using 
other opiates (34%). Of all adults 13% of respondents said 
they had used sedatives and/or tranquillisers and 10% of 
respondents said they had used anti-depressants at some  
point in their lives. A total of 56% reported smoking tobacco  
and 92% reported consuming alcohol during their lifetime.
Gender
Lifetime use of any illegal drug was substantially higher among 
men (44%) than women (31%). Comparing men and 
women’s lifetime use for each of the illegal drugs separately, 
the largest difference in the ratio of use between men and 
women is recorded for solvents (6% vs 0.2%). In this region 
men were at least twice as likely as women to report ever using 
amphetamines and LSD (both 9% vs 4%). Lifetime use was 
also higher for men’s use of cocaine powder (11% vs 8%)  
and cannabis (42% vs 29%)
Men were slightly more likely than women to report lifetime  
use of anti-depressants (10% vs 9%).
Women were more likely to report ever using other opiates 
(36% vs 33%) as well as ever using sedatives and/or 
tranquillisers (16% vs 10%).
Slightly higher lifetime rates were recorded among men for 
alcohol (93% vs 91%) and for tobacco (57% vs 54%).
Age
Lifetime prevalence of any illegal drug among young adults 
(aged 15-34 yrs) was higher than among older (35-64 yrs) 
adults at (43% vs 35%).
Of the illegal drugs surveyed the illegal drugs most commonly 
used on a lifetime basis by young adults (15-34 yrs) were 
cannabis (39%), ecstasy (13%), cocaine (including crack) and 
magic mushrooms (each 11%), poppers (8%), amphetamines 
(6%), LSD (5%) and solvents (4%).
Among older adults (35-64 yrs) the most common illegal drugs 
ever used were cannabis (34%), magic mushrooms (12%), 
cocaine (including crack) (10%), LSD, ecstasy and amphetamines 
(each 7%) poppers and heroin (each 3%) and solvents (2%).
Lifetime use was higher among older adults (35-64 yrs) 
than younger adults (15-34 yrs) for other opiates (37% vs 
31%), sedatives and/or tranquillisers (16% vs 8%) and anti-
depressants (14% vs 4%).
Lifetime tobacco use among older adults (35-64) was 60% 
while the corresponding figure was 49% for younger adults  
(15-34). Lifetime consumption of alcohol was slightly higher 
among the older than the younger age group (94% vs 89%)
East Coast Regional Drug Task Force – Last 
Year Prevalence (Recent Use)
The overall prevalence rate for last year use of any illegal drugs 
was 9% in the East Coast Regional Drug Task Force area.
Drug Type
With regard to recent illicit drug use, cannabis (8%) was the 
most frequently reported of the illegal drugs surveyed. This is 
followed by new psychoactive substances (6%) and cocaine 
(including crack) (3%). Less than one percent of those surveyed 
reported recent use of magic mushrooms, amphetamines, 
poppers, ecstasy, LSD, solvents, heroin and methadone.
Last year prevalence of other opiates was 26%, for sedatives 
and/or tranquillisers the rate for last year use was 6% and this 
was 5% for anti-depressants. A total of 29% of those surveyed 
reported smoking tobacco in the year prior to the survey and 
88% said they had consumed alcohol in the 12 months prior  
to the survey.
Gender
Use of any illegal drug in the 12 months prior to the survey 
was higher among men (12%) than women (6%). Men were 
almost four times more likely than women to report recent use 
of cannabis (11% vs 4%), more than three times more likely 
to report use of new psychoactive substances (9% vs 3%) and 
twice as likely to report recent use of magic mushrooms (1% 
vs 0.3%). In relation to other illegal drugs, men and women in 
this region were equally likely to report recent use of cocaine 
(including crack) (each 3%).
Women (29%) were more likely than men (23%) to report 
recent use of other opiates and sedatives and/or tranquillisers 
(6% vs 5%). More men (6%) than women (4%) reported 
recent use of anti-depressants.
Men’s tobacco use in the last year was substantially higher than 
women’s (33% vs 25%) and men were also more likely than 
women to report alcohol consumption in the last year (90%  
vs 86%).
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Age
Last year prevalence of any illegal drug among young adults 
(aged 15-34 years) was almost twice that of older adults (13% 
vs 7%). Among young adults the most frequently reported of the 
illegal drugs was cannabis (10%) followed by new psychoactive 
substances (11%). Among older adults (35-64 years) the illegal 
drugs used most in the year prior to the survey were cannabis 
(7%) followed by new psychoactive substances (3%), magic 
mushrooms, poppers and cocaine (including crack) (each 1%). 
Less than one per cent of the younger and older adults reported 
recent use of the remaining illegal drugs covered by the survey.
Last year prevalence was higher among older than younger 
adults for other opiates (27% vs 23%), sedatives and/or 
tranquillisers (8% vs 2%) and anti-depressants (7% vs 2%).
Tobacco use in the last year was higher among younger (34%) 
than older (26%) adults. There was no difference between  
the two age groups regarding recent consumption of alcohol 
(both 88%).
East Coast Regional Drug Task Force – Last 
Month Prevalence (Current Use)
Table 8.1 show that 4% of those surveyed had used an illegal 
drug in the four weeks prior to the survey.
Drug Type
In this region the most commonly used illegal drug in the month 
preceding the survey was cannabis (4%). Less than one per 
cent of respondents reported current use of the remaining illegal 
drugs covered by the survey.
Current use of other opiates was reported by 15% of 
respondents and the corresponding figure for current use of anti-
depressants was 4% and for sedatives and/or tranquillisers 2%
A total of 25% reported smoking tobacco in the last month and 
77% said they had consumed alcohol in last month.
Gender
Last month prevalence for any illegal drugs was 6% among men 
and 2% among women. Men were substantially more likely than 
women to report current use of cannabis (5% vs 1%) and men 
also reported more current use of anti-depressants (5% vs 3%).
Current use of other opiates was higher among women (18%) 
when compared to men (12%). Currently use of sedatives and/
or tranquillisers was also higher among women than men (4% 
vs 1%).
Slightly more men (28%) smoked tobacco in the month prior to 
the survey than women (22%). Current alcohol consumption was 
considerably higher among men (80%) than women (73%).
Age
Last month prevalence of using any illegal drug among younger 
adults (15-34 yrs) was 5% and greater than that of older adults 
(35-64) at 3%. Cannabis and cocaine (including crack) were 
the illegal drugs most frequently reported by both age groups. 
Among young adults cannabis the most common illegal drug 
recorded was used by 5% in the last month and 1% reported 
current use of cocaine (including crack). Fewer than 3% of older 
adults (34-65 yrs) reported cannabis use in the last month and 
cocaine (including crack) use was reported by less than 1%.
Current use was higher among older than younger adults for 
other opiates (17% vs 11%), anti-depressants (6% vs 2%) and 
sedatives and/or tranquillisers (3% vs 1%).
Tobacco use in the last month was higher among younger 
(29%) than older (23%) adults. Alcohol use in the last month 
was also higher among older (80%) than younger adults (72%).
East Coast Regional Drug Task Force – 
Comparison 2006/7–2010/11
Any illegal drugs
There were no statistically significant changes in the use of 
any illegal drug for lifetime, last year or last month prevalence 
measures since 2006/7.
Cannabis
Recent use of cannabis decreased among women since the last 
survey, dropping from 9% in 2006/7 to 4% in 2010/11 (-5.3 
percentage points). There were no other statistically significant 
changes for cannabis recorded since the last survey.
Alcohol and Tobacco
In relation to tobacco, there was a statistically significant change 
in recent use among all adults (15-64 yrs). Use of tobacco in 
the last year dropped from 39% in 2006/7 to 29% in 2010/11 
(-9.3 percentage points). The results for men and women 
examined separately shows that recent tobacco use dropped 
substantially among women in this region, falling from 36% in 
2006/7 to 25% in 2010/11 (-11.7 percentage points).
No other significant changes were recorded for use of alcohol  
or tobacco since the last survey.
Other significant changes
Since the survey in 2006/7 there has been a decrease in the 
share of adults (15-64 yrs) reporting recent use of solvents 
which was 2% in 2006/7 falling to less than 1% in 2010/11  
(-2 percentage points). This primarily reflects changes in recent 
use of ecstasy among young adults, falling from 4% in 2006/7 
to less than 1% in 2010/11 (-3.6 percentage points) and 
among men, which fell from 5% in 2006/7 to less than 1%  
in 2010/11 (-4.6 percentage points).
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No other statistically significant changes were found in drug 
prevalence since the last survey.
Midlands Regional Drug Task force – Lifetime 
Prevalence (Ever Used)
Results from the 2010/11 survey show that 19% of respondents 
had used an illegal drug in their lifetime.
Drug Type
Cannabis was the illegal drug most frequently reported for 
lifetime use; 17% said they had ever used cannabis. Nearly 5% 
reported ever using magic mushrooms, 4% cocaine (including 
crack), 3% said they had used poppers, ecstasy and LSD and 
1% reported using solvents at some point in their lives. Less 
than 1% said they had used heroin, methadone and crack in 
their lifetime.
With regard to lifetime use of prescription and over-the-counter 
medicines, 37% reported using other opiates, 12% used 
sedatives and/or tranquillisers and 9% had used anti-depressants 
in their lives. Nearly 53% had ever smoked tobacco and 90% 
had consumed alcohol at some point in their lives.
Gender
Lifetime use of illegal drugs was higher among males with 25% 
of men and 14% of women reporting use of any of the illegal 
drugs in their lifetime. Men were three times as likely to use 
cocaine (including crack) (6% vs 2%) and at least twice as 
likely to use magic mushrooms (7% vs 3%), LSD (4% vs 2%), 
solvents (2% vs 0.3%) and poppers (4% vs 2%). Men (22%) 
were also more likely to report use of cannabis than women 
(13%) while use of amphetamines was equally likely to be 
reported by men and women at 2%.
Women’s lifetime use of drugs was higher than men’s for other 
opiates (46% vs 27%), sedatives and/or tranquillisers (14% vs 
10%) and anti-depressants (14% vs 5%).
In this region men were more likely to report lifetime use of 
tobacco (62% vs 43%) and alcohol (92% vs 86%).
Age
Lifetime prevalence of any illegal drug was 25% among young 
adults (15-34 yrs) and 15% among older adults (35-64 yrs). The 
illegal drugs most commonly used by young adults were cannabis 
(23%), poppers, ecstasy and cocaine (including crack) (each 5%), 
LSD (4%) and amphetamines (3%). Less than one per cent of 
young adults reported use of crack, heroin or methadone.
Among older adults cannabis was the most frequently 
reported illegal drug (14%) for lifetime use followed by magic 
mushrooms and cocaine (including crack) (each 4%), LSD 
and poppers (each 2%), heroin and ecstasy (each 1%). Less 
than one per cent of older adults said they had used crack, 
methadone or solvents.
Older adults were more likely than younger adults to report use 
of other opiates (40% vs 32%), sedatives and/or tranquillisers 
(17% vs 6%) and anti-depressants (13% vs 8%). Lifetime use 
of tobacco was also higher among older (54%) than younger 
(51%) adults while lifetime alcohol was higher among younger 
adults (91% vs 88%).
Midlands Regional Drug Task force – Last 
Year Prevalence (Recent Use)
Results from the 2010/11 survey show that 5% of respondents 
in the Midlands Regional Drug Task Force area reported use of 
an illegal drug in the year prior to the survey.
Drug Type
In relation to recent use the most commonly reported illegal 
drug was cannabis (4%), followed by new psychoactive 
substances (3%). Less than 1% of respondents reported  
recent use of the remaining illegal drugs surveyed.
In this region 25% reported recent use of other opiates. Recent 
use of sedatives and/or tranquillisers and Anti-depressants were 
very close at 5%, respectively.
In relation to recent tobacco 29% reported smoking tobacco  
and 85% reported consuming alcohol in the last year.
Gender
Recent use of illegal drugs was higher among males with 7% of 
men and 2% of women reporting use of any of the illegal drugs 
in the last year. Men were much more likely than women to use 
cannabis (7% vs 2%). There are hardly any differences between 
men and women in relation to recent use of ecstasy, LSD, 
magic mushrooms, solvents, amphetamines, cocaine powder, 
methadone and poppers, use of which are all close to zero for 
men and women alike.
Last year prevalence for women was higher than for men for 
other opiates (31% vs 20%), sedatives and/or tranquillisers  
(7% vs 4%) and anti-depressants (6% vs 3%).
Men were more likely to report recent use of tobacco (34% vs 
25%) and alcohol (87% vs 84%).
Age
Use of any illegal drug in the year prior to the survey was 
reported by 9% of young adults (15-34 yrs) and almost 2% 
of older adults (35-64 yrs). Among younger adults the most 
commonly used illegal drugs in the last year were cannabis (8%) 
and new psychoactive substances (6%). Among older adults 
cannabis was also the most frequently reported drug used in the 
last year (2%) and again this was followed by new psychoactive 
substances (3%) for older adults’ last year use. In both age 
groups less than one percent of respondents reported last year 
use of the other illegal drugs surveyed.
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Older adults were more likely than younger adults to report 
recent use of other opiates (27% vs 23%), sedatives and/or 
tranquillisers (7% vs 3%) and anti-depressants (6% vs 3%). 
Recent use of tobacco was higher among younger adults (36%) 
than older adults (24%) and alcohol consumption in the last 
year was also higher among younger adults (90% vs 82%).
Midlands Regional Drug Task force – Last 
Month Prevalence (Current Use)
Just over 2% of respondents had used an illegal drug in the  
last month.
Drug Type
Cannabis (2%) was the most frequently reported of the illegal drugs 
in the month prior to the survey. Less than 1% of respondents 
reported current use of the other illegal drugs surveyed.
In Midlands RDTF, 11% reported current use of other opiates, 
4% reported current use of anti-depressants and 3% reported 
current use of sedatives and/or tranquillisers.
In relation to smoking tobacco, 25% had done so in the last 
month and 70% reported drinking alcohol in the last month.
Gender
Current use of illegal drugs was higher among men (3%) than 
women (1%). Last month prevalence of cannabis was higher 
for men than women (3% vs 1%). For the prevalence of the 
remaining illegal drugs, men and women differed little in terms 
of their current use, with rates of last month use close to zero  
for each of the illegal drugs.
Last month prevalence was higher for women for other opiates 
(18% vs 5%), anti-depressants (6% vs 3%) and sedatives and/
or tranquillisers (4% vs 2%).
In this region men were more likely to report last month use of 
tobacco (30% vs 19%) and alcohol (74% vs 65%).
Age
Last month prevalence of any illegal drug was 5% among 
young adults (15-34 yrs) and less than 1% among older adults 
(35-64 yrs). The most commonly illegal drug among younger 
adults was cannabis (4%) followed by cocaine (including crack) 
(1%). Among older adults, cannabis was marginally the most 
commonly reported illegal drug used in the last month (0.4%). 
Use of each of the remaining illegal drugs among younger and 
older adults, was less than 1%.
Older adults were more likely than younger adults to report current 
use of other opiates (13% vs 10%), sedatives and/or tranquillisers 
(4% vs 2%) and anti-depressants (5% vs 3%). Use of tobacco 
in the last month was higher among younger (30%) than older 
adults (21%). Alcohol consumption in the last month was also 
higher among younger (71%) than older adults (69%).
Midlands Regional Drug Task Force – 
Comparison 2006/7–2010/11
Any illegal drugs
Since the last survey in 2006/7 no statistically significant changes 
were recorded in lifetime, last year or last month prevalence 
of any of the illegal drugs surveyed. Changes were also not 
recorded in any of the prevalence measures for sedatives and/or 
tranquillisers or anti-depressants in this region.
Alcohol and Tobacco
The prevalence of tobacco decreased among women since the 
last survey and this applies to lifetime (-13.2 percentage points), 
last year (-13.9 percentage points) and last month (-16.3 
percentage points). Last month tobacco use also decreased 
among older adults (-13.6 percentage points).
No other statistically significant changes were found in drug 
prevalence since the last survey.
Mid-Western Regional Drug Task force – 
Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey show that among all adults 
(15-64 yrs) almost 19% reported having ever used an illegal 
drug.
Drug Type
Cannabis was drug most commonly used by all adults (15-64 
yrs); 18% said they had ever used cannabis and nearly 5% 
said they had ever used cocaine (including crack) and 5% also 
reported ever using ecstasy. Just under 4% reported ever using 
amphetamines, followed by 3% for LSD and magic mushrooms, 
respectively. Among all adults, 2% reported ever using poppers 
or solvents, respectively. Less than 1% reported lifetime use of 
heroin, methadone and crack.
A total of 33% said they had used other opiates at some 
point in their life, 13% reported ever using sedatives and/or 
tranquillisers and 10% did so for anti-depressants. Just over 52% 
reported ever smoking tobacco and 88% reported consuming 
alcohol in their lifetime.
Gender
Lifetime use of illegal drugs was higher among men (26%) 
than women (11%). Men were more likely to report lifetime 
use of ecstasy (8% vs 2%), cocaine (including crack) (7% vs 
2%), amphetamines (5% vs 2%), LSD (5% vs 1%), magic 
mushrooms (4% vs 2%), solvents (2% vs 0.5%) and poppers 
(3% vs 1%). Men were also more likely to report lifetime use  
of heroin (2% vs 0.0%) and crack (1% vs 0.0%).
Women’s lifetime use was higher for other opiates (37% vs 
30%), sedatives and/or tranquillisers (13% vs 12%) and anti-
depressants (12% vs 8%).
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Men were more likely to report lifetime use of tobacco (56% vs 
48%) and alcohol (89% vs 88%).
Age
Lifetime prevalence of any illegal drug was 27% for young adults 
(aged 15-34 years) and 12% for older adults (35-64).
Of the illegal drugs surveyed the most the drugs most frequently 
reported as ever used by young adults (15-34 yrs) were 
cannabis (27%), ecstasy (7%), cocaine (including crack) (6%), 
amphetamines (5%), LSD and magic mushrooms (each 3%). 
Among older adults (35-64 yrs) the most commonly reported 
for lifetime use were cannabis (11%), cocaine (including crack), 
ecstasy and magic mushrooms (each 3%), poppers and LSD 
(each 2%).
The lifetime rate for other drugs was higher among older (35-64 
yrs) than younger adults (15-35 yrs) for other opiates (39% vs 
25%), sedatives and/or tranquillisers (17% vs 7%) and for anti-
depressants (12% vs 6%).
Lifetime tobacco use among older adults (35-64 yrs) was 57% 
while the corresponding figure for younger adults (15-34yrs) was 
46%. The lifetime rate for ever consuming alcohol was higher 
among the older than younger age group (90% vs 87%).
Mid-Western Regional Drug Task force – Last 
Year Prevalence (Recent Use)
Last year prevalence for use of any illegal drugs was 5% in the 
Mid-Western Regional Drug Task Force area.
Drug Type
Cannabis (5%) was the illegal drug most frequently reported 
for use in the last year, followed by new psychoactive substance 
(3%). Less than one percent of respondents reported recent use 
of the other illegal drugs surveyed.
Last year prevalence of other opiates was 21%, of sedatives 
and/or tranquillisers was 6% and the rate of recent use of anti-
depressants was 5%. A total of 28% of those people surveyed 
reported smoking tobacco and 82% reported consuming alcohol 
in the year prior to the survey.
Gender
Recent use of any illegal drug was higher among men (7%) 
than women (3%). Men were more likely than women to report 
recent year use of cannabis (7% vs 3%), new psychoactive 
substances (5% vs 1%) and ecstasy (0.6% vs 0.3%). Among 
men recent use of anti-depressants was slightly higher than 
women (83% vs 82%) and men’s use of sedatives and/or 
tranquillisers was also higher than women’s recent use (32% vs 
23%). Women were more likely than men to report recent use 
of other opiates (25% vs 18%). Last year prevalence of poppers 
was the same for men and women at 0.3%.
Men were more likely than women to report smoking tobacco 
in the last year (33% vs 23%) and to report consuming alcohol 
(83% vs 82%) in the last year.
Age (see Tables 1.3 and 1.4)
Last year prevalence of any illegal drug use was higher among 
younger than older adults (10% vs 1%). Among young adults 
(15-34 yrs) cannabis was the most frequently used illegal 
drug (10%) followed by new psychoactive substances (7%). 
Approximately 1% of respondents said they had used ecstasy, 
cocaine, (including crack), LSD and magic mushrooms in the 
year prior to the survey. Among older adults (35-64 years) the 
illegal drugs most commonly used in the year prior to the survey 
were cannabis (1%) and new psychoactive substances (1%).
Last year prevalence of other opiates was higher among older 
adults (24% vs 18%) while last year rate of sedatives and/or 
tranquillisers was higher among younger adults (32% vs 25%). 
Recent use of anti-depressants however was similar in the age 
groups (83% vs 82%).
Last year prevalence of tobacco smoking was higher among 
younger adults (15-34 yrs) at 32%, than the rate for older adults 
(35-64 yrs) at 25%. With regard to recent alcohol consumption 
there was little difference between younger (83%) and older 
adults (82%).
Mid-Western Regional Drug Task force –  
Last Month Prevalence (Current Use)
Of those surveyed, 2% reported the use of any illegal drugs  
in the month prior to the survey.
Drug Type
In this region the most frequently reported illegal drug used in 
the last month was cannabis (2%). Less than one per cent of 
respondents reported current use of the remaining illegal drugs 
surveyed.
Last month prevalence of other opiates was 11%, for anti-
depressants the rate was 4% and for sedatives and/or 
tranquillisers it was 3%.
A total of 26% of those surveyed in the Mid-Western RDFT 
region reported smoking tobacco and 66% reported consuming 
alcohol in the month prior to the survey.
Gender
Last month prevalence of any illegal drugs was 3% among men 
and 1% among women. Men were more likely than women to 
report current use of cannabis (3% vs 0.3%).
Among women last month prevalence was higher than men’s for 
other opiates (15% vs 7%), Anti-depressants (6% vs 3%) and 
sedatives and/or tranquillisers (4% vs 2%).
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More men (30%) smoked tobacco in the last month than 
women (20%). The prevalence of alcohol consumption was  
also higher among men (73%) than women (60%).
Age
Last month prevalence of any illegal drug was higher among 
younger adults (15-34 yrs) than older adults (35-64) (5% vs 
0.0%). Younger adults were most likely to report current use of 
cannabis (4%) than any of the other illegal drugs (all of which 
was reported by less than 1%). Among older adults (35-64 yrs), 
current use of all illegal drugs surveyed was very close to zero.
Among older adults, last month prevalence was higher than 
younger adults for other opiates (11% vs 10%), sedatives and/
or tranquillisers (5% vs 1%), and anti-depressants (5% vs 2%).
Use of tobacco use in the last month was more likely to be 
reported by younger adults (28%) than older (24%) adults. 
Consumption of alcohol in the month prior to the survey was 
also more likely to be reported by younger (68%) than older 
adults (65%).
Mid-Western Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
No statistically significant changes between 2006/7 and 
2010/11 was recorded in lifetime, last year or last month 
prevalence for any of the illegal drugs.
Cannabis, cocaine
Since 2006/7 no statistically significant changes were recorded 
in lifetime, last year or last month prevalence of either cannabis 
or cocaine (including crack).
Sedatives, Tranquillisers and Anti-depressants
Men’s use of sedatives and/or tranquillisers increased since the 
last survey. Lifetime prevalence of sedatives and/or tranquillisers 
increased from 5% in 2006/7 to almost 12% in 2010/11  
(+6.7 percentage points).
Alcohol and Tobacco
Tobacco use also decreased since the last survey. Among all 
adults of tobacco lifetime use of tobacco was 60% in 2006/7, 
decreasing to 52% in 2010/11 (-7.9 percentage points). 
Changes were also found for recent tobacco use which was 39% 
in 2006/7 and 28% in 2010/11 (-10.9 percentage points). For 
women recent tobacco use went from 38% in 2006/7 to 23% 
in 2010 (-15.3 percentage points). Among older adults recent 
tobacco use also fell, from almost 38% in 2006/7 to 25% in 
2010/11 (-12.3 percentage points).
Other significant changes
No other statistically significant changes were found in drug 
prevalence since the last survey for this region.
North Eastern Regional Drug Task force – 
Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey show that among all adults 
(15-64 yrs) 24% said they had used an illegal drug at some 
stage in their lifetime.
Drug Type
Cannabis was the illegal drug most common reported by all adults 
(15-64 yrs); 21% said they had ever used cannabis in their life. 
Just over 5% said they had ever used cocaine (including crack) 
and 5% also said they had ever used ecstasy in their life. Just over 
4% reported ever using magic mushrooms, 4% solvents and just 
under 4% reported ever using LSD. A total of 3% said they had 
used poppers and 3% had used amphetamines at some point in 
their life. The lifetime prevalence for heroin, methadone and crack 
in this region was less than 1% for each.
A total of 35% reported ever using other opiates, 23% said 
they had ever used sedatives and/or tranquillisers and 14% 
Anti-depressants. Just over 54% smoked tobacco and 87% had 
consumed alcohol in their lifetime.
Gender
In this region use of illegal drugs was higher among men (34%) 
than women (16%). Men were more likely to report ever using 
cannabis (31% vs 12%), cocaine (including crack) (8% vs 3%) 
and ecstasy (also 8% vs 3%), magic mushrooms (7% vs 2%), 
LSD (6% vs 2%), poppers (5% vs 1%) and solvents (5% vs 
3%). Men were more likely than women to report ever using 
heroin (1% vs 0.0%) and methadone (1% vs 0.6%).
Lifetime prevalence was higher for women than men in relation 
to other opiates (37% vs 33%), sedatives and/or tranquillisers 
(27% vs 19%) and anti-depressants (16% vs 11%).
Men were more likely to report lifetime use of tobacco (56%  
vs 53%) and alcohol (89% vs 85%).
Age
Lifetime prevalence of any illegal drug was 27% among young 
adults (15-34 yrs) and 22% among older adults (35-64 yrs).
The most commonly reported illegal drug ever used by young 
adults (15-34 yrs) was cannabis (25%) followed by ecstasy 
(8%), cocaine (including crack) (7%), solvents and poppers 
(each 5%) amphetamines, LSD and magic mushrooms (each 
4%). Among older adults (35-64 yrs) the illegal drug most 
frequently reported as ever used was cannabis (17%) followed 
by cocaine (including crack), magic mushrooms (each 4%), LSD 
(3%) and poppers and ecstasy (each 2%).
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In relation to other opiates, sedatives and/or tranquillisers and 
anti-depressants, lifetime prevalence of each of these substances 
was higher among older (37%, 24%, 15%) than younger adults 
(33%, 21%, 12%).
Lifetime prevalence of tobacco was higher among older adults 
(35-64 yrs) at 61% when compared to younger adults (15-34 
yrs) (45%). Lifetime prevalence of alcohol was the same for 
younger and older age groups (87% for both age groups).
North Eastern Regional Drug Task force –  
Last Year Prevalence (Recent Use)
The last year prevalence of any illegal drugs was 4% in the North 
Eastern RDTF area.
Drug Type
Cannabis (3%) was the most frequently reported of the illegal 
drugs followed by new psychoactive substances (2%). Less than 
one percent of respondents reported recent use of the other 
illegal drugs covered by the survey.
25% of respondents reported recent use of other opiates in 
the last year, 10% reported recent use of sedatives and/or 
tranquillisers and 7% did so for anti-depressants. A total of 31% 
of those surveyed reported smoking tobacco and 83% reported 
consuming alcohol in the year prior to the survey.
Gender
Use of any illegal drug in the 12 months prior to the survey was 
higher among men (7%) than women (1%). In terms of the 
individual drugs, men were more likely than women to report 
last year use of cannabis (7% vs 0.2%) and new psychoactive 
substances (3% vs 0.6%). Women were more likely than men to 
report recent use of other opiates (29% vs 20%), sedatives and/
or tranquillisers (10% vs 9%) and anti-depressants (9% vs 6%).
Men were more likely to report using tobacco (33% vs 29%) 
and alcohol (86% vs 81%) in the year prior to the survey.
Age
Last year prevalence of any illegal drugs was higher among 
younger than older adults (8% vs 1%). Among young adults  
(15-34 yrs) cannabis (6%) was the most frequently reported 
illegal drug in the last year followed by new psychoactive 
substances (4%) and solvents (2%). Approximately 1% of 
respondents said they had used, cocaine, (including crack), 
amphetamines, heroin and methadone in the year prior to the 
survey. Among older adults (35-64 years) the illegal drug most 
commonly used in the year prior to the survey was cannabis (1%).
Last year prevalence of other opiates was the same for older 
and younger adults (both 25%). Recent use of sedatives and/or 
tranquillisers was higher among younger than older adults (13% 
vs 7%) as was recent use of anti-depressants (8% vs 7%).
Last year prevalence of tobacco was higher among younger 
(15-34 yrs) than older (35-64 yrs) adults (33% vs 30%) and 
last year prevalence of alcohol was also higher among younger 
adults (84% vs 82%).
North Eastern Regional Drug Task force –  
Last Month Prevalence (Current Use)
2% reported current use of any illegal drugs in the North Eastern 
Regional Drug Task Force area.
Drug Type
In this region the illegal drug most used in the month preceding 
the survey was cannabis (2%). Less than one per cent reported 
having used the remaining illegal drugs in the month prior to the 
survey.
Last month prevalence of other opiates was 10%, the rate for 
anti-depressants was 6% and for sedatives and/or tranquillisers 
last month prevalence was 3%.
A total of 29% of those surveyed in the region reported smoking 
tobacco and 66% reported consuming alcohol in the month 
prior to the survey.
Gender
Last month prevalence for any illegal drugs was 4% among men 
and 0.2% among women. Men were more likely than women to 
report use of cannabis in the last month (3% vs 0.2%).
Last month prevalence was higher for women than men for 
other opiates (13% vs 8%), anti-depressants (7% vs 4%) and 
sedatives and/or tranquillisers (4% vs 1%).
More men (31%) smoked tobacco in the month prior to the 
survey than women (28%) and more men (72%) reported 
consuming alcohol than women (61%).
Age
Last month prevalence of any illegal drug was higher among 
younger adults (3%) than older adults (1%). The illegal drugs 
most frequently used by younger adults were cannabis (3%) 
and cocaine (including crack) (1%). Among older adults, less 
than 1% reported using cannabis, and the rates of use of the 
remaining illegal drugs were close to zero.
Last month prevalence was higher among older (35-64 yrs) 
than younger adults (15-34 yrs) for other opiates (11% vs 9%), 
sedatives and/or tranquillisers (3% vs 2%) and anti-depressants 
(6% vs 5%).
Younger adults (30%) were more likely to report current use 
of tobacco than older adults (28%). Consumption of alcohol in 
the month prior to the survey was marginally more likely to be 
reported by younger adults (67% vs 66%).
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North Eastern Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
No significant changes in lifetime, last year or last month 
prevalence of any illegal drugs were recorded for the period 
between 2006/7 and 2010/11.
Sedatives, Tranquillisers and Anti-depressants
Since 2006/7 the prevalence of sedatives and/or tranquillisers 
changed. Lifetime prevalence for sedatives and/or tranquillisers 
increased from 11% in 2006 to 23% in 2010/11 (+12.6 
percentage points). Last year prevalence also changed since the 
last survey increasing from 5% in 2006/7 to 10% in 2010/11 
(+4.3 percentage points). Statistically significant changes were 
found for women’s lifetime use (+12.2 percentage points) and 
men’s lifetime use (+12.2 percentage points). In this region 
there was a substantial change in the use of sedatives and/ 
or tranquillisers by younger adults since the last survey for  
both lifetime (+18.1 percentage points) and last year  
(+11.7 percentage points) measures.
Since the last survey recent use of anti-depressants among 
young adults increased (+7.1 percentage points).
Alcohol and Tobacco
There were no significant changes in the use of alcohol or 
tobacco in this region since the last survey.
Other significant changes
No other statistically significant changes were found in drug 
prevalence since the last survey.
North Western Regional Drug Task force – 
Lifetime Prevalence (Ever Used)
Among all adults (15-64 yrs) 17% had used an illegal drug  
at some stage in their lifetime.
Drug Type
Cannabis was the most commonly used illegal drug among and 
16% reported ever using the drug. Just over 4% reported ever 
using magic mushrooms and almost 4% reported ever using 
ecstasy. After this, 3% reported use of cocaine (including crack) 
LSD or amphetamines in their life. Less than 1% reported ever 
using heroin, methadone and crack.
Lifetime prevalence is 25% for other opiates, 11% for sedatives 
and/or tranquillisers and 7% for anti-depressants. Just over 53% 
reported smoking tobacco and 91% said they had consumed 
alcohol at some stage in their lifetime.
Gender
In this region lifetime prevalence for any illegal drugs was higher 
among men (18%) than women (15%). In relation to specific 
illegal drugs, men were more likely to report lifetime use of 
cocaine (including crack) (5% vs 1%), magic mushrooms (6% 
vs 2%), ecstasy (5% vs 2%), amphetamines (4% vs 2%) and 
cannabis (18% vs 15%).
Women’s lifetime use was higher for other opiates (26% vs 
25%), sedatives and/or tranquillisers (14% vs 8%), Anti-
depressants (11% vs 4%).
Men were also more likely to report lifetime use of tobacco 
(56% vs 49%) and alcohol (93% vs 90%).
Age
Lifetime prevalence of any illegal drug was 24% among young 
adults (15-34 yrs) and 11% among older adults (35-64 yrs).
Of the illegal drugs surveyed those most reported as ever used 
by young adults (15-34 yrs) were cannabis (23%), ecstasy 
(8%), magic mushrooms (6%), amphetamines (5%), cocaine 
(including crack) (4%) and LSD (3%). Among older adults (35-
64 yrs) the most commonly reported lifetime illegal drug use 
was for cannabis (11%), magic mushrooms (3%), LSD (2%), 
cocaine (including crack) (2%) and amphetamines (1%).
Lifetime prevalence for other drugs was marginally higher among 
older than young adults for other opiates (26% vs 25%) and 
considerably higher among older adults for sedatives and/or 
tranquillisers (17% vs 3%) and Anti-depressants (10% vs 4%).
There was little difference between lifetime rates of tobacco 
reported by older adults and younger adults (53% vs 52%). 
Older adults were also only marginally more likely to report 
lifetime alcohol use than younger adults (92% vs 91%).
North Western Regional Drug Task force – 
Last Year Prevalence (Recent Use)
Last year prevalence for any illegal drugs was 3% in the North 
Western RDTF area.
Drug Type
Cannabis was the illegal drug (3%) most likely to be reported 
for recent use, followed by new psychoactive substances (2%). 
Less than one percent of respondents reported recent use of the 
other illegal drugs covered by the survey.
Last year prevalence was 19% for other opiates, 4% for 
sedatives and/or tranquillisers and 3% for Anti-depressants. A 
total of 32% of those surveyed reported smoking tobacco and 
82% reported consuming alcohol in the year prior to the survey.
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Gender
Use of any illegal drug in the 12 months prior to the survey was 
higher among men (4%) than women (1%). Men were more 
likely than women to report recent use of cannabis (4% vs 1%) 
as well as recent use of new psychoactive substances (3% vs 
0.4%). Men (20%) were also more likely than women (19%) to 
report use of other opiates in the year prior to the survey.
Women were more likely than men to report recent use of 
sedatives and/or tranquillisers (6% vs 2%) and recent use of 
Anti-depressants (5% vs 1%).
Men were more likely to report use of tobacco (33% vs 31%) 
and alcohol (83% vs 81%) in the 12 months prior to the survey.
Age
Last year prevalence of any illegal drug use was higher among 
younger (6%) than older adults (1%). Among young adults (15-
34 yrs) cannabis (6%) was the most frequently used illegal drug 
followed by new psychoactive substances (3%). Among older 
adults (35-64 years) the illegal drug most commonly used in 
the year prior to the survey was cannabis (1%). Less than 1% 
of respondents said they had used the remaining illegal drugs 
surveyed.
Last year use of other opiates was higher among younger (21%) 
than older adults (18%). Among older adults last year use was 
higher for sedatives and/or tranquillisers (6% vs 1%) and there 
was little difference between the age groups in relation to last 
year use of Anti-depressants (both 3%).
Last year prevalence of tobacco among younger adults (15-
34 yrs) was higher than older adults (41% vs 26%). Last year 
prevalence of alcohol was also higher among younger adults 
(86% vs 79%).
North Western Regional Drug Task force – 
Last Month Prevalence (Current Use)
1% of respondents reported current use of any illegal drug in the 
North Western RDTF area.
Drug Type
The most commonly used illegal drug in the month preceding 
the survey was cannabis (1%) and less than one per cent 
reported current use of the remaining illegal drugs surveyed.
In this region 9% reported current use of other opiates, 3% 
reported use of Anti-depressants and 3% reported use of 
sedatives and/or tranquillisers in the last month.
A total of 29% of those surveyed in the region reported smoking 
tobacco in the last month and 67% consumed alcohol in the 
month prior to the survey.
Gender
Last month prevalence rate for any illegal drugs was equally  
1% among women and men.
Last month use was higher among women for other opiates 
(11% vs 7%), Anti-depressants (5% vs 1%) and sedatives and/
or tranquillisers (4% vs 1%).
More men (31%) smoked tobacco in the last month than 
women (27%) and men (74%) were also more likely to report 
consuming alcohol in the last month than women (60%).
Age
In this region last month prevalence of any illegal drug was 
higher among younger (3%) than older adults (0.0%). Cannabis 
(3%) was the illegal drug most frequently reported by younger 
adults. Among older adults (35-64 yrs) levels of use of the 
remaining illegal drugs surveyed were close to zero.
Last month use was higher among older than younger adults for 
other opiates (10% vs 8%), sedatives and/or tranquillisers (4% 
vs 0.0%) and the rates were the same between the two age 
groups for last month use of Anti-depressants (each 3%).
Tobacco use in the last month was higher among younger 
(35%) than older (25%) adults. Consumption of alcohol in the 
month prior to the survey was also higher among younger than 
older adults (71% vs 65%)
North Western Regional Drug Task force – 
Comparison 2006/7–2010/11
No changes in lifetime, last year or last month use of any of the 
illegal drugs.
There were no statistically significant changes recorded in relation 
to the use of prescription/over-the counter medicines between 
2006/7 and 2010/11.
There were also no statistically significant changes recorded for 
the use of alcohol or tobacco in this region since the last survey.
There were no other statistically significant changes in drug 
prevalence rates since the last survey.
Northern Regional Drug Task force – Lifetime 
Prevalence (Ever Used)
Results from the 2010/11 survey show that 35% of all adults 
(15-64 yrs) surveyed reported ever using an illegal drug in  
their life.
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Drug Type
Cannabis was the most commonly used illegal drug (30%) 
among all adults (15-64 yrs). This was followed by 12% 
of respondents who reported ever using cocaine (including 
crack), 11% ecstasy, 9% magic mushrooms, 7% LSD, 6% 
each for poppers and amphetamines, 3% for solvents and 
2% of respondents said they had used heroin in their life. 
Approximately 1% reported lifetime use each for methadone 
and crack.
A total of 40% had used other opiates, 14% sedatives and/or 
tranquillisers and 10% Anti-depressants at some point in their 
life. Just over 60% had ever smoked tobacco and 89% had 
consumed alcohol in their lifetime.
Gender
In the Northern RDTF area, use of an illegal drug was higher 
among men (46%) than women (25%). In terms of specific 
drugs, men were more than three times likely than women 
to have ever used amphetamines (10% vs 3%), magic 
mushrooms (15% vs 4%) and solvents (5% vs 1%). Men were 
between two and three times more likely to have ever used 
cocaine (including crack) (18% vs 7%), ecstasy (17% vs 6%) 
and poppers (9% vs 4%). Men’s lifetime use was also higher 
than women’s for cannabis (41% vs 22%) and sedatives and/or 
tranquillisers (16% vs 13%).
Women were more likely than men to report lifetime use of 
other opiates (45% vs 35%). Men and women were equally 
likely to report lifetime use of Anti-depressants (each 10%).
Men were more likely than women to report ever using tobacco 
(62% vs 59%) and ever drinking alcohol (92% vs 87%).
Age
Lifetime prevalence of any illegal drug was 40% among young 
adults (aged 15-34 years) and 29% among older adults (35-64).
Of the illegal drugs surveyed the most commonly used 
substance among young adults was cannabis (35%). Lifetime 
prevalence of the other illicit drugs among young adults 
was 18% each for ecstasy and cocaine (including crack), 
12% for magic mushrooms, 10% for LSD, 9% poppers, 8% 
amphetamines and 4% for solvents. Among older adults 
the illegal drugs most frequently reported as ever used were 
cannabis (26%) followed by cocaine (including crack) (7%), 
magic mushrooms (6%), LSD (5%), and heroin (2%).
Among older adults the lifetime use was higher for other opiates 
(42% vs 38%), sedatives and/or tranquillisers (18% vs 10%) 
and for anti-depressants (14% vs 6%).
Lifetime tobacco use among older adults was 64% compared 
to 57% among younger adults. Lifetime consumption of alcohol 
was also higher among the older age group (94% vs 85%).
Northern Regional Drug Task force – Last Year 
Prevalence (Recent Use)
Among all adults (15-64 yrs) 11% had used an illegal drug  
in the 12 months prior to the survey.
Drug Type
In terms of recent use, cannabis was the most frequently 
reported illegal drug (9%) followed by cocaine (including crack) 
(3%), new psychoactive substance (2%) and ecstasy (1%). 
Less than one percent of respondents reported recent use of the 
other illegal drugs covered by the survey.
Among all adults, 28% reported recent use of other opiates, 8% 
reported recent use of sedatives and/or tranquillisers and 3% 
did so for anti-depressants. A total of 39% of those surveyed 
reported smoking tobacco and 86% had consumed alcohol in 
the year prior to the survey.
Gender
The use of any illegal drug in the year prior to the survey was 
higher among men (18%) than women (5%). Men were almost 
four times more likely than women to report last year use of 
cannabis (16% vs 4%). Recent use was also higher for men for 
cocaine (including crack) (5% vs 0.3%), magic mushrooms (2% 
vs 0.4%), ecstasy (2% vs 1%).
Recent use of sedatives and/or tranquillisers was higher among 
men than women (9% vs 7%). Women were more likely than 
men to report recent use of other opiates (32% vs 23%). 
Recent use of anti-depressants was similar among men and 
women (each 3%).
Men were more likely to report use of tobacco (40% vs 37%) 
and alcohol (88% vs 84%) in the 12 months prior to the survey.
Age
Last year prevalence of any illegal drug use was higher among 
younger than older adults (17% vs 5%). Among young adults 
(15-34 yrs) the most commonly used illegal drug in the 12 
months prior to the survey was cannabis (16%), cocaine 
(including crack) (4%), ecstasy and magic mushrooms (each 
2%). Among older adults (35-64 years) the illegal drug most 
commonly used in the year prior to the survey was cannabis 
(4%) followed by new psychoactive substances cocaine 
(including crack) and ecstasy (each 1%). Less than 1% of 
respondents reported use of the remaining illegal drugs.
Last year use of other opiates was the same for older and 
younger adults (both 28%). Recent use of for older adults was 
higher for sedatives and/or tranquillisers (11% vs 4%) and anti-
depressants (4% vs 2%).
Tobacco use in the last year was higher among younger than 
older adults (43% vs 35%) and the rate of alcohol consumption 
was higher among older adults (89% vs 83%).
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Northern Regional Drug Task force –  
Last Month Prevalence (Current Use)
In the Northern Regional Drug Task Force area 5% reported 
using any illegal drug in the month preceding the survey.
Drug Type
The illegal drug most frequently reported for current use was 
cannabis (5%). Less than one per cent reported current use for 
each of the remaining illegal drugs covered by the survey.
Last month prevalence was 15% for other opiates, 3% for anti-
depressants and 2% for sedatives and/or tranquillisers.
A total of 33% of those surveyed in the region reported smoking 
tobacco and 76% said they had consumed alcohol in the month 
prior to the survey.
Gender
Current use of any illegal drugs was reported by 9% of men and 
1% of women. Men were more likely than women to report 
current use of cannabis (9% vs 1%). Use of sedatives and/or 
tranquillisers was also more likely to be reported by men (4%) 
than women (2%) in the region.
Current use was higher among women for other opiates (16% 
vs 12%), sedatives and/or tranquillisers (3% vs 2%) and anti-
depressants (3% vs 2%).
Slightly more men (34%) smoked tobacco in the last month 
than women (32%) and men were also more likely to report 
consuming alcohol in month prior to the survey than women 
(81% vs 72%).
Age
Last month prevalence of any illegal drug was higher among 
younger (7%) than older adults (2%). Younger adults were 
most likely to report current use of cannabis (7%) and cocaine 
(including crack) (2%) than any other illegal drug. Among older 
adults, cannabis (2%) was also the most frequently reported 
drug for current use. The rates of current use for each of the 
remaining illegal drugs were very close to zero.
Younger adults (15-34 yrs) were more likely than older adults 
(35-64 yrs) to report current use of other opiates (15% vs 
14%) but older adults were more likely to report current use 
of sedatives and/or tranquillisers (4% vs 0.3%) and anti-
depressants (3% vs 2%).
Tobacco use in the last month was higher among younger 
(34%) than older (32%) adults. Consumption of alcohol in the 
month prior to the survey was also higher among older (80% vs 
73%) adults.
Northern Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
No statistically significant changes in lifetime, last year or last 
month prevalence of any illegal drugs among all adults were 
recorded between 2006/7 and 2010/11.
Sedatives, Tranquillisers and Anti-depressants
Among all adults (15-64 yrs) recent use of sedatives and/or 
tranquillisers increased from 4% in 2006/7 to 8% in 2010/11 
(+3.6 percentage points). This is most likely reflecting the 
increase found in recent use of sedatives and/or tranquillisers 
among older adults since the last survey: last year prevalence 
went from 5% in 2006/7 to almost 11% in 2010/11 (+6.5 
percentage points). No changes were recorded for anti-
depressants.
Alcohol and Tobacco
There were no changes in alcohol or tobacco use since the last 
survey in this region.
Other significant changes
Among men, lifetime use of solvents in the Northern RDTF area 
increased sharply from 0.5% in 2006/7 to 5% in 2010/11 
(+4.5 percentage points).
Among all adults (15-64 yrs) recent use of poppers declined 
since the survey from 1% in 2006/07 to 0.1% in 2010/11 
(-0.9 percentage points). Recent use of amphetamines by 
young adults also declined in this region from 2% in 2006/7 to 
0.3% in 2010/11 (-1.8 percentage points). Finally recent use of 
methadone by women declined from 2% in 2006/7 to close to 
zero in 2010/11 (-1.5 percentage points).
Current use of ecstasy declined among all adults in this region, 
from 1% in 2006/7 to close to zero in 2010/11 (-1 percentage 
point).
South Eastern Regional Drug Task force – 
Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey show that 25% of all adults 
(15-64 yrs) surveyed had used an illegal drug at some stage in 
their lifetime.
Drug Type
Cannabis was the most commonly used illegal drug and 24% of 
all adults (15-64 yrs) said they had used cannabis at some point 
in their lives in this region. After cannabis, 7% of respondents 
said they had ever used magic mushrooms, 6% had ever used 
ecstasy, amphetamines, cocaine (including crack) or poppers. 
4% of respondents had used LSD and 2% reported ever 
using solvents. Less than 1% reported lifetime use of heroin, 
methadone and crack.
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A total of 38% had used other opiates, 13% sedatives and/
or tranquillisers and 8% anti-depressants at some point in their 
life. Just over 57% had ever smoked tobacco and 91% had 
consumed alcohol in their lifetime.
Gender
In the South Eastern RDTF region, use of illegal drugs was 
higher among men (36%) than women (15%). Lifetime use 
was higher for men than women in relation to poppers (10% 
vs 1%), ecstasy (11% vs 2%), LSD (7% vs 1%) and magic 
mushrooms (12% vs 2%). Men were also more likely to report 
lifetime use of amphetamines (10% vs 2%) and cocaine 
(including crack) (9% vs 2%).
Women were more likely than men to report lifetime use of 
other opiates (40% vs 36%) and anti-depressants (10% vs 
5%). Men and women were equally likely to report ever using 
sedatives and/or tranquillisers (13%).
Men were more likely than women to report ever using tobacco 
(65% vs 49%) or alcohol (96% vs 87%).
Age
Lifetime prevalence of any illegal drug was 35% among young 
adults (aged 15-34 years) and 18% among older adults (35-64).
Of the illegal drugs surveyed the most commonly used 
substances among young adults were cannabis (33%) 
followed by ecstasy (12%), poppers, magic mushrooms and 
amphetamines (each 10%), cocaine (including crack) (9%) and 
LSD (5%). Among older adults (35-64 yrs) the most commonly 
used illegal drugs ever used were cannabis (18%) followed 
by magic mushrooms (5%), and amphetamines and cocaine 
(including crack) (each 3%).
Among older adults the lifetime use was higher for other opiates 
(39% vs 37%), sedatives and/or tranquillisers (14% vs 12%) 
and for anti-depressants (11% vs 4%).
Lifetime tobacco use among older adults (35-64) was 58% 
compared to 54% among younger adults (15-34). Lifetime 
consumption of alcohol was also higher among the older age 
group (93% vs 89%).
South Eastern Regional Drug Task force –  
Last Year Prevalence (Recent Use)
Among all adults 6% had used an illegal drug in the 12 months 
prior to the survey.
Drug Type
Cannabis was the most frequently reported illegal drug (4%) 
followed by new psychoactive substance (4%) and cocaine 
(including crack) (2%). Less than one percent of respondents 
reported recent use of the other illegal drugs covered by the 
survey.
28% of respondents reported using other opiates in year prior to 
the survey, 6% reported using sedatives and/or tranquillisers and 
4% did so for anti-depressants. A total of 33% of those surveyed 
reported smoking tobacco and 87% had consumed alcohol in 
the year prior to the survey.
Gender
The use of any illegal drug in the 12 months prior to the survey 
was higher among men (10%) than women (2%). Men were 
more likely than women to report last year use of cannabis (7% 
vs 1%), new psychoactive substances (6% vs 2%), cocaine 
(including crack) (3% vs 0.4%), amphetamines (2% vs 0.2%) 
and sedatives and/or tranquillisers (7% vs 4%). Women were 
more likely than men to report recent use of other opiates (30% 
vs 27%) and anti-depressants (5% vs 3%).
Men were more likely to report use of tobacco (38% vs 28%) 
and alcohol (92% vs 83%) in the 12 months prior to the survey.
Age
Last year prevalence of any illegal drug use was higher among 
younger than older adults (10% vs 3%). Among young adults 
(15-34 yrs) new psychoactive substances (9%) were most 
commonly used followed by cannabis (7%), cocaine (including 
crack) (4%) and amphetamines (2%). Approximately 1% of 
young adults reported last year use of ecstasy, LSD or magic 
mushrooms. Among older adults (35-64 years) the illegal 
drug most commonly used in the year prior to the survey was 
cannabis (2%).
Last year use of other opiates was the same for older and 
younger adults (both 28%). The rate for last year use of Anti-
depressants was higher for older adults (6% vs 1%) and this 
group also had slightly higher rates recent use of sedatives and/
or tranquillisers (6% vs 5%).
Tobacco use in the last year was similar for younger and older 
adults (33% for both age groups) as was the rate of alcohol 
consumption in the last year (87% for both age groups).
South Eastern Regional Drug Task force –  
Last Month Prevalence (Current Use)
In the South Eastern Regional Drug Task Force area 3% reported 
using any illegal drug in the month preceding the survey.
Drug Type
The illegal drug most frequently reported for current use was 
cannabis (2%). Less than one per cent reported current use  
for each of the remaining illegal drugs covered by the survey.
Last month prevalence was 13% for other opiates, 4% for  
anti-depressants and 3% for sedatives and/or tranquillisers.
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A total of 28% of those surveyed in the region reported smoking 
tobacco and 66% consuming alcohol in the month prior to the 
survey.
Gender
Current use of any illegal drugs was reported by 6% of men 
0.4% of women. Men were more likely than women to report 
current use of cannabis (4% vs 0.4%). Use of sedatives and/or 
tranquillisers was also more likely to be reported by men (4%) 
than women (2%) in the region.
Current use was higher among women for other opiates (14% 
vs 11%) and also for Anti-depressants (5% vs 3%).
More men (33%) smoked tobacco in the last month than 
women (24%) and the level of reports of consuming alcohol in 
month prior to the survey was also higher among men (73%) 
than women (59%).
Age
Last month prevalence of any illegal drug was higher among 
younger (5%) than older adults (1%). Younger adults were 
most likely to report current use of cannabis (4%) and cocaine 
(including crack) (1%) than any other illegal drug. Among 
older adults, less than 1% reported using cannabis, and rates 
of current use for each of the remaining illegal drugs were very 
close to zero.
Older adults (35-64 yrs) were more likely than younger adults 
(15-34 yrs) to report use of anti-depressants (6% vs 1%), 
sedatives and/or tranquillisers (4% vs 2%) and other opiates 
(14% vs 11%).
Tobacco use in the last month was higher among older (29%) 
than younger (27%). Consumption of alcohol in the month prior 
to the survey was also higher among older (67% vs 65%) adults.
South Eastern Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
No statistically significant changes in lifetime, last year or last 
month prevalence of any illegal drugs were recorded between 
2006/7 and 2010/11.
Sedatives, Tranquillisers and Anti-depressants
There were no changes recorded in this region for lifetime, last 
year or last month use of sedatives and/or tranquillisers since the 
last survey. There were also no changes in any of the prevalence 
measures recorded for anti-depressants since the last survey.
Alcohol and Tobacco
Alcohol consumption among older adults (35-64 yrs) changed 
since the last survey. The share that had ever consumed alcohol 
increased from 79% in 2006/7 to 87% in 2010/11 (+8 
percentage points). There were no other statistically significant 
changes in alcohol and no statistically significant changes in 
tobacco use since the last survey in this region.
Other significant changes
No other statistically significant changes were found in drug 
prevalence since the last survey.
South Western Regional Drug Task Force – 
Lifetime Prevalence (Ever Used)
Results from the 2010/11 survey show that 36% of those aged 
between 15-64 years in the South Western RDTF area have used 
an illegal drug in their lifetime.
Drug Type
Cannabis (33%) use was the most common illegal drug used 
on a lifetime basis. Among the other illegal drugs, lifetime 
prevalence was highest for ecstasy and magic mushrooms (each 
10%), cocaine powder (9%), amphetamines and LSD (each 
7%), poppers (6%), solvents (5%), crack (2%) and heroin 
(1%). 1% reported lifetime use of methadone.
Of all adults 38% reported ever using other opiates, 18% said they 
had used sedatives and/or tranquillisers and 14% had used anti-
depressants at some point in their lives. 61% reported smoking 
tobacco and 92% had consumed alcohol during their lifetime.
Gender
Lifetime use of any illegal drug was substantially higher among 
men (47%) than women (25%). Men were almost five times 
more likely to report lifetime use of poppers (10% vs 2%) and 
between three and four times likely to report lifetime use of 
solvents (9% vs 2%), ecstasy (15% vs 5%) and LSD (11% vs 
3%). Lifetime rates were also higher for men than women in 
relation to use of cocaine powder (13% vs 6%), amphetamines 
(10% vs 5%), magic mushrooms (13% vs 6%) and cannabis 
(43% vs 23%).
While women were more likely than men to report lifetime use 
of other opiates (39% vs 37%) and anti-depressants (16% 
vs 11%), lifetime use of sedatives and/or tranquillisers was 
marginally higher for men in this region (18% vs 17%).
Lifetime prevalence of tobacco was higher among men than 
women (66% vs 55%) as was consumption of alcohol on a 
lifetime basis (94% vs 90%).
Age
Lifetime prevalence of any illegal drug among young adults 
(aged 15-34 yrs) was higher than among older (35-64 yrs) 
adults at (46% vs 26%).
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Of the illegal drugs surveyed the illegal drugs most commonly 
used on a lifetime basis by young adults were cannabis (43%), 
ecstasy (15%), cocaine powder (14%), magic mushrooms 
(13%), amphetamines (10%), LSD and poppers (each 9%), 
solvents (7%) and heroin and crack (each 2%).
Among older adults the most common illegal drugs ever used 
were cannabis (24%), magic mushrooms and ecstasy (each 
6%), cocaine, LSD and amphetamines (each 5%), solvents and 
poppers, (each 3%) and heroin and crack (each 1%).
Lifetime use was higher among older adults in relation to other 
opiates (40% vs 37%), sedatives and/or tranquillisers (23% vs 
13%) and anti-depressants (19% vs 8%).
Lifetime tobacco use among older adults was 63% while the 
corresponding figure was 58% for younger adults. Lifetime 
consumption of alcohol was higher among the younger age 
group (93% vs 91%)
South Western Regional Drug Task Force – 
Last Year Prevalence (Recent Use)
Last year prevalence of any illegal drugs was 11% in the South 
Western Regional Drug Task Force area.
Drug Type
With regard to recent illicit drug use, cannabis (9%) was the 
most frequently reported of the illegal drugs surveyed, followed 
by new psychoactive substances (6%), cocaine (including crack) 
(3%) and magic mushrooms (1%). Less than one percent of 
those surveyed reported recent use of the remaining illegal drugs 
(including use of methadone).
Last year prevalence of other opiates was 26%, for sedatives 
and/or tranquillisers the rate for last year use was 9% and was 
7% for Anti-depressants. Of those surveyed 37% reported 
smoking tobacco in the year prior to the survey and 87% said 
they had consumed alcohol in the last year.
Gender
Use of any illegal drug in the 12 months prior to the survey was 
higher among men (14%) than women (8%). Men were almost 
twice as likely to report recent use of cannabis (12% vs 6%), 
cocaine (including crack) (4% vs 2%) and magic mushrooms 
(2% vs 1%). There were few differences between men and 
women’s recent use of the remaining illegal drugs.
Men and women were equally like to report recent use of other 
opiates (26%), but women were more likely than men to report 
recent use of anti-depressants (8% vs 5%) and sedatives and/or 
tranquillisers (10% vs 8%).
Men’s tobacco use in the last year was higher than women’s 
(38% vs 35%) and men were also more likely than women to 
report alcohol consumption in the last year (89% vs 85%).
Age
Last year prevalence of any illegal drug among young adults 
(aged 15-34 years) was just over six times that of older adults 
(19% vs 3%). Among young adults, the most frequently 
reported of the illegal drugs was cannabis (15%) followed by 
new psychoactive substances (10%), cocaine (including crack) 
(5%), magic mushrooms (2%) and amphetamines, ecstasy and 
LSD (each 1%). Among older adults (35-64 years) the illegal 
drugs used most in the year prior to the survey were cannabis 
(3%) followed by new psychoactive substances and cocaine 
(including crack) (each 1%).
Last year prevalence was higher among younger adults for 
other opiates (27% vs 25%) and higher among older adults 
for sedatives and/or tranquillisers (11% vs 6%) and anti-
depressants (10% vs 3%).
Recent use of tobacco was higher among younger adults (42% 
vs 32%) as was consumption of alcohol (89% vs 84%).
South West Regional Drug Task Force –  
Last Month Prevalence (Current Use)
The results show that 6% of those surveyed had used an illegal 
drug in the four weeks prior to the survey.
Drug Type
In this region the most commonly used illegal drug in the month 
preceding the survey was cannabis (5%) followed by cocaine 
(including crack) (1%). Less than one per cent of respondents 
reported current use of the remaining illegal drugs covered by 
the survey.
Current use of other opiates was reported by 15% of respondents 
and the corresponding figure for current use of sedatives and/or 
tranquillisers was 4% and for anti-depressants 6%.
A total of 33% reported smoking tobacco in the last month and 
71% said they had consumed alcohol in last month.
Gender
Last month prevalence for any illegal drugs was 9% among men 
and 2% among women. Men were substantially more likely than 
women to report current use of cannabis (8% vs 1%), more men 
also reported current use of cocaine (including crack) (2% vs 1%).
More women than men reported current use of other opiates 
(17% vs 14%) and current use of anti-depressants by women 
was almost twice that of men’s (8% vs 4%). Current use of 
sedatives and/or tranquillisers was similar between women and 
men (each 4%).
Slightly more men (35%) reported current tobacco use than 
women (30%). Current alcohol consumption was higher among 
men (78%) than women (65%).
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Age
Last month prevalence of using any illegal drug among younger 
adults (15-34 yrs) was 9% and greater than that of older adults 
(35-64) at 2%. Cannabis was the illegal drug most frequently 
reported by younger (7%) as well as older (2%) adults and 
this was followed by cocaine (including crack) for both groups 
(younger 2% and older 0.6%). Current use of the remaining 
illegal drugs was reported by less than 1% of both age groups.
Current use was higher among younger adults for other opiates 
(18% vs 13%) while current use was higher among older 
for Anti-depressants (9% vs 2%) and for sedatives and/or 
tranquillisers (7% vs 1%).
Tobacco use in the last month was higher among younger (37%) 
than older (29%) adults. Alcohol use in the last month was higher 
among younger adults (72%) than older adults (71%).
South West Regional Drug Task Force – 
Comparison 2006/7–2010/11
Any illegal drugs
Lifetime use of any illegal drug increased in this region from 
26% in 2006/7 to 36% in 2010/11 (+10.7 percentage points). 
Statistically significant changes were found in relation to lifetime 
use of any illegal drug for men (+15.4 percentage points) 
and for younger adults (+15.5 percentage points). Use of any 
illegal drug by young adults also increased for last year (+9.2 
percentage points) and last month (+6.6 percentage points).
Cannabis
Since the last survey lifetime use of cannabis increased among 
all adults (15-64 yrs) (+9.4 percentage points). Lifetime 
increases were found specifically for males (+13.6 percentage 
points as well as young adults (+15.3 percentage points). 
Statistically significant changes were also found for current use  
of cannabis by men (+5 percentage points) and by young adults 
(+4.8 percentage points).
Alcohol and Tobacco
In relation to tobacco, there was an increase in lifetime use by 
males in this region from 54% in 2006/7 to 66% in 2010/11 
(+12.1 percentage points). Last month prevalence of alcohol 
decreased among women from 74% in 2006/7 to 65% in 
2010/11 (-8.7 percentage points) and among older adults from 
79% in 2006/7 to 71% in 2010/11 (-7.8 percentage points).
Sedatives, Tranquillisers and Anti-depressants
Changes were recorded in this region for lifetime use of sedatives 
and/or tranquillisers in relation to use by all adults (15-64 yrs) 
(+8.8 percentage points). This change reflects the increases that 
took place in lifetime use by men (+11.3 percentage points) 
and women (+6.2 percentage points) and among younger 
adults (+5.8 percentage points) as well as older adults (+11.6 
percentage points). Since the last survey, there have also been 
changes in recent use of sedatives and/or tranquillisers among all 
adults (+5 percentage points), capturing change in men’s recent 
use (+5.8 percentage points) and women’s recent use (+ 4.1 
percentage points). Statistically significant increases in recent use 
of sedatives and/or tranquillisers were also found for older adults 
(+6 percentage points).
In relation to anti-depressants, since the last survey there have 
been increases in men’s lifetime use (+ 5.7 percentage points)  
as well as in lifetime use by older adults (+8.5 percentage points).
An increase was also found for older adults in their use of anti-
depressants in terms of last year (+4.7 percentage points) and 
last month (+5.7 percentage points).
Other significant changes
Among all adults (15-64 yrs) there has been an increase in 
lifetime use of various substances since the last survey in 
2006/7: there have been statistically significant changes in 
ecstasy (+6.3 percentage points), cocaine (including crack) 
(+5.8 percentage points), amphetamines and LSD (each +5.3 
percentage points), magic mushrooms (+4.1 percentage points), 
poppers (+4 percentage points), and solvents (+3.3 percentage 
points). Increases were also found in recent use among all 
adults were found for cocaine powder (+2.1 percentage points), 
amphetamines (+ 0.8 percentage points).
Since the last survey increases took place in men’s lifetime 
use of ecstasy (+10.6 percentage points), cocaine (including 
crack) (+8.2 percentage points), LSD (+7.9 percentage 
points), poppers (+ 7.8 percentage points), amphetamines 
(+6.8 percentage points) and solvents (+5.8 percentage 
points). Changes were also found in lifetime use by women 
of amphetamines (+3.8 percentage points) and LSD (+ 
2.5 percentage points). In terms of recent use, men’s drug 
use increased in relation to cocaine (including crack) (+ 3.2 
percentage points) and for current use there was an increase in 
men’s use of cocaine powder (+1.8 percentage points).
There have also been increases in lifetime use among young 
adults (15-34 yrs) since the last survey in relation to ecstasy (+ 
8.8 percentage points), amphetamines (+8.5 percentage points), 
cocaine (including crack) (+ 7.3 percentage points), LSD (+ 
7.5 percentage points) and poppers (+ 5.4 percentage points). 
Corresponding changes in lifetime use were found for older 
adults in relation to cocaine (including crack) (+ 4.3 percentage 
points), ecstasy (+4.1 percentage points), solvents (+ 2.7 
percentage points) and poppers (+ 2.8 percentage points).
Southern Regional Drug Task force – Lifetime 
Prevalence (Ever Used)
Results from the 2010/11 survey show that among all adults 
(15-64 yrs) 24% reported using an illegal drug at some stage  
in their life.
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Drug Type
Cannabis (23%) was the most likely the illegal drug to be 
reported for lifetime use by adults (15-64 yrs) in this region.  
6% reported ever using ecstasy and a similar share reported 
using cocaine (including crack) or magic mushrooms (each 5%). 
A total of 3% reported ever using amphetamines and 2% said 
they had used poppers at some stage in their lifetime. Less than 
1% reported lifetime use of heroin, methadone and crack.
A total of 46% reported they had used other opiates, 12% 
sedatives and/or tranquillisers and 10% anti-depressants in their 
lifetime. Just over 57% said they had smoked tobacco and 90% 
had consumed alcohol in their lifetime.
Gender
In the Southern RDTF region, use of illegal drugs was higher 
among men (32%) than women (17%). Men were at least four 
times more likely than women to report use of cocaine (including 
crack) (8% vs 2%), LSD (5% vs 1%) and poppers (4% vs 1%); 
men were approximately three times more likely to report lifetime 
use of ecstasy (9% vs 3%) and magic mushrooms (7% vs 3%). 
Use among men was higher than women also for amphetamines 
(4% vs 2%) and solvents (2% vs 1%).
Women were more likely than men to report ever using other 
opiates (49% vs 43%), sedatives and/or tranquillisers (15% vs 
8%) and anti-depressants (12% vs 8%).
Men were more likely than women to report ever smoking 
tobacco (61% vs 53%) and alcohol (93% vs 87%).
Age
Lifetime prevalence of any illegal drug in the Southern RDTF was 
36% among young adults (aged 15-34 years) and 15% among 
older adults (35-64).
Among young adults (15-34 yrs) the most frequently mentioned 
substances used on a lifetime basis were cannabis (35%), 
ecstasy (9%), magic mushrooms (7%), cocaine (including 
crack) (6%), amphetamines (4%), LSD and poppers (each 3%) 
and solvents (2%).
Lifetime use of other opiates was higher among younger adults 
(50% vs 43%). Older adults (34-65 yrs) were more likely  
to report lifetime use of sedatives and/or tranquillisers than 
younger adults (13% vs 5%) and to report lifetime use of  
anti-depressants (13% vs 8%).
Lifetime tobacco use among younger and older adults was 
equally 57% for the two age groups. Lifetime consumption  
of alcohol was also the same for the two age groups, at 90%.
Southern Regional Drug Task force –  
Last Year Prevalence (Recent Use)
The overall prevalence rate of any illegal drug was 6% in the 
South Eastern RDTF area.
Drug Type
Cannabis (6%) was the most frequently reported illegal drug, 
followed by new psychoactive substance (4%) and cocaine 
(1%). Less than one percent of respondents reported recent  
use of the other illegal drugs covered by the survey.
In this region 35% of respondents reported recent use of other 
opiates, 5% reported recent use of anti-depressants and 5% 
also reported use of sedatives and/or tranquillisers in the last 
year. A total of 32% of those surveyed reported smoking tobacco 
and 85% said they had consumed alcohol in the year prior to 
the survey.
Gender
Use of any illegal drug in the 12 months prior to the survey 
was higher among men (9%) than women (3%). Men were 
more likely to report last year use of cannabis (8% vs 3%), new 
psychoactive substances (5% vs 2%), cocaine (including crack) 
(2% vs 0.4%), LSD (0.6% vs 0.0%) and magic mushrooms 
(0.9% vs 0.0%). Women were more likely than men to report 
recent use of other opiates (40% vs 30%), sedatives and/or 
tranquillisers (7% vs 3%) and anti-depressants (6% vs 4%).
Men were more likely to report recent use of tobacco (37% vs 
27%) and alcohol (87% vs 82%).
Age
Last year prevalence of any illegal drug use was higher among 
younger (11%) than older adults (2%). Among young adults 
(15-34 yrs) cannabis was the most commonly used illegal 
drug (10%) followed by new psychoactive substances (7%) 
and cocaine (including crack) (2%). Less than 1% of young 
adults reported recent use of amphetamines, LSD or magic 
mushrooms. Among older adults (35-64 years) the illegal 
drug most commonly used in the year prior to the survey was 
cannabis (2%). Less than 1% of young adults reported recent 
use of each of the remaining illegal drugs surveyed.
Last year use of other opiates was higher among younger 
(40%) than older adults (32%). Recent use of sedatives and/
or tranquillisers was higher for older than younger adults (7% 
vs 3%) and the same pattern was found for recent use of anti-
depressants (also 7% vs 3%).
Recent tobacco use was higher among younger adults (41% vs 
25%) and recent alcohol was also slightly higher among younger 
adults (85% vs 84%).
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Southern Regional Drug Task force –  
Last Month Prevalence (Current Use)
Last month prevalence of any illegal drugs is 3% in the Southern 
Regional Drug Task Force area.
Drug Type
In this region the most commonly used illegal drug in the month 
preceding the survey was cannabis (3%). Less than one per  
cent of respondents reported last month use of the remaining 
illegal drugs.
Last month prevalence of other opiates was 19%, for Anti-
depressants it was 4% and for sedatives and/or tranquillisers the 
rate was 3%.
A total of 27% of those surveyed in the region reported smoking 
tobacco and 73% reported consuming alcohol in the month 
prior to the survey.
Gender
Last month prevalence for any illegal drug was 4% among men 
and 2% among women. Men were more likely than women to 
report current use of cannabis (4% vs 2%). There are no other 
notable differences between men and women’s current use of 
illegal drugs.
Last month prevalence was higher among women for other 
opiates (24% vs 14%), sedatives and/or tranquillisers (4% vs 
2%) and for anti-depressants (6% vs 3%).
More men (32%) smoked tobacco in the last month than 
women (23%) and the rate for consuming alcohol in the last 
month was also higher among men (77%) than women (68%).
Age
Last month prevalence of any illegal drug was higher among 
younger (15-34 yrs) adults (4%) than older (35-64 yrs) adults 
(2%). Younger adults were most likely to report last month use 
of cannabis (4%). Among older adults cannabis (2%) was also 
most commonly reported for current use of illegal drugs; current 
use of the other illegal drugs were all very close to zero among 
older adults.
Younger adults (15-34 yrs) were more likely to report current 
use of other opiates (20% vs 18%) while older adults (35-64 
yrs) were more likely to report current use of sedatives and/or 
tranquillisers (4% vs 1%) and current use of anti-depressants 
(6% vs 2%).
Tobacco use in the last month was higher among younger 
(34%) than older (22%) adults. Consumption of alcohol in the 
month prior to the survey was marginally higher among younger 
adults (73% vs 72%).
Southern Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
Since the last survey there was an increase in use of cannabis 
in the Southern RDTF area. Since 2006/7 the share reporting 
lifetime use of cannabis increased from 15% to 23% (+8 
percentage points). Lifetime cannabis used increased among 
men (+13.1 percentage points) and women (+3.8 percentage 
points). An increase in lifetime prevalence for cannabis was 
recorded for younger adults (+15 percentage points). Among 
older adults, there was an increase in lifetime prevalence for 
ecstasy (+2.2 percentage points), LSD (+2 percentage points) 
and cocaine (including crack) (+2.8 percentage points).
Since 2006/7 no statistically significant changes were found for 
recent or current measures of use of the illegal drugs surveyed.
Sedatives, Tranquillisers and Anti-depressants
In this region lifetime prevalence for anti-depressants increased 
among older adults (+8 percentage points) since the last 
survey while last month prevalence increased among women 
(+ 3 percentage points) in this survey. No statistically significant 
changes for lifetime, last year or last month use of sedatives 
and/or tranquillisers were recorded since the last survey.
Alcohol and Tobacco
Since the last survey there were some changes in alcohol and 
tobacco use in this region. While recent tobacco use increased 
among men (+10 percentage points), current use of tobacco had 
declined among women (-7 percentage points) since the last 
survey. Alcohol consumption increased among older adults (35-
64 yrs) (+4.6 percentage points). There were no other statistically 
significant changes in tobacco or alcohol use since the last survey.
Other significant changes
No other statistically significant changes were found in drug 
prevalence since the last survey.
Western Regional Drug Task force – Lifetime 
Prevalence (Ever Used)
Results from the 2010/11 survey show that among all adults 
(15-64 yrs) 24% reported using an illegal drug at some stage in 
their life.
Drug Type
The most likely the illegal drug to be reported for lifetime use 
among adults (15-64 yrs) in this region was cannabis (23%), 
followed by cocaine (including crack) (6%) and an equal share 
of 4% reported ever using ecstasy or magic mushrooms in 
their lifetime. 3% reported ever using LSD and 2% poppers 
in their lifetime. Less than 1% reported lifetime use of heroin, 
methadone and crack.
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A total of 51% reported they had used other opiates, 9% 
sedatives and/or tranquillisers and 11% anti-depressants in their 
lifetime. Just over 57% said they had smoked tobacco and 91% 
had consumed alcohol in their lifetime.
Gender
In the Western RDTF region, use of illegal drugs was higher 
among men (31%) than women (17%). Men were at least 
three times more likely than women to report use of magic 
mushrooms (7% vs 2%), amphetamines (4% vs 1%), LSD 
(4% vs 0.1%), and at least twice as likely to have ever used 
cocaine (including crack) (8% vs 3%), ecstasy (5% vs 2%) and 
cannabis (30% vs 17%). Lifetime popper use was marginally 
higher among men (2% vs 3%). Men and women were equally 
likely to have reported lifetime use of solvents (2%).
Women were more likely than men to report ever using other 
opiates (61% vs 41%), sedatives and/or tranquillisers (12% vs 
6%) and anti-depressants (13% vs 8%).
Men and women were equally likely to report having smoked 
tobacco (57%) or consumed alcohol (91%) in their lifetime.
Age
Lifetime prevalence of any illegal drug in the Western RDTF was 
33% among young adults (aged 15-34 years) and 17% among 
older adults (35-64).
Among young adults the most frequently mentioned illegal drugs 
for lifetime use were cannabis (31%), cocaine (including crack) 
(7%), ecstasy and poppers (each 6%), magic mushrooms 
(4%) and LSD (2%). Among older adults, the most frequently 
mentioned illegal drugs were cannabis (17%), cocaine (including 
crack) (5%), magic mushrooms (4%), LSD (3%), ecstasy and 
amphetamines (each 2%) and solvents (1%).
Lifetime use of other opiates was higher among older adults (53% 
vs 48%). Lifetime prevalence of anti-depressants was similar for 
the two age groups (11% vs 10%) and rates were almost equal 
for lifetime use of sedatives and/or tranquillisers (each 9%).
Lifetime tobacco use was higher among older than younger 
adults (63% vs 48%). Lifetime consumption of alcohol was the 
same for the two age groups, at 91%.
Western Regional Drug Task force – Last Year 
Prevalence (Recent Use)
Last year prevalence any illegal drug was 5% in the Western 
RDTF area.
Drug Type
Cannabis (5%) was the most frequently reported illegal drug, 
followed by new psychoactive substance (3%). Less than one 
percent of respondents reported recent use of the other illegal 
drugs covered by the survey.
In the Western RDFT region 38% reported recent use of 
other opiates, 5% reported recent use of sedatives and/or 
tranquillisers and 3% reported recent use of anti-depressants.  
A total of 28% of those surveyed reported smoking tobacco and 
85% had consumed alcohol in the year prior to the survey.
Gender
Use of any illegal drug in the 12 months prior to the survey was 
higher among men (8%) than women (2%). Men were more 
likely to report last year use of cannabis (7% vs 2%) and new 
psychoactive substances (4% vs 1%). There are few differences 
between men and women in relation to recent use of the other 
illegal drugs surveyed. Lifetime use of anti-depressants was 
higher among men (4%) than women (3%) in this region.
Women were more likely than men to report recent use of other 
opiates (49% vs 26%) and sedatives and/or tranquillisers (7% 
vs 3%).
Men were more likely to report recent use of tobacco (37% vs 
25%) and alcohol (87% vs 84%).
Age
Last year prevalence of any illegal drug use was higher among 
younger (8%) than older adults (3%). Among young adults 
(15-34 yrs) cannabis (8%) was the most commonly used illegal 
drug followed by new psychoactive substances (4%), cocaine 
(including crack) and amphetamines (each 1%). Less than 1% 
of young adults reported recent use of the remaining illegal 
drugs surveyed. Among older adults (35-64 years) the illegal 
drug most commonly used in the year prior to the survey was 
cannabis (3%). Less than 1% of young adults reported recent 
use of each of the remaining illegal drugs surveyed.
Last year use of other opiates was slightly higher among older 
(38%) than young (37%) adults. Recent use of sedatives and/
or tranquillisers was reported equally by the two age groups 
(5%) and recent use of anti-depressants was higher for older 
than younger adults (4% vs 2%).
Young adults (15-34 yrs) were more likely than older adults 
(35-64 yrs) to report recent tobacco use (31% vs 26%) and to 
report drinking alcohol in the last month (88% vs 83%).
Western Regional Drug Task force –  
Last Month Prevalence (Current Use)
Last month prevalence of any illegal drugs was 2% in the 
Western Regional Drug Task Force area.
Drug Type
In this region the most commonly used illegal drug in the month 
preceding the survey was cannabis (2%). Less than one per cent of 
respondents reported last month use of the remaining illegal drugs.
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Current use of other opiates was 18%, while current use for anti-
depressants and sedatives and/or tranquillisers was 2% each.
A total of 23% of those surveyed in the region reported smoking 
tobacco and 70% reported consuming alcohol in the month 
prior to the survey.
Gender
Last month prevalence for any illegal drug was 3% among 
men and less than 1% for women. Men were more likely than 
women to report current use of cannabis (3% vs 0.3%) and to 
report current use of anti-depressants (3% vs 2%). There are no 
other notable differences between men and women’s current 
use of illegal drugs.
Last month prevalence was higher among women for other opiates 
(22% vs 13%) and recent use of sedatives and/or tranquillisers 
was almost equally reported by men and women (2%).
More men (26%) smoked tobacco in the last month than 
women (20%) and the rate for consuming alcohol in the last 
month was also higher among men (77%) than women (64%).
Age
There was little difference between last month prevalence of any 
illegal drug for younger (15-34 yrs) and older (35-64 yrs) adults 
(each 2%). Older adults were slightly more likely to report current 
use of cannabis (2%) and current use of the other illegal drugs 
were all very close to zero for both age groups in this region.
Younger adults (15-34 yrs) were more likely to report current 
use of other opiates (20% vs 16%) while older adults (35-64 
yrs) were more likely to report current use of sedatives and/or 
tranquillisers (3% vs 1%) and current use of anti-depressants 
(also 3% vs 1%).
Tobacco use in the last month was slightly higher among 
younger (24%) than older (22%) adults. Consumption of 
alcohol in the month prior to the survey was higher among 
younger than older adults (74% vs 68%).
Western Regional Drug Task force – 
Comparison 2006/7–2010/11
Any illegal drugs
In the Western RDTF area, the only illegal drug for which a 
statistically significant difference is recorded since 2006/7 is 
cocaine (including crack). Lifetime use of cocaine (including 
crack) increased from 3% in 2006/7 to 8% in 2010/11 (+5 
percentage points). This appears to reflect a change in lifetime 
cocaine use by men (+5.6 percentage points) and by older 
adults (+3.9 percentage points).
Since 2006/7 no statistically significant results were found in 
relation to changes in recent or current use of any of the illegal 
drugs surveyed.
Sedatives, Tranquillisers and Anti-depressants
In this region last month prevalence for Anti-depressants 
had decreased from 5% in 2006/7 to 2% in 2010/11 (-2.7 
percentage points). No statistically significant changes for lifetime, 
last year or last month use of sedatives and/or tranquillisers were 
recorded since the last survey.
Alcohol and Tobacco
While no decrease in lifetime tobacco use was found among 
all adults, there was a change recorded for young adults (-12 
percentage points). Last year prevalence among all adults for 
tobacco did decline from 38% in 2006/7 to 28% (35-64yrs) 
(-9.4 percentage points). A decrease in recent use was found 
for women (-14.4 percentage points), young adults (-9.8 
percentage points) as well as older adults (-9.3 percentage 
points). Last month prevalence for tobacco fell among women 
(-12.4 percentage points), young adults (-9.9 percentage points) 
and older adults (-8.9 percentage points).
There were no other statistically significant changes in use  
of tobacco or alcohol since the last survey.
Other significant changes
No other statistically significant changes were found in drug 
prevalence since the last survey.
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Prevalence Table 1 – Northern Ireland Prevalence Rates 
Table 1.1 Lifetime prevalence of drug use in Northern Ireland, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 3,516 2,002 2,535 1,575 893 1,163 1,941 1,109 1,372 1,397 714 855 2,119 1,280 1,678
Any illegal drug* 20.0 28.0 27.3b 26.7 33.9 32.3b 13.5 22.1 22.4b 30.9 40.2 36.9b 11.5 19.3 20.4b
Cannabis 16.8 24.7 24.0b 23.3 30.1 29.2b 10.5 19.3 18.8b 25.1 35.0 32.2b 10.3 17.3 18.0b
Heroin 0.2 0.5 0.4 0.4 0.6 0.6 0.0 0.4 0.1b 0.3 0.6 0.2 0.1 0.4 0.5
Methadone 0.1 0.1 1.0a 0.2 0.1 1.5a 0.1 0.1 0.5 0.2 0.1 2.0a 0.1 0.1 0.3
Other opiates† 18.0 20.2 15.6 16.4 17.4 13.9 19.5 23.0 17.4ab 17.9 14.4 13.0 18.0 24.7 17.6ab
Cocaine (including crack) 1.6 5.2 6.7b 2.8 7.4 8.8b 0.5 2.9 4.5b 2.9 9.1 11.2b 0.6 2.3 3.4b
Crack 0.2 0.4 0.9 0.4 0.4 1.2a 0.1 0.4 0.6b 0.4 0.6 1.1 0.1 0.3 0.7
Cocaine powder 1.6 5.1 6.5b 2.7 7.3 8.7b 0.5 2.9 4.3b 2.9 9.1 10.8b 0.6 2.2 3.3b
Amphetamines 4.0 5.8 6.3b 6.3 7.3 8.1 1.8 4.4 4.6b 7.2 9.1 8.9 1.5 3.4 4.4b
Ecstasy 5.8 7.7 8.8b 8.3 9.9 11.1 3.3 5.5 6.5b 11.3 14.3 14.2 1.4 2.9 4.8ab
LSD 4.5 6.6 5.1b 7.0 9.7 6.9b 2.0 3.5 3.3b 7.8 9.4 5.7a 1.9 4.5 4.6b
Magic mushrooms 4.3 6.7 5.8b 6.3 11.2 8.6b 2.4 2.4 3.0 6.4 8.3 7.7 2.7 5.6 4.4b
Solvents 2.9 3.5 3.9 4.1 5.1 4.2 1.7 2.0 3.7a 5.4 5.5 5.2 1.0 2.1 3.1b
Poppers 5.5 7.8 8.8b 7.3 10.9 10.0b 3.8 4.9 7.6a 10.9 14.0 13.6 1.3 3.4 5.2ab
Anabolic steroids 0.7 1.0 1.4 0.7 0.9 1.9 0.8 1.0 0.9 0.9 1.0 0.9 0.6 0.9 1.8
Sedatives and tranquillisers – 20.2 20.7 – 18.1 17.2 – 22.3 24.1 – 11.7 13.6 – 26.5 25.8
Anti-depressants – 21.0 21.9 – 13.4 15.3 – 28.4 28.4 – 13.6 13.6 – 26.6 28.0
Mephedrone – – 2.0 – – 3.1 – – 0.9 – – 4.3 – – 0.4
Legal highs – – 2.4 – – 3.0 – – 1.8 – – 4.8 – – 0.6
Alcohol 88.2 87.3 88.9 90.3 89.4 91.5 86.0 85.2 86.3 89.1 87.9 88.9 87.4 87.2 89.1
Tobacco 58.6 55.3 54.9b 61.4 59.7 59.5 55.8 51.1 50.3b 56.8 54.6 50.8 59.9 56.1 58.0b
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
- Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 1.2 Last year prevalence of drug use in Northern Ireland, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 3,516 2,002 2,535 1,575 893 1,163 1,941 1,109 1,372 1,397 714 855 2,119 1,280 1,678
Any illegal drug* 6.4 9.4 6.6ab 9.7 13.7 9.2ab 3.1 5.2 3.9b 11.6 17.3 11.8ab 2.2 3.7 2.7b
Cannabis 5.4 7.2 5.1ab 8.7 10.3 7.4 2.2 4.1 2.7b 9.8 12.4 9.4 2.0 3.3 1.9ab
Heroin 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1
Methadone 0.0 0.0 0.4a 0.0 0.0 0.6a 0.1 0.0 0.3 0.0 0.0 0.8a 0.1 0.0 0.2
Other opiates† 8.0 8.4 6.4a 6.9 8.0 5.8 9.0 8.7 7.0 7.5 7.1 5.6 8.3 9.3 6.9a
Cocaine (including crack) 0.5 1.9 1.5b 1.0 2.8 2.1b 0.1 0.9 0.9b 1.0 3.5 2.5b 0.1 0.7 0.8b
Crack 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.2
Cocaine powder 0.5 1.9 1.5b 0.9 2.8 2.1b 0.1 0.9 0.8b 0.9 3.5 2.5b 0.1 0.7 0.7b
Amphetamines 0.8 1.0 1.1 1.4 1.1 1.5 0.2 0.9 0.8b 1.5 1.7 1.5 0.2 0.4 0.9
Ecstasy 1.6 1.8 1.1 2.7 2.4 1.9 0.6 1.2 0.4 3.3 3.4 2.0 0.4 0.6 0.4
LSD 0.1 0.2 0.2 0.0 0.2 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.0 0.3 0.1b
Magic mushrooms 0.2 0.2 0.2 0.4 0.1 0.2 0.1 0.3 0.1 0.3 0.5 0.3 0.1 0.0 0.1
Solvents 0.2 0.2 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.2 0.0 0.1 0.0
Poppers 0.5 1.3 0.8b 0.7 2.3 1.1b 0.3 0.3 0.4 1.1 2.7 1.5b 0.0 0.2 0.2
Anabolic steroids 0.3 0.2 0.8a 0.3 0.2 0.9 0.3 0.2 0.7 0.4 0.3 0.7 0.3 0.2 0.9
Sedatives and tranquillisers – 9.2 11.0 – 8.2 9.3 – 10.2 12.7 – 4.6 6.4 – 12.6 14.3
Anti-depressants – 9.1 12.0a – 5.8 8.9a – 12.4 15.2 – 5.8 7.1 – 11.7 15.7a
Mephedrone – – 1.1 – – 1.9 – – 0.3 – – 2.2 – – 0.3
Legal highs – – 1.0 – – 1.6 – – 0.3 – – 2.0 – – 0.2
Alcohol 79.3 79.0 79.1 82.2 79.0 82.5 76.5 75.9 75.8 83.4 82.0 82.4 76.1 77.1 76.9
Tobacco 40.2 33.5 33.2b 40.9 33.5 35.5b 39.6 31.2 31.0b 43.2 39.1 36.7b 37.9 29.5 30.7b
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 1.3 Last month prevalence of drug use in Northern Ireland, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 3,516 2,002 2,535 1,575 893 1,163 1,941 1,109 1,372 1,397 1,109 855 2,119 1,280 1,678
Any illegal drug* 3.4 3.6 3.3 5.7 4.9 5.1 1.1 2.4 1.6b 6.1 5.9 5.7 1.2 2.0 1.7b
Cannabis 2.9 2.6 2.7 5.1 3.7 4.4 0.8 1.6 1.1b 5.4 3.7 4.6 1.0 1.8 1.3b
Heroin 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1
Other opiates† 4.1 4.9 3.6 3.1 5.1 3.3b 5.2 4.7 3.8 3.3 3.6 2.9 4.8 5.8 4.0a
Cocaine (including crack) 0.1 0.3 0.5 0.2 0.7 0.9 0.0 0.0 0.2 0.2 0.6 0.6 0.0 0.2 0.5
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1
Cocaine powder 0.1 0.3 0.5 0.2 0.7 0.9 0.0 0.0 0.1 0.2 0.6 0.6 0.0 0.2 0.4
Amphetamines 0.2 0.3 0.3 0.5 0.4 0.5 0.0 0.2 0.2 0.3 0.3 0.3 0.1 0.3 0.4
Ecstasy 0.5 0.8 0.3 0.9 0.8 0.5 0.1 0.7 0.1b 1.1 1.4 0.6 0.1 0.3 0.1
LSD 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1
Magic mushrooms 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0
Solvents 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0
Poppers 0.2 0.3 0.1 0.2 0.6 0.1 0.1 0.0 0.1 0.3 0.7 0.2 0.0 0.0 0.0
Anabolic steroids 0.1 0.2 0.5 0.1 0.2 0.7 0.2 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.7a
Sedatives and tranquillisers – 7.1 8.0 – 5.7 7.3 – 8.4 8.7 – 2.3 3.6 – 10.7 11.2
Anti-depressants – 7.5 10.2a – 4.2 7.6a – 10.7 12.8 – 4.2 5.0 – 10.0 14.0a
Mephedrone – – 0.1 – – 0.1 – – 0.0 – – 0.1 – – 0.0
Legal highs – – 0.2 – – 0.3 – – 0.1 – – 0.4 – – 0.0
Alcohol 67.6 69.5 67.5 72.7 69.5 72.4 62.5 64.5 62.6 70.1 71.0 70.2 65.5 68.6 65.6
Tobacco 37.0 29.5 30.0b 37.0 29.5 31.7b 37.1 28.1 28.3b 39.3 32.8 32.2b 35.2 27.1 28.4
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Prevalence Table 2 – Belfast HSCT Prevalence Rates 
Table 2.1 Lifetime prevalence of drug use in BHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 462 – – 194 – – 268 – – 187 – – 274
Any illegal drug* – – 40.6 – – 46.4 – – 35.2 – – 49.3 – – 33.2
Cannabis – – 33.8 – – 39.9 – – 28.0 – – 39.6 – – 28.8
Heroin – – 1.4 – – 2.9 – – 0.0 – – 0.9 – – 1.9
Methadone – – 1.0 – – 1.3 – – 0.6 – – 1.6 – – 0.4
Other opiates† – – 22.7 – – 21.7 – – 23.7 – – 21.4 – – 23.9
Cocaine (including crack) – – 14.3 – – 20.1 – – 8.8 – – 19.8 – – 9.6
Crack – – 2.8 – – 4.4 – – 1.3 – – 2.9 – – 2.7
Cocaine powder – – 13.8 – – 19.3 – – 8.5 – – 19.0 – – 9.2
Amphetamines – – 12.3 – – 16.5 – – 8.2 – – 14.3 – – 10.6
Ecstasy – – 16.2 – – 20.4 – – 12.3 – – 20.8 – – 12.3
LSD – – 9.1 – – 12.2 – – 6.1 – – 7.8 – – 10.2
Magic mushrooms – – 9.6 – – 14.0 – – 5.4 – – 10.1 – – 9.2
Solvents – – 7.8 – – 9.7 – – 6.0 – – 8.5 – – 7.2
Poppers – – 17.1 – – 19.1 – – 15.2 – – 22.1 – – 12.7
Anabolic steroids – – 2.4 – – 3.9 – – 1.0 – – 1.6 – – 3.0
Sedatives and tranquillisers – – 27.0 – – 23.0 – – 30.9 – – 18.4 – – 34.5
Anti-depressants – – 23.5 – – 19.3 – – 27.5 – – 15.2 – – 30.7
Mephedrone – – 3.3 – – 4.8 – – 1.9 – – 6.2 – – 0.9
Legal highs – – 3.6 – – 4.8 – – 2.5 – – 5.9 – – 1.6
Alcohol – – 90.4 – – 90.4 – – 90.3 – – 87.8 – – 92.6
Tobacco – – 55.1 – – 59.4 – – 50.9 – – 46.9 – – 62.1
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The BHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11.
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Table 2.2 Last year prevalence of drug use in BHSCT, 2002/3, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 462 – – 194 – – 268 – – 187 – – 274
Any illegal drug* – – 11.3 – – 14.9 – – 7.9 – – 18.1 – – 5.4
Cannabis – – 8.5 – – 12.1 – – 5.0 – – 14.0 – – 3.8
Heroin – – 0.4 – – 0.8 – – 0.0 – – 0.4 – – 0.4
Methadone – – 0.4 – – 0.5 – – 0.3 – – 0.3 – – 0.4
Other opiates† – – 10.4 – – 10.8 – – 10.0 – – 11.0 – – 9.9
Cocaine (including crack) – – 3.2 – – 4.0 – – 2.5 – – 4.2 – – 2.3
Crack – – 0.7 – – 0.4 – – 1.0 – – 0.7 – – 0.7
Cocaine powder – – 3.1 – – 4.0 – – 2.2 – – 4.2 – – 2.0
Amphetamines – – 2.0 – – 2.7 – – 1.2 – – 2.3 – – 1.7
Ecstasy – – 1.6 – – 2.2 – – 0.9 – – 2.0 – – 1.2
LSD – – 0.5 – – 0.4 – – 0.6 – – 0.7 – – 0.4
Magic mushrooms – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Solvents – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Poppers – – 1.8 – – 1.8 – – 1.9 – – 3.5 – – 0.4
Anabolic steroids – – 1.2 – – 1.5 – – 1.0 – – 0.7 – – 1.6
Sedatives and tranquillisers – – 13.3 – – 11.6 – – 14.8 – – 6.3 – – 19.3
Anti-depressants – – 13.5 – – 11.8 – – 15.1 – – 7.9 – – 18.3
Mephedrone – – 2.0 – – 3.1 – – 0.9 – – 3.3 – – 0.9
Legal highs – – 1.4 – – 2.2 – – 0.6 – – 1.6 – – 1.2
Alcohol – – 80.5 – – 81.0 – – 80.0 – – 81.2 – – 79.8
Tobacco – – 36.7 – – 39.6 – – 33.9 – – 35.9 – – 37.3
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The BHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11.
Drug use in Ireland and Northern Ireland 2010/11: Drug Prevalence Survey: Regional Drug Task Force (Ireland) and Health and Social Care Trust (Northern Ireland) Results
41 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB)
Table 2.3 Last month prevalence of drug use in BHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 462 – – 194 – – 268 – – 187 – – 274
Any illegal drug* – – 6.3 – – 8.7 – – 4.1 – – 9.7 – – 3.5
Cannabis – – 4.7 – – 7.3 – – 2.2 – – 7.5 – – 2.3
Heroin – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Methadone – – 0.2 – – 0.5 – – 0.0 – – 0.0 – – 0.4
Other opiates† – – 5.5 – – 6.5 – – 4.5 – – 5.3 – – 5.7
Cocaine (including crack) – – 1.4 – – 1.9 – – 0.9 – – 0.7 – – 2.0
Crack – – 0.2 – – 0.0 – – 0.3 – – 0.0 – – 0.3
Cocaine powder – – 1.2 – – 1.9 – – 0.6 – – 0.7 – – 1.7
Amphetamines – – 0.6 – – 1.3 – – 0.0 – – 0.4 – – 0.8
Ecstasy – – 0.8 – – 0.9 – – 0.6 – – 0.7 – – 0.8
LSD – – 0.2 – – 0.4 – – 0.0 – – 0.0 – – 0.4
Magic mushrooms – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Solvents – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Poppers – – 0.3 – – 0.0 – – 0.6 – – 0.7 – – 0.0
Anabolic steroids – – 0.9 – – 1.5 – – 0.3 – – 0.0 – – 1.6
Sedatives and tranquillisers – – 8.9 – – 8.1 – – 9.6 – – 1.6 – – 15.3
Anti-depressants – – 10.8 – – 9.2 – – 12.2 – – 3.9 – – 16.7
Mephedrone – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Legal highs – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Alcohol – – 70.8 – – 73.5 – – 68.2 – – 70.4 – – 71.1
Tobacco – – 33.4 – – 36.9 – – 30.1 – – 32.9 – – 33.8
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The BHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11.
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Prevalence Table 3 – Northern HSCT Prevalence Rates 
Table 3.1 Lifetime prevalence of drug use in NHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 877 498 495 401 211 246 476 287 249 331 175 161 546 322 333
Any illegal drug* 17.8 24.8 22.1 22.9 28.7 25.1 12.7 21.0 19.1 29.3 38.0 31.6 9.1 15.9 15.6b
Cannabis 14.4 22.2 18.9 19.5 26.2 23.3 9.3 18.3 14.6 22.8 33.8 27.9 8.1 14.4 12.8b
Heroin 0.4 0.1 0.2 0.8 0.0 0.3 0.0 0.3 0.0 0.4 0.4 0.0 0.4 0.0 0.3
Methadone 0.0 0.0 1.2ab 0.0 0.0 1.8b 0.0 0.0 0.6 0.0 0.0 2.6b 0.0 0.0 0.3
Other opiates† 18.0 20.3 13.4a 15.3 14.7 10.5 20.7 25.8 16.4a 20.8 16.5 10.1b 15.9 22.9 15.7a
Cocaine (including crack) 1.0 3.8 4.9b 2.1 5.6 5.3 0.0 1.9 4.5b 1.3 6.7 10.1b 0.9 1.8 1.5
Crack 0.3 0.6 0.7 0.6 0.0 0.7 0.0 1.1 0.6 0.4 1.4 0.8 0.2 0.0 0.6
Cocaine powder 1.0 3.8 4.6b 2.1 5.6 5.3 0.0 1.9 3.9b 1.3 6.7 9.3b 0.9 1.8 1.5
Amphetamines 4.1 5.5 6.2 6.3 6.6 6.4 1.8 4.4 6.1b 6.4 7.0 10.3 2.3 4.5 3.5
Ecstasy 5.9 5.6 6.1 8.7 6.6 6.6 3.2 4.6 5.6 11.3 10.7 11.3 1.9 2.2 2.6
LSD 4.7 6.3 4.6 7.9 8.2 6.8 1.4 4.4 2.3 7.3 8.5 6.6 2.7 4.9 3.2
Magic mushrooms 5.2 5.6 4.4 7.8 8.6 5.0 2.5 2.6 3.8 7.7 7.1 7.3 3.2 4.6 2.4
Solvents 2.9 2.3 3.1 4.0 3.0 3.0 1.8 1.7 3.3 5.6 4.8 3.5 0.8 0.6 2.9ab
Poppers 6.7 8.1 6.2 8.8 10.1 5.9 4.5 6.1 6.5 12.4 14.8 11.5 2.3 3.6 2.6
Anabolic steroids 0.2 1.0 1.7b 0.5 1.1 2.1 0.0 1.0 1.2b 0.5 0.9 0.4 0.0 1.2 2.5b
Sedatives and tranquillisers – 20.4 19.7 – 19.4 14.1 – 21.4 25.3 – 10.9 11.8 – 27.0 25.0
Anti-depressants – 20.7 22.6 – 12.9 12.8 – 28.4 32.4 – 13.5 14.9 – 25.7 27.9
Mephedrone – – 1.8 – – 2.0 – – 1.6 – – 4.0 – – 0.3
Legal highs – – 1.8 – – 0.7 – – 2.9 – – 4.5 – – 0.0
Alcohol 86.1 88.0 88.1 87.7 90.8 93.0 84.5 85.1 83.1 85.8 89.2 90.4 86.3 87.4 86.5
Tobacco 54.9 55.1 54.9 57.3 61.1 61.2 52.6 49.1 48.6 55.9 60.2 48.2 54.2 51.7 59.4
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 3.2 Last year prevalence of drug use in NHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 877 498 495 401 211 246 476 287 249 331 175 161 546 322 333
Any illegal drug* 6.2 7.2 4.6 9.8 10.2 5.9 2.7 4.3 3.2 11.7 13.4 7.5 2.1 3.0 2.6
Cannabis 5.4 6.5 3.0a 9.1 9.7 3.8b 1.7 3.4 2.3 9.8 11.8 5.3 2.1 3.0 1.5
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3
Other opiates† 9.5 8.4 5.3b 8.4 6.9 4.5 10.6 9.8 6.1b 10.2 9.0 4.9b 9.0 8.0 5.5
Cocaine (including crack) 0.0 1.1 1.2b 0.0 2.0 1.1 0.0 0.3 1.2 0.0 1.9 2.5b 0.0 0.6 0.3
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 1.1 1.2b 0.0 2.0 1.1 0.0 0.3 1.2 0.0 1.9 2.5b 0.0 0.6 0.3
Amphetamines 0.6 0.3 1.1 0.9 0.4 1.1 0.2 0.3 1.2 1.0 0.4 1.5 0.2 0.3 0.9
Ecstasy 1.5 0.9 1.1 3.1 1.5 1.8 0.0 0.3 0.3 3.0 1.2 2.3 0.4 0.6 0.3
LSD 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0
Magic mushrooms 0.3 0.0 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3
Solvents 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.3 0.0
Poppers 0.6 0.6 0.2 0.6 1.2 0.3 0.5 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.3
Anabolic steroids 0.0 0.5 0.5 0.0 0.7 0.4 0.0 0.3 0.6 0.0 0.9 0.4 0.0 0.3 0.6
Sedatives and tranquillisers – 9.3 10.3 – 8.4 6.6 – 10.1 14.0 – 4.0 5.4 – 12.9 13.7
Anti-depressants – 8.6 12.1 – 6.2 5.6 – 10.9 18.5a – 7.0 7.2 – 9.7 15.3a
Mephedrone – – 0.8 – – 1.6 – – 0.0 – – 1.5 – – 0.3
Legal highs – – 0.4 – – 0.7 – – 0.0 – – 0.9 – – 0.0
Alcohol 77.1 79.5 76.4 78.3 82.8 83.0 75.9 76.2 69.7 79.1 82.3 83.3 75.6 77.9 71.6
Tobacco 38.3 34.7 31.8 38.7 37.0 35.1 38.0 32.3 28.4b 41.9 41.3 33.7 35.7 30.3 30.4
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
Drug use in Ireland and Northern Ireland 2010/11: Drug Prevalence Survey: Regional Drug Task Force (Ireland) and Health and Social Care Trust (Northern Ireland) Results
44 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB)
Table 3.3 Last month prevalence of drug use in NHSCT, 2002/3, 2006/7 and 2010/111
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 877 498 495 401 211 246 476 287 249 331 175 161 546 322 333
Any illegal drug* 3.8 1.6 2.1 6.5 2.0 3.3 1.0 1.1 0.9 6.8 2.5 3.2 1.5 0.9 1.4
Cannabis 3.5 1.6 1.3b 6.2 2.0 2.2 0.8 1.1 0.3 6.1 2.5 1.5b 1.5 0.9 1.2
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 5.2 5.1 2.4b 3.8 5.2 1.2b 6.6 4.9 3.7 5.2 5.2 2.1 5.3 5.0 2.7b
Cocaine (including crack) 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0
Amphetamines 0.2 0.2 0.7 0.3 0.4 0.7 0.0 0.0 0.6 0.4 0.0 0.8 0.0 0.3 0.6
Ecstasy 1.1 0.0 0.4 2.2 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.9 0.2 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0
Anabolic steroids 0.0 0.2 0.3 0.0 0.7 0.4 0.0 0.3 0.3 0.0 0.9 0.0 0.0 0.3 0.6
Sedatives and tranquillisers – 7.4 7.1 – 6.1 5.2 – 8.7 8.9 – 1.7 2.5 – 11.3 10.1
Anti-depressants – 6.8 9.5 – 4.6 4.6 – 8.9 14.5 – 4.0 6.0 – 8.6 11.9
Mephedrone – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Legal highs – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Alcohol 64.5 66.6 65.4 67.8 73.0 71.6 61.3 60.1 59.2 65.0 68.5 70.9 64.2 65.5 61.7
Tobacco 35.4 30.0 28.4b 35.6 32.7 30.3 35.3 27.3 26.5b 37.6 31.8 28.6 33.8 28.8 28.2
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Prevalence Table 4 – South Eastern HSCT Prevalence Rates 
Table 4.1 Lifetime prevalence of drug use in SEHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 517 – – 242 – – 275 – – 145 – – 372
Any illegal drug* – – 31.2 – – 35.8 – – 26.7 – – 42.4 – – 24.0
Cannabis – – 27.4 – – 32.3 – – 22.6 – – 37.1 – – 21.2
Heroin – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Methadone – – 0.5 – – 0.4 – – 0.5 – – 1.2 – – 0.0
Other opiates† – – 22.4 – – 22.3 – – 22.4 – – 17.3 – – 25.7
Cocaine (including crack) – – 7.0 – – 9.3 – – 4.8 – – 11.7 – – 4.1
Crack – – 0.8 – – 0.8 – – 0.9 – – 1.2 – – 0.6
Cocaine powder – – 7.0 – – 9.3 – – 4.8 – – 11.7 – – 4.1
Amphetamines – – 6.1 – – 8.2 – – 4.0 – – 9.5 – – 3.8
Ecstasy – – 11.0 – – 14.4 – – 7.6 – – 19.0 – – 5.8
LSD – – 7.2 – – 9.6 – – 4.8 – – 7.3 – – 7.1
Magic mushrooms – – 7.9 – – 12.7 – – 3.2 – – 10.7 – – 6.1
Solvents – – 4.1 – – 3.8 – – 4.5 – – 6.1 – – 2.8
Poppers – – 11.7 – – 14.9 – – 8.6 – – 18.8 – – 7.1
Anabolic steroids – – 1.4 – – 1.8 – – 0.9 – – 1.9 – – 1.0
Sedatives and tranquillisers – – 23.9 – – 21.7 – – 26.0 – – 18.6 – – 27.2
Anti-depressants – – 24.1 – – 15.9 – – 32.3 – – 16.7 – – 28.9
Mephedrone – – 2.3 – – 4.7 – – 0.0 – – 5.9 – – 0.0
Legal highs – – 3.2 – – 4.7 – – 1.7 – – 6.8 – – 0.9
Alcohol – – 90.3 – – 92.7 – – 87.9 – – 88.1 – – 91.8
Tobacco – – 54.7 – – 58.6 – – 51.0 – – 55.0 – – 54.6
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The SEHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11.
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Table 4.2 Last year prevalence of drug use in SEHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 517 – – 242 – – 275 – – 145 – – 372
Any illegal drug* – – 6.4 – – 10.3 – – 2.7 – – 13.5 – – 1.8
Cannabis – – 5.2 – – 8.2 – – 2.1 – – 11.2 – – 1.2
Heroin – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Methadone – – 0.3 – – 0.0 – – 0.5 – – 0.7 – – 0.0
Other opiates† – – 8.5 – – 7.6 – – 9.4 – – 6.8 – – 9.6
Cocaine (including crack) – – 1.8 – – 3.1 – – 0.5 – – 3.1 – – 0.9
Crack – – 0.5 – – 0.4 – – 0.5 – – 0.7 – – 0.3
Cocaine powder – – 1.8 – – 3.1 – – 0.5 – – 3.1 – – 0.9
Amphetamines – – 1.2 – – 1.9 – – 0.5 – – 1.6 – – 0.9
Ecstasy – – 1.0 – – 1.9 – – 0.0 – – 2.4 – – 0.0
LSD – – 0.6 – – 1.2 – – 0.0 – – 1.5 – – 0.0
Magic mushrooms – – 0.6 – – 0.7 – – 0.5 – – 1.6 – – 0.0
Solvents – – 0.2 – – 0.4 – – 0.0 – – 0.5 – – 0.0
Poppers – – 0.6 – – 1.2 – – 0.0 – – 1.5 – – 0.0
Anabolic steroids – – 1.2 – – 1.8 – – 0.7 – – 1.9 – – 0.8
Sedatives and tranquillisers – – 11.2 – – 11.4 – – 11.1 – – 9.2 – – 12.5
Anti-depressants – – 12.9 – – 10.3 – – 15.6 – – 9.1 – – 15.4
Mephedrone – – 0.7 – – 1.5 – – 0.0 – – 1.9 – – 0.0
Legal highs – – 1.4 – – 2.2 – – 0.5 – – 3.5 – – 0.0
Alcohol – – 82.6 – – 86.4 – – 78.8 – – 80.2 – – 84.1
Tobacco – – 30.2 – – 31.7 – – 28.7 – – 36.1 – – 26.3
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The SEHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11.
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Table 4.3 Last month prevalence of drug use in SEHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) – – 517 – – 242 – – 275 – – 145 – – 372
Any illegal drug* – – 4.0 – – 7.1 – – 1.1 – – 8.4 – – 1.2
Cannabis – – 3.6 – – 6.3 – – 1.1 – – 7.8 – – 0.9
Heroin – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Methadone – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Other opiates† – – 5.3 – – 5.3 – – 5.3 – – 3.3 – – 6.6
Cocaine (including crack) – – 0.8 – – 1.5 – – 0.0 – – 0.9 – – 0.6
Crack – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Cocaine powder – – 0.8 – – 1.5 – – 0.0 – – 0.9 – – 0.6
Amphetamines – – 0.2 – – 0.4 – – 0.0 – – 0.0 – – 0.3
Ecstasy – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
LSD – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Magic mushrooms – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Solvents – – 0.2 – – 0.4 – – 0.0 – – 0.5 – – 0.0
Poppers – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Anabolic steroids – – 0.7 – – 1.0 – – 0.3 – – 0.9 – – 0.5
Sedatives and tranquillisers – – 9.0 – – 9.4 – – 8.5 – – 6.9 – – 10.3
Anti-depressants – – 11.5 – – 8.7 – – 14.2 – – 7.9 – – 13.8
Mephedrone – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Legal highs – – 0.6 – – 0.7 – – 0.5 – – 1.6 – – 0.0
Alcohol – – 71.2 – – 78.0 – – 64.6 – – 68.9 – – 72.8
Tobacco – – 26.3 – – 26.3 – – 26.2 – – 30.2 – – 23.8
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  The SEHSCT was established since the last survey and therefore it is not possible to make statistical comparisons between 2006/7 and 2010/11 or between 2002/3 and 2010/11. 
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Prevalence Table 5 – Southern HSCT Prevalence Rates 
Table 5.1 Lifetime prevalence of drug use in SHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 655 511 538 306 249 245 349 262 293 267 193 195 388 316 343
Any illegal drug* 19.1 21.6 23.1 26.4 25.5 29.3 11.8 17.8 16.8 28.8 28.6 30.5 11.4 16.5 17.4b
Cannabis 16.3 18.7 21.1b 23.0 23.1 26.4 9.5 14.3 15.6b 23.9 25.6 27.8 10.2 13.6 15.8b
Heroin 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.3 0.0
Methadone 0.2 0.2 0.8 0.0 0.4 1.0 0.3 0.0 0.5 0.0 0.4 1.7 0.3 0.0 0.0
Other opiates† 13.1 10.8 10.9 11.2 9.9 9.1 15.0 11.7 12.8 9.9 8.6 8.4 15.6 12.5 12.8
Cocaine (including crack) 0.8 3.5 2.7b 1.4 5.6 4.3 0.2 1.3 1.0 1.5 6.3 4.8 0.2 1.3 1.0
Crack 0.0 0.6 0.2 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.7 0.0
Cocaine powder 0.8 3.3 2.7b 1.4 5.2 4.3 0.2 1.3 1.0 1.5 6.3 4.8 0.2 1.0 1.0
Amphetamines 2.3 3.7 2.8 4.1 4.7 3.8 0.5 2.8 1.8 3.4 4.7 3.1 1.4 3.0 2.6
Ecstasy 3.2 5.4 5.3 4.9 7.2 7.6 1.5 3.7 2.9 6.1 10.4 9.1 0.9 1.6 2.4
LSD 3.4 2.9 2.2 4.4 4.3 2.5 2.4 1.5 2.0 6.5 3.3 2.6 0.9 2.6 2.0
Magic mushrooms 2.9 3.2 3.3 4.1 5.3 5.6 1.8 1.1 1.0 4.3 3.2 2.8 1.9 3.2 3.6
Solvents 3.2 3.2 1.7 3.7 5.4 2.4 2.7 1.0 1.0 6.1 5.0 2.1 0.9 1.9 1.4
Poppers 3.4 4.9 4.2 5.1 8.0 5.2 1.8 1.8 3.2 7.1 7.2 6.7 0.5 3.2 2.3b
Anabolic steroids 0.4 1.1 1.0 0.3 1.0 0.7 0.5 1.3 1.2 0.3 1.7 0.4 0.5 0.7 1.4
Sedatives and tranquillisers – 15.0 17.3 – 12.0 14.9 – 18.1 19.7 – 8.0 9.0 – 20.1 23.7
Anti-depressants – 17.8 19.8 – 11.7 15.6 – 23.9 24.2 – 13.2 8.2 – 21.4 28.8a
Mephedrone – – 1.1 – – 1.6 – – 0.5 – – 2.0 – – 0.4
Legal highs – – 1.3 – – 1.4 – – 1.2 – – 2.1 – – 0.7
Alcohol 85.7 80.9 88.4a 88.9 84.4 90.5a 82.5 77.5 86.3a 89.3 81.6 88.2 82.9 80.6 88.6ab
Tobacco 57.3 50.3 54.8 61.8 54.8 59.2 52.8 45.9 50.2 54.4 47.7 52.0 59.7 52.0 56.9
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 5.2 Last year prevalence of drug use in SHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 655 511 538 306 249 245 349 262 293 267 193 195 388 316 343
Any illegal drug* 5.1 7.4 4.7 8.2 10.8 6.5 1.8 4.0 2.8 9.6 13.7 8.6 1.5 2.7 1.7
Cannabis 4.3 7.1 3.5a 7.9 10.2 5.1a 0.7 4.0 2.0 7.9 13.0 6.5a 1.5 2.7 1.3
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.0 0.5 0.0 0.0 0.4 0.3 0.0 0.5 0.0 0.0 1.0 0.3 0.0 0.0
Other opiates† 5.5 5.7 4.9 4.1 4.9 4.0 6.9 6.5 5.8 4.0 4.9 2.5 6.7 6.4 6.7
Cocaine (including crack) 0.2 1.1 0.2 0.3 2.1 0.4 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.3 0.4
Crack 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0
Cocaine powder 0.2 1.1 0.2 0.3 2.1 0.4 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.3 0.4
Amphetamines 0.0 0.7 0.9b 0.0 1.4 1.2 0.0 0.0 0.5 0.0 1.1 1.0 0.0 0.3 0.7
Ecstasy 0.5 0.8 0.3 0.7 1.6 0.6 0.4 0.0 0.0 0.9 1.8 0.7 0.2 0.0 0.0
LSD 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.4 0.4 0.0 0.9 0.8 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0
Solvents 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0
Poppers 0.4 0.2 0.6 0.9 0.4 0.8 0.0 0.0 0.3 1.0 0.4 0.9 0.0 0.0 0.4
Anabolic steroids 0.3 0.1 0.8 0.0 0.0 0.4 0.5 0.3 1.2 0.3 0.0 0.4 0.2 0.2 1.1
Sedatives and tranquillisers – 6.8 10.7a – 4.5 9.5a – 9.1 12.0 – 3.4 5.2 – 9.5 15.0a
Anti-depressants – 9.3 11.0 – 5.6 9.8 – 13.0 12.3 – 9.7 3.6a – 9.0 16.8a
Mephedrone – – 0.8 – – 1.0 – – 0.5 – – 1.3 – – 0.4
Legal highs – – 0.8 – – 1.0 – – 0.5 – – 1.7 – – 0.0
Alcohol 76.5 73.6 78.3 79.9 76.1 79.3 73.1 71.1 77.3 85.0 75.3 83.3 69.7 72.4 74.4
Tobacco 38.6 29.6 34.3 41.9 33.3 35.1 35.3 25.9 33.3 41.2 36.2 38.2 36.5 24.4 31.2
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
Drug use in Ireland and Northern Ireland 2010/11: Drug Prevalence Survey: Regional Drug Task Force (Ireland) and Health and Social Care Trust (Northern Ireland) Results
50 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB)
Table 5.3 Last month prevalence of drug use in SHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 655 511 538 306 249 245 349 262 293 267 193 195 388 316 343
Any illegal drug* 2.1 3.8 1.3a 3.5 5.8 1.8a 0.8 1.8 0.7 4.3 8.5 1.6a 0.5 0.3 1.0
Cannabis 1.5 3.5 1.1a 3.1 5.2 1.4a 0.0 1.8 0.7 2.9 7.8 1.1a 0.5 0.3 1.0
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0
Other opiates† 2.8 3.2 3.1 1.2 3.9 2.1 4.5 2.5 4.0 1.8 2.4 2.5 3.7 3.8 3.5
Cocaine (including crack) 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.2 0.5 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0
Solvents 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0
Poppers 0.2 0.2 0.2 0.4 0.4 0.4 0.0 0.0 0.0 0.5 0.4 0.5 0.0 0.0 0.0
Anabolic steroids 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6
Sedatives and tranquillisers – 5.2 7.8 – 2.7 7.8a – 7.6 7.7 – 2.6 2.0 – 7.2 12.3a
Anti-depressants – 7.4 10.2 – 3.9 9.8a – 11.0 10.6 – 8.0 2.1a – 7.1 16.5a
Mephedrone – – 0.3 – – 0.6 – – 0.0 – – 0.7 – – 0.0
Legal highs – – 0.3 – – 0.6 – – 0.0 – – 0.7 – – 0.0
Alcohol 64.5 63.2 65.0 70.3 67.6 70.1 58.5 58.8 59.9 71.6 66.0 71.7 58.8 61.2 59.9
Tobacco 35.2 26.4 31.7 37.4 28.3 32.9 33.0 24.6 30.6 37.3 32.5 34.6 33.5 21.6 29.5a
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Prevalence Table 6 – Western HSCT Prevalence Rates  
Table 6.1 Lifetime prevalence of drug use in WHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 591 531 523 263 228 236 328 303 287 258 184 167 333 344 356
Any illegal drug* 18.7 20.3 21.0 25.5 23.7 27.6 11.8 16.8 14.3 28.9 25.5 31.3 9.9 16.5 13.4
Cannabis 16.3 18.1 20.2 22.5 21.5 26.5 9.9 14.6 13.8 24.5 22.6 29.3 9.2 14.8 13.4
Heroin 0.4 0.2 0.3 0.9 0.0 0.0 0.0 0.4 0.6 1.0 0.0 0.0 0.0 0.4 0.5
Methadone 0.2 0.2 1.7ab 0.4 0.0 3.0ab 0.0 0.4 0.3 0.4 0.0 2.6 0.0 0.4 1.0
Other opiates† 11.4 13.2 8.9a 9.6 11.0 6.5 13.3 15.5 11.3 11.8 5.8 7.6 11.1 19.2 9.8a
Cocaine (including crack) 1.6 4.6 4.9b 2.5 5.0 6.6b 0.8 4.2 3.3b 3.3 7.6 9.2b 0.2 2.3 1.8
Crack 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0
Cocaine powder 1.5 4.6 4.9b 2.1 5.0 6.6b 0.8 4.2 3.3b 2.9 7.6 9.2b 0.2 2.3 1.8
Amphetamines 3.8 5.2 4.1 6.1 5.6 6.3 1.4 4.8 1.9 7.5 8.0 6.8 0.6 3.0 2.1
Ecstasy 5.2 7.0 6.1 7.4 7.6 8.3 3.1 6.3 3.9 10.9 11.4 11.6 0.3 3.6 2.1
LSD 4.1 4.4 2.4 6.2 6.6 3.4 2.1 2.1 1.3 7.9 5.6 3.9 0.9 3.5 1.2
Magic mushrooms 4.7 4.0 4.3 7.5 6.5 7.1 1.8 1.5 1.4 8.2 4.7 7.9 1.6 3.5 1.6
Solvents 3.7 3.0 3.2 6.1 3.8 2.4 1.3 2.1 4.1b 7.3 5.0 6.0 0.6 1.4 1.2
Poppers 4.3 7.1 5.3 5.4 8.5 6.3 3.3 5.7 4.2 8.8 11.3 9.2 0.6 3.9 2.3
Anabolic steroids 1.6 0.6 0.4 1.2 0.4 0.7 2.1 0.8 0.0 1.9 0.4 0.0 1.4 0.8 0.6
Sedatives and tranquillisers – 17.0 15.2 – 15.1 12.8 – 19.0 17.6 – 6.8 10.3 – 25.1 18.8a
Anti-depressants – 17.5 18.9 – 11.8 13.8 – 23.3 24.0 – 8.3 12.9 – 24.8 23.3
Mephedrone – – 1.8 – – 3.1 – – 0.4 – – 3.6 – – 0.4
Legal highs – – 2.3 – – 4.7 – – 0.0 – – 5.0 – – 0.4
Alcohol 87.4 87.1 88.0 90.4 88.8 91.3 84.3 85.4 84.6 91.6 85.4 89.8 83.7 88.6 86.6
Tobacco 63.4 53.9 55.4b 66.2 55.2 59.1 60.4 52.6 51.6b 60.8 50.2 53.2 65.6 57.0 56.9b
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 6.2 Last year prevalence of drug use in WHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 591 531 523 263 228 236 328 303 287 258 184 167 333 344 356
Any illegal drug* 5.8 7.6 6.6 8.1 11.9 10.1 3.6 3.3 3.1 10.2 13.3 12.5 2.1 3.3 2.3
Cannabis 5.3 4.7 5.9 7.4 7.5 9.6 3.2 1.8 2.2 9.4 8.3 11.3 1.8 1.9 2.0
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0
Other opiates† 4.9 5.7 2.9a 4.0 5.7 2.3 5.9 5.8 3.4 5.0 2.8 2.7 4.9 8.1 3.0a
Cocaine (including crack) 0.4 1.7 1.4 0.9 2.3 2.7 0.0 1.2 0.0 1.0 3.0 2.7 0.0 0.8 0.4
Crack 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.2 1.7 1.4b 0.4 2.3 2.7b 0.0 1.2 0.0 0.4 3.0 2.7 0.0 0.8 0.4
Amphetamines 0.4 0.8 0.5 0.9 0.7 0.9 0.0 0.9 0.0 1.0 1.3 1.1 0.0 0.4 0.0
Ecstasy 1.4 1.3 1.8 2.5 1.0 2.9 0.3 1.6 0.6 3.0 2.1 3.0 0.0 0.8 0.9
LSD 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.3 0.0 0.0
Poppers 0.2 1.2 0.8 0.4 2.3 1.6 0.0 0.0 0.0 0.4 2.4 1.9 0.0 0.2 0.0
Anabolic steroids 0.9 0.3 0.4 0.9 0.0 0.7 0.9 0.6 0.0 1.2 0.4 0.0 0.6 0.2 0.6
Sedatives and tranquillisers – 8.4 9.4 – 7.6 8.1 – 9.2 10.8 – 3.1 6.6 – 12.6 11.5
Anti-depressants – 9.9 10.7 – 7.1 7.9 – 12.7 13.4 – 4.5 8.0 – 14.1 12.6
Mephedrone – – 1.3 – – 2.7 – – 0.0 – – 3.2 – – 0.0
Legal highs – – 1.1 – – 2.2 – – 0.0 – – 2.6 – – 0.0
Alcohol 78.4 78.5 79.3 82.6 81.1 83.3 74.2 75.7 75.3 85.3 81.7 83.7 72.5 76.1 76.1
Tobacco 44.7 32.6 34.1b 44.6 31.7 37.0 44.8 33.4 31.2b 48.7 32.3 40.9 41.3 32.8 29.1b
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 6.3 Last month prevalence of drug use in WHSCT, 2002/3, 2006/7 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 591 531 523 263 228 236 328 303 287 258 184 167 333 344 356
Any illegal drug* 3.0 2.1 3.5 4.7 2.8 5.7 1.2 1.3 1.3 4.9 3.3 6.4 1.3 1.2 1.4
Cannabis 2.6 1.2 3.5a 4.1 1.5 5.7a 1.2 0.9 1.3 4.5 1.2 6.4a 1.0 1.2 1.4
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 2.8 3.3 1.6 1.8 3.4 1.9 3.9 3.2 1.4 1.8 1.6 1.6 3.7 4.8 1.7a
Cocaine (including crack) 0.2 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.2 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0
Amphetamines 0.2 0.5 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.0 0.4 0.0
Ecstasy 0.0 0.2 0.5 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.5 1.1 0.0 0.0 0.0
LSD 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0
Poppers 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0
Anabolic steroids 0.5 0.1 0.2 0.3 0.0 0.4 0.6 0.3 0.0 0.7 0.0 0.0 0.3 0.2 0.4
Sedatives and tranquillisers – 6.5 7.5 – 6.2 6.1 – 6.8 9.0 – 1.8 6.0a – 10.3 8.6
Anti-depressants – 7.7 9.2 – 4.4 6.7 – 11.1 11.8 – 3.2 5.3 – 11.3 12.1
Mephedrone – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Legal highs – – 0.0 – – 0.0 – – 0.0 – – 0.0 – – 0.0
Alcohol 65.3 66.1 65.9 69.2 70.1 69.5 61.4 61.9 62.2 72.5 66.4 68.5 59.1 65.8 63.9
Tobacco 40.7 30.2 31.0b 40.1 31.3 32.9 41.4 29.0 29.0b 43.3 29.3 35.9 38.5 30.8 27.3b
a significant change (p<0.05) between 2006/7 and 2010/11.
b significant change (p<0.05) between 2002/3 and 2010/11.
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
-  Comparative figures are not available. In 2002/3 respondents were asked about their use of sedatives, tranquillisers or anti-depressants together and thus prevalence rates are not available for the separate categories. From 2006/7 onwards 
respondents were asked about their use of sedatives and tranquillisers and anti-depressants separately. Mephedrone and Legal Highs were asked in the survey for the first-time in 2010/11 and thus no comparisons are available.
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Table 7 – Prevalence by HSCT Area by age and gender 
Table 7.1 Prevalence of drug use in Northern Ireland by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 395 460 766 912 395 460 766 912 395 460 766 912
Any illegal drug* 41.1 32.6 25.8 15.2 15.7 7.9 4.4 1.1 8.5 2.8 2.6 0.7
Cannabis 37.5 26.8 23.1 13.1 13.5 5.2 2.9 0.9 7.5 1.7 2.1 0.6
Heroin 0.4 0.0 0.8 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Methadone 2.8 1.1 0.6 0.1 0.9 0.6 0.3 0.0 0.0 0.0 0.2 0.0
Other opiates† 10.7 15.3 16.3 18.9 5.1 6.2 6.3 7.5 3.1 2.8 3.4 4.6
Cocaine (including crack) 13.5 8.7 5.3 1.5 2.9 2.0 1.5 0.1 1.0 0.3 0.9 0.1
Crack 1.1 1.1 1.3 0.2 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.1
Cocaine powder 13.3 8.2 5.2 1.5 2.9 2.0 1.5 0.0 1.0 0.3 0.9 0.0
Amphetamines 9.7 8.1 6.9 2.0 1.3 1.8 1.7 0.0 0.2 0.4 0.7 0.0
Ecstasy 16.9 11.5 6.8 2.9 3.4 0.7 0.7 0.2 0.8 0.3 0.3 0.0
LSD 6.8 4.6 7.0 2.4 0.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0
Magic mushrooms 11.0 4.3 6.8 2.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0
Solvents 3.6 6.7 4.6 1.6 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0
Poppers 13.2 14.0 7.5 2.9 1.9 1.1 0.4 0.0 0.2 0.3 0.0 0.0
Anabolic steroids 1.0 0.7 2.5 1.1 0.7 0.7 1.1 0.7 0.3 0.0 1.0 0.4
Sedatives and tranquillisers 10.8 16.5 22.0 29.6 5.2 7.6 12.3 16.2 3.5 3.7 10.0 12.3
Anti-depressants 8.4 18.9 20.6 35.2 5.7 8.5 11.2 20.0 4.1 5.9 10.3 17.7
Mephedrone 6.3 2.2 0.7 0.0 3.6 0.7 0.6 0.0 0.3 0.0 0.0 0.0
Legal highs 5.8 3.8 1.0 0.3 3.1 0.8 0.4 0.0 0.6 0.2 0.0 0.0
Alcohol 89.9 87.9 93.1 85.2 83.5 81.2 81.9 72.0 73.3 67.0 71.9 59.5
Tobacco 53.1 48.3 64.5 51.8 37.7 35.7 34.0 27.6 32.2 32.2 31.3 25.6
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
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Table 7.2 Prevalence of drug use in BHSCT by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 81 106 112 162 81 106 112 162 81 106 112 162
Any illegal drug* 51.4 47.2 41.9 25.3 21.7 14.6 8.7 2.4 11.7 7.6 6.0 1.2
Cannabis 43.3 36.0 36.9 21.5 19.0 9.0 6.0 1.8 10.8 4.1 4.1 0.6
Heroin 1.8 0.0 4.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0
Methadone 1.8 1.3 0.9 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.9 0.0
Other opiates† 19.8 22.9 23.4 24.3 10.8 11.2 10.8 9.0 6.3 4.2 6.6 4.8
Cocaine (including crack) 24.3 15.3 16.2 3.5 3.6 4.9 4.3 0.6 0.0 1.3 3.5 0.6
Crack 3.6 2.1 5.0 0.6 0.0 1.4 0.8 0.6 0.0 0.0 0.0 0.6
Cocaine powder 23.4 14.6 15.5 3.5 3.6 4.9 4.3 0.0 0.0 1.3 3.5 0.0
Amphetamines 15.3 13.2 17.7 4.1 1.8 2.8 3.5 0.0 0.9 0.0 1.7 0.0
Ecstasy 21.6 20.1 19.3 5.8 1.8 2.1 2.6 0.0 0.0 1.4 1.7 0.0
LSD 7.2 8.3 16.7 4.2 0.0 1.4 0.8 0.0 0.0 0.0 0.8 0.0
Magic mushrooms 12.6 7.5 15.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 8.1 9.0 11.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 19.8 24.4 18.4 7.6 2.7 4.3 0.9 0.0 0.0 1.4 0.0 0.0
Anabolic steroids 1.8 1.4 5.7 0.6 0.0 1.4 2.8 0.6 0.0 0.0 2.8 0.6
Sedatives and tranquillisers 15.3 21.5 30.0 38.6 6.3 6.2 16.4 21.9 1.8 1.3 14.0 16.4
Anti-depressants 11.7 18.7 26.3 34.8 8.1 7.6 15.1 21.2 3.6 4.1 14.3 18.8
Mephedrone 8.1 4.2 1.8 0.0 4.5 2.1 1.8 0.0 0.0 0.0 0.0 0.0
Legal highs 6.3 5.5 3.4 0.0 1.8 1.4 2.6 0.0 0.0 0.0 0.0 0.0
Alcohol 84.7 90.9 95.5 89.8 79.3 83.2 82.6 77.3 72.1 68.7 74.7 67.9
Tobacco 48.7 45.1 69.1 55.7 35.1 36.7 43.7 31.6 32.4 33.3 40.9 27.4
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
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Table 7.3 Prevalence of drug use in NHSCT by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 72 89 173 160 72 89 173 160 72 89 173 160
Any illegal drug* 31.8 31.4 20.4 11.0 7.6 7.3 4.7 0.5 4.7 1.6 2.3 0.5
Cannabis 31.8 23.9 17.4 8.4 5.8 4.8 2.4 0.5 2.9 0.0 1.8 0.5
Heroin 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 3.6 1.6 0.6 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Other opiates† 6.2 14.2 13.5 17.8 3.3 6.6 5.3 5.7 1.1 3.1 1.2 4.1
Cocaine (including crack) 8.7 11.4 3.0 0.0 1.8 3.1 0.6 0.0 1.8 0.0 0.0 0.0
Crack 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 8.7 9.9 3.0 0.0 1.8 3.1 0.6 0.0 1.8 0.0 0.0 0.0
Amphetamines 6.9 13.7 6.0 1.1 0.0 3.1 1.8 0.0 0.0 1.6 1.2 0.0
Ecstasy 11.0 11.6 3.6 1.6 3.6 0.9 0.6 0.0 1.8 0.0 0.0 0.0
LSD 8.0 5.0 5.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 8.7 5.9 2.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Solvents 1.1 5.9 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 8.4 14.7 4.2 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Anabolic steroids 0.0 0.9 3.5 1.5 0.0 0.9 0.6 0.5 0.0 0.0 0.6 0.5
Sedatives and tranquillisers 6.5 17.2 19.3 30.6 1.8 9.0 9.9 17.3 1.8 3.3 7.6 12.6
Anti-depressants 6.2 23.7 17.4 38.1 2.9 11.6 7.4 23.1 2.9 9.2 5.7 18.0
Mephedrone 4.0 4.0 0.6 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Legal highs 1.8 7.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Alcohol 96.0 84.6 91.0 82.2 87.2 79.4 80.1 63.3 74.5 67.2 69.6 53.9
Tobacco 51.1 45.3 68.2 50.9 33.2 34.3 36.4 24.6 25.5 31.7 33.6 23.0
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
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Table 7.4 Prevalence of drug use in SEHSCT by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 73 72 169 203 73 72 169 203 72 169 203 72
Any illegal drug* 47.1 37.5 28.3 20.0 20.0 6.9 3.7 0.0 13.8 2.8 2.5 0.0
Cannabis 42.0 32.0 25.8 16.8 16.8 5.6 2.5 0.0 12.8 2.8 1.9 0.0
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 1.1 1.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 17.8 16.7 25.4 26.0 8.0 5.6 7.3 11.8 5.1 1.4 5.5 7.7
Cocaine (including crack) 14.9 8.3 5.6 2.6 4.8 1.4 1.9 0.0 1.9 0.0 1.3 0.0
Crack 1.1 1.4 0.7 0.5 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0
Cocaine powder 14.9 8.3 5.6 2.6 4.8 1.4 1.9 0.0 1.9 0.0 1.3 0.0
Amphetamines 12.0 6.9 5.7 2.1 1.9 1.4 1.9 0.0 0.0 0.0 0.6 0.0
Ecstasy 23.9 13.9 8.0 3.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0
LSD 10.4 4.2 9.1 5.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 17.0 4.2 9.8 2.5 1.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 4.0 8.3 3.7 2.1 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0
Poppers 19.4 18.1 11.8 2.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Anabolic steroids 3.7 0.0 0.5 1.5 3.7 0.0 0.5 1.1 1.9 0.0 0.5 0.5
Sedatives and tranquillisers 17.8 19.5 24.3 30.1 8.8 9.7 13.1 11.9 6.9 7.0 11.1 9.4
Anti-depressants 12.8 20.8 17.9 39.4 9.8 8.3 10.5 20.1 8.8 7.0 8.7 18.7
Mephedrone 11.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Legal highs 10.6 2.8 0.7 1.0 5.6 1.4 0.0 0.0 1.9 1.4 0.0 0.0
Alcohol 88.6 87.5 95.5 88.2 79.8 80.6 90.7 77.7 71.0 66.7 82.6 63.3
Tobacco 58.5 51.4 58.6 50.7 38.8 33.3 26.9 25.8 31.1 29.2 23.1 24.4
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
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Table 7.5 Prevalence of drug use in SHSCT by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 90 105 155 188 90 105 155 188 90 105 155 188
Any illegal drug* 37.2 23.5 23.1 11.8 12.0 5.1 2.2 1.1 2.3 0.8 1.5 0.6
Cannabis 34.0 21.5 20.4 11.2 9.7 3.1 1.5 1.1 1.4 0.8 1.5 0.6
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 2.3 1.2 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 5.1 11.9 12.3 13.4 1.4 3.6 6.0 7.5 1.4 3.6 2.7 4.4
Cocaine (including crack) 7.8 1.6 1.5 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0
Crack 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 7.8 1.6 1.5 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0
Amphetamines 4.1 2.0 3.6 1.7 0.9 1.2 1.5 0.0 0.0 0.0 0.0 0.0
Ecstasy 12.8 5.2 3.6 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0
LSD 2.8 2.4 2.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 5.6 0.0 5.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 1.9 2.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 7.4 5.9 3.5 1.1 0.9 0.8 0.7 0.0 0.9 0.0 0.0 0.0
Anabolic steroids 0.0 0.8 1.3 1.5 0.0 0.8 0.7 1.5 0.0 0.0 0.7 0.4
Sedatives and tranquillisers 5.5 12.7 22.3 25.0 3.7 6.7 14.1 15.9 2.3 1.6 12.2 12.3
Anti-depressants 1.9 14.8 26.4 31.3 0.9 6.4 16.9 16.7 0.9 3.2 16.9 16.2
Mephedrone 2.7 1.2 0.7 0.0 1.4 1.2 0.7 0.0 1.4 0.0 0.0 0.0
Legal highs 2.3 2.0 0.7 0.6 2.3 1.2 0.0 0.0 1.4 0.0 0.0 0.0
Alcohol 88.6 87.8 92.0 85.2 85.3 81.1 74.5 74.3 77.5 65.7 64.3 55.5
Tobacco 52.8 51.0 64.2 49.6 40.0 36.3 31.4 31.1 36.3 32.9 30.1 28.9
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers. 
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Table 7.6 Prevalence of drug use in WHSCT by age and gender (2010/11)
Lifetime prevalence Last year prevalence Last month prevalence
Young Adults Older Adults Young Adults Older Adults Young Adults Older Adults
Males Females Males Females Males Females Males Females Males Females Males Females
Total sample (unweighted) 79 88 157 199 79 88 157 199 79 88 157 199
Any illegal drug* 40.6 21.8 17.9 8.9 20.1 4.7 2.6 2.0 11.7 1.0 1.3 1.5
Cannabis 38.0 20.4 17.9 8.9 19.0 3.3 2.6 1.5 11.7 1.0 1.3 1.5
Heroin 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 5.2 0.0 1.4 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 5.4 9.9 7.3 12.2 2.2 3.3 2.5 3.5 2.2 1.0 1.7 1.7
Cocaine (including crack) 12.8 5.6 2.0 1.6 5.4 0.0 0.7 0.0 1.1 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 12.8 5.6 2.0 1.6 5.4 0.0 0.7 0.0 1.1 0.0 0.0 0.0
Amphetamines 11.3 2.3 2.6 1.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ecstasy 17.5 5.6 1.4 2.7 5.8 0.0 0.7 1.1 2.2 0.0 0.0 0.0
LSD 5.4 2.3 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 12.3 3.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 3.7 8.4 1.4 0.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 12.8 5.6 1.4 3.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Anabolic steroids 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0
Sedatives and tranquillisers 10.2 10.5 14.8 22.8 6.9 6.2 9.0 14.0 5.8 6.2 6.2 11.0
Anti-depressants 10.6 15.2 16.2 30.5 8.4 7.6 7.6 17.6 5.4 5.3 7.6 16.5
Mephedrone 6.3 1.0 0.7 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Legal highs 9.9 0.0 0.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Alcohol 90.3 89.3 92.1 81.1 85.1 82.3 81.9 70.3 70.6 66.3 68.6 59.2
Tobacco 56.2 50.2 61.3 52.6 43.4 38.3 32.2 26.1 37.6 34.2 29.4 25.3
*  For this study ‘any illegal drug’ refers to cannabis, heroin, crack, cocaine powder, amphetamines, ecstasy, LSD, magic mushrooms, solvents and poppers.
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Table 8 – Prevalence of drug use in Ireland 
Table 8.1 Lifetime prevalence of drug use in Ireland, 2002/03, 2006/07 and 2010/11 
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 4198 4967 5128 2147 2027 2239 2771 2940 2889 1195 1989 1960 2923 2987 3168
Any illegal drug* 18.5 24.0 27.2 23.8 29.4 35.5 13.1 18.5 19.0 25.9 31.4 35.7 11.8 17.6 20.6
Cannabis 17.3 21.9 25.3 22.2 27.0 33.2 12.3 16.6 17.5 23.8 28.6 33.4 11.4 16.1 19.0
Heroin 0.5 0.4 0.8 0.7 0.5 1.2 0.3 0.4 0.3 0.7 0.4 0.7 0.3 0.4 0.8
Methadone 0.3 0.3 0.5 0.4 0.4 0.7 0.3 0.3 0.2 0.6 0.5 0.4 0.1 0.2 0.5
Other opiates† 3.0 6.2 38.8 2.0 4.7 35.2 3.9 7.8 42.4 2.9 4.6 37.0 3.0 7.6 40.2
Cocaine (including crack) 3.0 5.3 6.8 4.3 7.0 9.9 1.6 3.5 3.8 4.7 8.2 9.4 1.4 2.7 4.8
Crack 0.3 0.6 0.6 0.5 0.8 1.0 0.1 0.4 0.2 0.5 1.0 0.7 0.2 0.2 0.5
Cocaine powder 2.9 5.1 6.7 4.1 6.7 9.7 1.6 3.3 3.8 4.5 7.8 9.3 1.4 2.6 4.7
Amphetamines 2.9 3.5 4.5 4.0 4.6 6.6 1.9 2.5 2.5 4.8 5.1 6.4 1.3 2.1 3.0
Ecstasy 3.7 5.4 6.9 4.9 7.2 10.1 2.6 3.6 3.7 7.1 9.0 10.9 0.7 2.3 3.7
LSD 2.9 2.9 4.4 4.3 4.0 6.7 1.4 1.7 2.2 4.5 3.6 5.4 1.4 2.2 3.7
Magic mushrooms 3.8 5.8 6.5 5.6 7.7 9.5 2.0 3.8 3.6 5.9 8.4 8.2 2.0 3.5 5.2
Solvents 1.7 1.9 2.6 2.2 2.3 3.8 1.1 1.4 1.3 3.3 3.2 3.8 0.2 0.8 1.5
Poppers 2.6 3.3 3.9 3.8 4.2 6.0 1.3 2.4 1.9 4.7 5.5 6.2 0.7 1.4 2.2
Sedatives and tranquillisers ** 10.5 13.9 ** 8.0 12.4 ** 13.2 15.5 ** 5.9 10.1 ** 14.6 16.9
Anti-depressants ** 9.2 10.4 ** 5.9 8.3 ** 12.5 12.4 ** 7.1 6.8 ** 11.0 13.2
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 60.0 57.9 56.7 61.6 59.1 60.6 58.4 56.8 52.7 57.4 56.3 53.0 62.3 59.4 59.5
Alcohol 90.1 90.2 90.3 92.5 91.8 92.5 87.7 88.8 88.1 92.0 90.4 89.4 88.3 90.1 91.0
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 8.2 Last year prevalence of drug use in Ireland, 2002/03, 2006/07 and 2010/11 
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 4198 4967 5128 2147 2027 2239 2771 2940 2889 1195 1989 1960 2923 2987 3168
Any illegal drug* 5.6 7.2 7.0 7.8 9.6 10.4 3.4 4.7 3.6 9.8 12.1 12.3 1.9 2.9 2.9
Cannabis 5.1 6.3 6.0 7.2 8.6 9.1 2.9 3.9 2.9 8.7 10.4 10.3 1.8 2.6 2.6
Heroin 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1
Methadone 0.2 0.1 0.2 0.2 0.1 0.4 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.1 0.2
Other opiates† 0.5 2.1 27.9 0.4 1.5 24.0 0.5 2.8 31.7 0.6 1.8 28.3 0.4 2.5 27.6
Cocaine (including crack) 1.1 1.7 1.5 1.7 2.3 2.3 0.5 1.0 0.7 2.0 3.1 2.8 0.3 0.5 0.5
Crack 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.1
Cocaine powder 1.1 1.6 1.5 1.7 2.2 2.3 0.5 0.9 0.7 2.0 2.9 2.7 0.3 0.5 0.5
Amphetamines 0.4 0.4 0.4 0.6 0.5 0.4 0.2 0.3 0.4 0.8 0.8 0.8 0.1 0.1 0.1
Ecstasy 1.1 1.2 0.5 1.5 1.8 0.6 0.6 0.6 0.3 2.3 2.4 0.9 0.0 0.2 0.2
LSD 0.1 0.2 0.3 0.2 0.2 0.5 0.0 0.1 0.1 0.2 0.4 0.6 0.0 0.0 0.1
Magic mushrooms 0.4 0.6 0.5 0.6 0.9 0.8 0.1 0.4 0.2 0.7 1.2 0.8 0.1 0.2 0.2
Solvents 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1
Poppers 0.4 0.5 0.2 0.4 0.6 0.3 0.4 0.3 0.1 0.8 0.9 0.2 0.0 0.1 0.2
Sedatives and tranquillisers ** 4.7 6.5 ** 3.7 5.7 ** 5.7 7.3 ** 2.6 4.8 ** 6.5 7.8
Anti-depressants ** 4.3 4.8 ** 3.0 4.0 ** 5.6 5.6 ** 3.2 3.0 ** 5.2 6.2
New Psychoactive Substances *** *** 3.5 *** *** 5.4 *** *** 1.6 *** *** 6.7 *** *** 1.0
Tobacco 38.0 36.3 32.5 38.2 36.8 35.7 37.8 35.8 29.4 43.1 40.8 37.3 33.4 32.3 28.8
Alcohol 83.3 84.0 85.3 86.0 86.4 87.5 81.5 81.7 83.2 86.5 86.3 86.3 81.3 82.0 84.5
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 8.3 Last month prevalence of drug use in Ireland, 2002/03, 2006/07 and 2010/11 
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 4198 4967 5128 2147 2027 2239 2771 2940 2889 1195 1989 1960 2923 2987 3168
Any illegal drug* 3.0 2.9 3.2 4.1 4.3 5.3 1.8 1.4 1.1 5.2 4.8 5.3 0.9 1.2 1.6
Cannabis 2.6 2.6 2.8 3.4 4.0 4.7 1.7 1.2 0.9 4.3 4.2 4.5 0.9 1.2 1.4
Heroin 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1
Methadone 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.2
Other opiates† 0.2 1.0 14.2 0.2 0.9 11.1 0.1 1.1 17.1 0.1 0.8 14.2 0.2 1.1 14.1
Cocaine (including crack) 0.4 0.5 0.5 0.7 0.8 0.8 0.0 0.2 0.3 0.7 1.1 1.0 0.0 0.1 0.1
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0
Cocaine powder 0.4 0.5 0.5 0.7 0.8 0.8 0.0 0.2 0.3 0.7 1.0 1.0 0.0 0.1 0.1
Amphetamines 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1
Ecstasy 0.3 0.3 0.1 0.6 0.5 0.1 0.0 0.2 0.0 0.6 0.6 0.1 0.0 0.1 0.0
LSD 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1
Solvents 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1
Poppers 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1
Sedatives and tranquillisers ** 3.0 2.8 ** 2.4 2.3 ** 3.5 3.3 ** 1.3 1.0 ** 4.4 4.1
Anti-depressants ** 3.1 4.1 ** 2.3 3.2 ** 3.9 5.0 ** 2.2 2.3 ** 3.9 5.5
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 33.2 32.6 28.3 33.4 33.6 31.3 33.0 31.6 25.3 36.9 36.0 31.3 29.8 29.7 25.9
Alcohol 73.9 73.2 70.6 78.3 78.1 76.3 69.4 68.4 65.1 74.6 73.8 70.9 73.3 73.0 70.4
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 9.1 Lifetime prevalence of drug use in ECRDTF, 2002/03, 2006/07 and 2010/11 
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 455 360 1646 205 139 728 250 221 918 167 150 644 288 210 1002
Any illegal drug* 25.9 38.4 38.0 b 34.0 45.4 44.1 17.6 31.9 30.8 b 35.9 42.5 42.5 18.0 34.4 35.1 b
Cannabis 24.5 35.9 36.2 b 32.4 42.9 42.4 16.4 29.5 28.7 b 33.4 38.1 38.9 17.4 33.7 34.4 b
Heroin 0.7 0.3 1.7 0.9 0.7 2.6 0.4 0.0 0.7 1.1 0.0 0.5 0.3 0.6 2.5 b
Methadone 0.5 0.8 0.7 0.5 1.6 1.2 0.4 0.0 0.2 1.1 1.6 0.5 0.0 0.0 0.9
Other opiates† 3.9 12.8 34.1 2.6 6.7 32.6 5.1 18.4 35.9 3.2 10.7 30.5 4.4 14.8 36.5
Cocaine (including crack) 6.3 9.1 10.1 10.5 11.4 11.5 2.0 6.9 8.3 b 10.5 11.0 10.9 3.0 7.2 9.5 b
Crack 1.0 0.9 0.5 1.5 1.4 0.8 0.4 0.5 0.2 1.8 1.2 0.5 0.3 0.6 0.6
Cocaine powder 6.3 9.1 9.8 10.5 11.4 11.1 2.0 6.9 8.3 b 10.5 11.0 10.9 3.0 7.2 9.1 b
Amphetamines 4.8 4.0 6.7 6.6 4.8 8.7 3.0 3.2 4.2 8.0 4.2 6.1 2.3 3.7 7.0 b
Ecstasy 5.4 7.6 9.4 b 7.8 11.0 10.0 3.0 4.5 8.7 b 9.8 10.5 12.6 2.0 4.8 7.3 b
LSD 4.9 4.1 6.5 8.0 4.1 8.6 1.7 4.1 3.9 8.0 4.5 5.0 2.4 3.7 7.4 b
Magic mushrooms 5.9 10.6 11.4 b 8.6 10.9 13.4 3.2 10.3 9.1 b 9.7 13.9 10.9 2.9 7.3 11.8 b
Solvents 2.5 2.1 3.1 3.0 1.6 5.5 1.9 2.6 0.2 ab 4.7 3.3 4.3 0.7 1.0 2.4
Poppers 3.6 5.4 5.0 5.9 6.9 5.9 1.3 4.1 3.8 7.4 7.7 8.0 0.7 3.2 3.0
Sedatives and tranquillisers ** 12.3 13.0 ** 7.1 10.4 ** 17.2 16.1 ** 8.3 8.4 ** 16.3 16.0
Anti-depressants ** 7.8 9.8 ** 4.6 10.2 ** 10.9 9.4 ** 5.3 4.1 ** 10.3 13.6
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco ** 59.8 55.7 61.3 61.2 57.0 63.0 58.5 54.1 58.5 56.0 48.5 65.0 63.6 60.4
Alcohol 94.1 92.8 92.1 95.3 95.2 92.8 92.8 90.7 91.1 96.3 91.1 89.1 92.3 94.5 93.9
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 9.2 Last year prevalence of drug use in ECRDTF, 2002/03, 2006/07 and 2010/11 
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 455 360 1646 205 139 728 250 221 918 167 150 644 288 210 1002
Any illegal drug* 6.3 12.4 9.2 10.0 13.8 11.9 2.5 11.1 6.0 11.4 17.9 13.1 2.3 7.0 6.7b
Cannabis 6.1 11.3 7.7 9.6 13.8 11.1 2.5 9.0 3.7a 11.4 16.2 9.6 1.9 6.5 6.5b
Heroin 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2
Methadone 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2
Other opiates† 0.4 4.6 25.7 0.0 0.7 22.7 0.8 8.2 29.4 0.5 3.8 23.4a 0.3 5.3 27.3
Cocaine (including crack) 2.3 3.1 2.7 4.2 3.7 2.9 0.4 2.6 2.6 4.4 4.6 5.0 0.7 1.6 1.2
Crack 0.5 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.2
Cocaine powder 2.3 3.1 2.7 4.2 3.7 2.9 0.4 2.6 2.6 4.4 4.6 5.0 0.7 1.6 1.2
Amphetamines 0.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0
Ecstasy 2.5 2.3 0.3ab 4.0 4.9 0.3 ab 0.9 0.0 0.3 5.6 4.1 0.5 ab 0.0 0.6 0.2
LSD 0.0 0.2 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0
Magic mushrooms 0.0 2.0 0.7 0.0 2.3 1.1 0.0 1.8 0.3 0.0 3.0 0.0 0.0 1.1 1.2
Solvents 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0
Poppers 1.0 0.3 0.4 1.5 0.0 0.5 0.4 0.7 0.3 1.8 0.7 0.0 0.3 0.0 0.7
Sedatives and tranquillisers ** 5.3 5.8 ** 3.6 5.3 ** 6.8 6.2 ** 3.1 2.2 ** 7.4 8.1
Anti-depressants ** 3.6 4.9 ** 2.5 5.7 ** 4.6 4.0 ** 1.5 2.0 ** 5.7 6.9
New Psychoactive Substances *** *** 6.1 *** *** 9.0 *** *** 2.6 *** *** 10.8 *** *** 3.0
Tobacco 39.2 38.7 29.4ab 39.9 41.3 33.3 38.6 36.3 24.6ab 42.8 44.5 33.9 36.4 33.1 26.4b
Alcohol 89.2 86.1 88.0 91.8 87.2 90.1 86.5 85.1 85.5 93.4 87.8 88.3 85.8 84.4 87.9
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 9.3 Last month prevalence of drug use in ECRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 455 360 1646 205 139 728 250 221 918 167 150 644 288 210 1002
Any illegal drug* 4.1 5.3 4.1 6.0 7.2 6.25 2.2 3.7 1.6 8.1 7.8 5.2 1.0 2.9 3.4
Cannabis 3.8 4.2 3.5 5.4 5.5 5.3 2.2 3.0 1.4 7.5 5.5 4.7 1.0 2.9 2.8
Heroin 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2
Methadone 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2
Other opiates† 0.0 1.9 14.6 0.0 0.7 11.6 0.0 3.1 18.3 0.0 1.7 11.0 0.0 2.2 17.0
Cocaine (including crack) 0.5 0.8 0.4 0.9 1.6 0.3 0.0 0.0 0.5 0.6 1.6 0.5 0.3 0.0 0.4
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.5 0.8 0.4 0.9 1.6 0.3 0.0 0.0 0.5 0.6 1.6 0.5 0.3 0.0 0.4
Amphetamines 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0
Ecstasy 0.9 0.5 0.1 1.7 0.9 0.0 0.0 0.0 0.3 1.9 0.9 0.0 0.0 0.0 0.2
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.7 0.3 0.0 0.7 0.0 0.0 0.0 0.7
Sedatives and tranquillisers ** 2.3 2.4 ** 0.7 1.3 ** 3.8 3.6 ** 0.5 1.0 ** 4.1 3.3
Anti-depressants ** 2.9 4.1 ** 1.9 5.0 ** 3.8 3.0 ** 1.5 1.6 ** 4.3 5.7
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 32.0 32.4 25.2 33.4 35.5 27.6 30.5 29.5 22.4b 34.6 37.2 29.0 29.9 27.7 23.1
Alcohol 81.2 77.2 76.6 86.6 79.8 80.0 75.6 74.9 72.5 80.1 78.4 72.2 82.1 76.1 79.5
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 10.1 Lifetime prevalence of drug use in MRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 315 401 454 138 160 190 177 241 264 141 164 179 174 237 275
Any illegal drug* 11.0 19.6 19.1b 13.3 23.9 24.6b 8.5 14.9 13.6 15.2 27.7 25.0 7.4 12.9 14.7
Cannabis 10.7 17.0 17.4 13.3 19.7 21.9 7.9 14.1 13.0 14.6 23.6 22.6 7.4 11.6 13.7
Heroin 0.3 0.2 0.8 0.6 0.0 1.1 0.0 0.4 0.6 0.7 0.0 0.7 0.0 0.4 1.0
Methadone 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Other opiates† 1.3 5.1 36.6ab 1.5 1.7 26.6ab 1.2 8.8 46.4ab 1.3 1.8 31.8ab 1.3 7.8 40.0ab
Cocaine (including crack) 1.3 4.4 4.0b 2.0 5.2 6.0 0.6 3.5 2.1 1.9 6.7 4.7 0.8 2.4 3.5
Crack 0.3 0.3 0.6 0.6 0.7 0.3 0.0 0.0 1.0 0.7 0.7 0.8 0.0 0.0 0.5
Cocaine powder 1.3 4.0 4.0b 2.0 4.5 6.0 0.6 3.5 2.1 1.9 6.0 4.7 0.8 2.4 3.5
Amphetamines 0.6 3.6 2.3 1.2 4.9 2.2 0.0 2.1 2.3 1.3 4.7 2.6 0.0 2.7 2.0
Ecstasy 2.0 5.8 3.0 2.6 8.7 3.9 1.3 2.7 2.2 3.4 10.5 5.2 0.8 2.0 1.4ab
LSD 1.6 2.4 2.9 2.6 3.7 4.1 0.6 1.1 1.8 2.6 3.3 3.8 0.8 1.8 2.3
Magic mushrooms 1.8 5.5 4.8b 2.8 9.6 6.9 0.7 1.1 2.7 2.9 10.5 5.7 0.8 1.4 4.1
Solvents 1.2 2.7 1.2 1.7 3.7 2.1 0.6 1.6 0.3 2.6 3.7 2.8 0.0 1.9 0.0a
Poppers 1.6 2.6 2.9 2.5 2.7 3.6 0.7 2.5 2.3 3.5 4.2 4.9 0.0 1.4 1.5
Sedatives and tranquillisers ** 12.1 12.3 ** 9.2 10.2 ** 15.3 14.4 ** 4.2 6.3 ** 18.6 16.7
Anti-depressants ** 10.0 8.9 ** 6.6 5.4 ** 13.7 13.7 ** 6.5 7.7 ** 13.0 13.0
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 60.4 60.2 52.5 61.5 60.6 62.2 59.2 59.8 43.0ab 55.5 63.3 50.9 64.6 57.6 53.7
Alcohol 87.1 90.9 89.2 92.6 91.0 92.2 81.3 90.8 86.2 89.5 89.8 91.0 85.1 91.8 87.8
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 10.2 Last year prevalence of drug use in MRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 315 401 454 138 160 190 177 241 264 141 164 179 174 237 275
Any illegal drug* 2.8 4.4 4.8b 3.6 6.0 7.2 1.9 2.7 2.4 5.1 9.2 9.1 0.8 0.5 1.6
Cannabis 2.8 4.1 4.3 3.6 5.4 6.7 1.9 2.7 1.9 5.1 8.5 8.1 0.8 0.5 1.5
Heroin 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Methadone 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Other opiates† 0.0 1.4 25.4ab 0.0 1.2 19.5ab 0.0 1.5 31.3ab 0.0 0.4 23.2ab 0.0 2.1 27.0ab
Cocaine (including crack) 0.3 1.7 0.7b 0.6 1.4 0.5 0.0 2.0 0.8 0.7 3.7 1.4 0.0 0.0 0.1
Crack 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0
Cocaine powder 0.3 1.3 0.7b 0.6 0.8 0.5 0.0 2.0 0.8 0.7 3.0 1.4 0.0 0.0 0.1
Amphetamines 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.4 0.4 0.7 0.4 0.5 0.0 0.0 0.0
Ecstasy 0.9 0.9 0.0 1.2 0.8 0.0 0.7 1.0 0.0 2.0 1.9 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.3 0.3 0.0b 0.6 0.7 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0
Poppers 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1
Sedatives or tranquillisers ** 5.1 5.4 ** 2.0 3.6 ** 8.4 7.1 ** 1.4 3.2 ** 8.1 6.9
Anti-depressants ** 3.3 4.5 ** 0.7 2.7 ** 6.0 6.3 ** 3.5 3.2 ** 3.1 5.5
New Psychoactive Substances *** *** 3.0 *** *** 3.6 *** *** 2.4 *** *** 6.3 *** *** 0.5
Tobacco 36.5 39.5 29.2 35.5 37.5 34.0 37.6 41.5 24.5ab 44.6 46.6 35.9 29.7 33.7 24.2
Alcohol 78.6 83.5 85.4b 83.5 85.9 86.6 73.5 81.0 84.3b 82.1 86.0 89.9 75.7 81.5 82.2
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 10.3 Last month prevalence of drug use in MRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 315 401 454 138 160 190 177 241 264 141 164 179 174 237 275
Any illegal drug* 1.0 1.7 2.3 2.0 2.1 3.3 0.0 1.3 1.3 1.3 3.8 4.9 0.8 0.0 0.4
Cannabis 1.0 1.1 2.1 2.0 1.4 3.3 0.0 0.7 0.9 1.3 2.4 4.4 0.8 0.0 0.4
Heroin 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Methadone 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Other opiates† 0.0 0.7 11.3ab 0.0 0.7 5.0ab 0.0 0.8 17.6ab 0.0 0.0 9.5ab 0.0 1.3 12.7ab
Cocaine (including crack) 0.3 0.9 0.2 0.6 1.4 0.0 0.0 0.4 0.4 0.7 2.0 0.5 0.0 0.0 0.0
Crack 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Cocaine powder 0.3 0.6 0.2 0.6 0.8 0.0 0.0 0.4 0.4 0.7 1.3 0.5 0.0 0.0 0.0
Amphetamines 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0
Poppers 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0
Sedatives and tranquillisers ** 3.2 2.8 ** 1.3 2.0 ** 5.1 3.6 ** 0.0 1.6 ** 5.7 3.7
Anti-depressants ** 2.6 4.2 ** 0.7 2.7 ** 4.7 5.7 ** 2.1 2.8 ** 3.1 5.2
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 31.4 36.2 24.5a 30.8 35.9 30.3 32.1 36.4 18.9ab 38.8 42.0 29.9 25.3 31.4 20.6a
Alcohol 69.0 70.3 69.4 73.9 73.8 73.8 63.8 66.6 65.1 71.0 71.2 70.5 67.3 69.5 68.6
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
Drug use in Ireland and Northern Ireland 2010/11: Drug Prevalence Survey: Regional Drug Task Force (Ireland) and Health and Social Care Trust (Northern Ireland) Results
69 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB)
Table 11.1 Lifetime prevalence of drug use in MWRDTF, 2002/03, 2006/07 and 2010/11 (MWHB)
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 424 537 438 184 214 193 240 323 245 157 208 156 267 329 282
Any illegal drug* 12.0 18.0 18.7 15.3 21.6 25.8 8.5 14.2 11.4 17.8 26.0 27.2 7.0 11.4 12.4
Cannabis 10.9 17.0 17.9b 13.7 20.6 24.7 8.1 13.3 10.9 16.5 24.6 26.6 6.1 10.8 11.4
Heroin 0.0 0.3 0.8 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.8
Methadone 0.0 0.3 0.3 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6
Other opiates† 1.8 6.1 33.2ab 1.2 3.9 29.8ab 2.5 8.4 36.6ab 2.2 6.0 25.2ab 1.5 6.2 39.1ab
Cocaine (including crack) 1.1 2.9 4.5b 1.2 4.2 6.6 1.1 1.7 2.3 1.9 4.9 6.0 0.5 1.4 3.3b
Crack 0.0 0.6 0.7 0.0 1.2 1.3 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.0 0.6
Cocaine powder 1.1 2.9 4.5b 1.2 4.2 6.6 1.1 1.7 2.3 1.9 4.9 6.0 0.5 1.4 3.3b
Amphetamines 1.3 2.6 3.6b 1.2 3.6 5.2b 1.5 1.6 2.0 2.3 4.6 5.0 0.5 1.0 2.6
Ecstasy 1.7 2.9 4.9b 0.7 3.8 7.9b 2.7 2.1 1.8 3.7 6.0 7.3 0.0 0.4 3.2ab
LSD 1.4 2.3 2.7 2.3 3.6 4.7 0.5 1.0 0.7 2.0 4.3 3.2 0.9 0.7 2.4
Magic mushrooms 1.7 3.1 2.9 2.3 4.4 3.7 1.1 1.7 1.9 2.6 4.4 2.7 0.9 1.9 3.0
Solvents 0.9 2.2 1.5 1.4 3.0 2.4 0.5 1.3 0.5 2.0 4.4 1.7 0.0 0.4 1.3
Poppers 0.8 1.8 2.0 1.2 2.2 3.1 0.5 1.5 0.8 1.2 3.7 2.2 0.5 0.3 1.8
Sedatives and tranquillisers ** 8.8 12.5 ** 5.2 11.9a ** 12.6 13.2 ** 5.3 6.8 ** 11.7 16.8
Anti-depressants ** 10.0 9.7 ** 5.6 7.6 ** 14.6 11.8 ** 9.0 6.0 ** 10.8 12.4
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 58.5 60.0 52.1a 61.2 63.5 56.2 55.7 56.2 47.9 59.5 57.7 45.8b 57.6 61.8 56.9
Alcohol 87.5 90.0 88.4 91.4 92.7 89.3 83.5 87.2 87.5 88.6 90.9 86.9 86.6 89.3 89.6
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 11.2 Last year prevalence of drug use in MWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 424 537 438 184 214 193 240 323 245 157 208 156 267 329 282
Any illegal drug* 3.2 5.8 5.1 3.9 7.9 7.2 2.5 3.5 3.0 6.0 11.4 10.4 0.8 1.2 1.2
Cannabis 3.0 4.7 5.0 3.9 6.6 3.0 2.0 2.8 2.7 5.5 9.3 10.0 0.8 1.0 1.2
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.0 3.1 21.4ab 0.0 2.3 18.4ab 0.0 4.0 24.5ab 0.0 5.5 18.3ab 0.0 1.2 23.7ab
Cocaine (including crack) 0.7 1.0 0.4 0.7 1.6 0.3 0.6 0.3 0.6 1.4 2.2 1.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.7 1.0 0.4 0.7 1.6 0.3 0.6 0.3 0.6 1.4 2.2 1.0 0.0 0.0 0.0
Amphetamines 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0
Ecstasy 0.6 0.8 0.4 0.7 1.6 0.6 0.5 0.0 0.3 1.2 1.8 1.1 0.0 0.0 0.0
LSD 0.0 0.3 0.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0
Magic mushrooms 0.0 0.4 0.3 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.7 0.7 0.0 0.3 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 1.3 0.3 0.0 1.4 0.3 0.0 1.1 0.3 0.0 2.5 0.4 0.0 0.3 0.3
Sedatives and tranquillisers ** 4.3 5.9 ** 2.9 32.7 ** 5.7 23.1 ** 2.8 31.5 ** 5.5 25.4
Anti-depressants ** 4.3 4.5 ** 3.5 82.9 ** 5.2 81.9 ** 2.7 82.8 ** 5.6 82.1
New Psychoactive Substances *** *** 3.4 *** *** 5.2 *** *** 1.4 *** *** 6.7 *** *** 0.9
Tobacco 35.6 38.9 28.0a 35.0 39.4 32.7 36.3 38.4 23.1ab 41.1 40.4 31.5 30.9 37.7 25.4a
Alcohol 81.2 82.7 82.4 82.6 85.4 82.9 79.7 79.9 81.9 83.8 86.0 82.8 78.9 80.0 82.1
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 11.3 Last month prevalence of drug use in MWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 424 537 438 184 214 193 240 323 245 157 208 156 267 329 282
Any illegal drug* 1.6 1.4 2.0 1.9 2.8 3.3 1.4 0.0 0.6 2.6 2.7 4.6 0.8 0.4 0.0
Cannabis 1.6 1.4 1.5 1.9 2.8 2.7 1.4 0.0 0.3 2.6 2.7 3.6 0.8 0.4 0.0
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.0 1.3 10.9ab 0.0 1.4 7.3ab 0.0 1.1 14.6ab 0.0 2.5 10.1ab 0.0 0.3 11.4ab
Cocaine (including crack) 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.3 0.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0
LSD 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 2.0 3.2 ** 2.0 2.1 ** 2.1 4.4 ** 0.5 1.3 ** 3.3 4.6
Anti-depressants ** 2.5 4.0 ** 1.8 2.5 ** 3.2 5.6 ** 1.5 2.2 ** 3.3 5.3
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 29.8 35.9 25.7a 30.3 36.5 30.3 29.2 35.2 20.9a 32.6 38.0 28.2 27.3 34.2 23.8a
Alcohol 71.8 72.2 66.5 74.0 76.2 73.1 69.6 67.9 59.7 72.7 73.8 68.4 71.1 70.9 65.2
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 12.1 Lifetime prevalence of drug use in NERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 433 446 451 181 171 193 252 275 258 177 170 161 256 276 290
Any illegal drug* 18.9 22.1 23.9 24.7 29.0 33.5 12.9 15.7 15.6 32.5 28.1 27.1 7.2 17.4 21.5
Cannabis 17.8 19.2 20.5 24.2 25.3 30.6 11.0 13.5 11.8 30.4 24.5 25.3 6.7 15.0 16.9
Heroin 0.4 0.6 0.4 0.8 0.9 1.0 0.0 0.3 0.0 0.9 1.0 1.0 0.0 0.3 0.0
Methadone 0.0 0.6 0.8 0.0 0.9 1.0 0.0 0.3 0.6 0.0 1.0 1.0 0.0 0.3 0.5
Other opiates† 1.3 4.1 35.2ab 0.5 3.2 33.4ab 2.1 4.8 36.8ab 0.8 4.8 32.5ab 1.7 3.5 37.3ab
Cocaine (including crack) 1.2 5.4 5.3b 2.4 8.4 8.0b 0.0 2.6 3.1b 2.1 9.9 6.8 0.5 1.9 4.2b
Crack 0.3 1.3 0.2 0.6 2.2 0.0 0.0 0.5 0.3 0.6 3.0 0.4 0.0 0.0 0.0
Cocaine powder 0.9 4.8 5.3b 1.8 7.7 8.0b 0.0 2.1 3.1b 1.5 8.6 6.8b 0.5 1.9 4.2b
Amphetamines 2.6 3.1 2.5 3.8 4.1 4.4 1.4 2.1 0.9 4.1 5.7 4.4 1.4 1.0 1.1
Ecstasy 2.6 5.2 4.9 3.2 7.1 7.8 1.9 3.5 2.5 4.9 9.7 8.8 0.5 1.8 2.1
LSD 2.0 2.8 3.5 2.8 4.8 5.6 1.2 0.9 1.7 3.5 4.1 4.1 0.7 1.8 3.1
Magic mushrooms 3.2 4.6 4.2 4.7 7.6 6.6 1.7 1.8 2.1 5.6 8.0 4.0 1.1 1.9 4.3b
Solvents 3.3 2.2 4.0 4.6 3.8 5.0 2.0 0.7 3.1 7.1 4.0 4.7 0.0 0.8 3.4b
Poppers 5.0 3.0 2.8 6.8 4.0 4.8 3.2 2.1 1.1 9.2 5.0 4.5 1.4 1.4 1.5
Sedatives and tranquillisers ** 10.5 23.1a ** 6.9 19.1a ** 13.9 26.5a ** 3.3 21.4a ** 16.2 24.3
Anti-depressants ** 9.0 13.6 ** 5.1 11.2 ** 12.6 15.6 ** 3.5 12.0 ** 13.2 14.8
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 57.6 58.4 54.1 59.4 62.1 55.5 55.6 54.8 52.9 58.9 58.4 45.3ab 56.4 58.4 60.7
Alcohol 87.6 90.4 86.9 91.0 90.9 88.8 84.2 90.0 85.4 90.6 88.3 86.8 85.1 92.1 87.0
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 12.2 Last year prevalence of drug use in NERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 433 446 451 181 171 193 252 275 258 177 170 161 256 276 290
Any illegal drug* 6.4 5.4 4.0 8.3 8.3 7.2 4.3 2.8 1.2 13.2 9.1 7.7 0.4 2.6 1.2
Cannabis 5.2 4.3 3.3 7.8 6.4 7.0 2.4 2.5 0.2 10.6 7.6 6.1 0.4 1.8 1.2
Heroin 0.0 0.2 0.4 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.3 0.0
Methadone 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.2
Other opiates† 0.2 1.0 24.9ab 0.0 0.0 20.4ab 0.4 2.0 28.8ab 0.0 1.2 25.3ab 0.4 0.9 24.6ab
Cocaine (including crack) 0.0 1.4 0.5 0.0 2.9 0.9 0.0 0.0 0.2 0.0 3.2 1.0 0.0 0.0 0.2
Crack 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Cocaine powder 0.0 1.1 0.5 0.0 2.3 0.9 0.0 0.0 0.2 0.0 2.5 1.0 0.0 0.0 0.2
Amphetamines 0.3 0.5 0.4 0.0 0.7 1.0 0.5 0.3 0.0 0.5 0.7 1.0 0.0 0.3 0.0
Ecstasy 0.5 0.8 0.1 0.0 1.4 0.2 1.0 0.3 0.0 1.1 1.5 0.3 0.0 0.3 0.0
LSD 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0
Magic mushrooms 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0
Solvents 0.5 0.2 0.8 0.6 0.0 1.0 0.5 0.4 0.7 1.1 0.0 2.0 0.0 0.3 0.0
Poppers 1.2 0.6 0.2 0.6 1.2 0.0 1.9 0.0 0.3 2.6 0.7 0.4 0.0 0.5 0.0
Sedatives and tranquillisers ** 5.3 9.6a ** 2.8 8.7a ** 7.6 10.4 ** 1.7 13.4a ** 8.0 6.8
Anti-depressants ** 4.1 7.3 ** 2.3 5.5 ** 5.9 8.8 ** 0.8 7.9a ** 6.7 6.9
New Psychoactive Substances *** *** 1.8 *** *** 3.3 *** *** 0.6 *** *** 4.3 *** *** 0.00
Tobacco 34.6 36.8 30.9 37.1 43.3 33.1 31.9 30.8 29.0 43.0 43.6 32.5 27.3 31.6 29.6
Alcohol 82.3 83.9 83.1 84.5 84.9 85.6 80.0 83.0 80.9 85.1 83.7 84.3 79.9 84.1 82.2
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 12.3 Last month prevalence of drug use in NERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 433 446 451 181 171 193 252 275 258 177 170 161 256 276 290
Any illegal drug* 2.4 1.2 1.8 3.4 2.1 3.7 1.4 0.3 0.2 4.8 1.7 3.2 0.4 0.8 0.7
Cannabis 1.9 0.9 1.5 2.9 1.6 3.0 0.9 0.3 0.2 3.6 1.7 2.5 0.4 0.3 0.7
Heroin 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.0 0.3 10.4ab 0.0 0.0 7.5ab 0.0 0.6 12.9ab 0.0 0.0 9.2ab 0.0 0.6 11.4ab
Cocaine (including crack) 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0
Amphetamines 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0
Solvents 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0
Poppers 0.3 0.3 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0
Sedatives and tranquillisers 3.1 2.6 1.7 1.4 4.4 3.7 0.8 1.8 4.9 3.2
Anti-depressants 2.8 5.7 1.3 4.2 4.1 7.0 0.8 5.4a 4.3 5.9
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 31.1 34.6 29.0 33.7 41.6 30.7 28.3 28.1 27.5 36.9 40.4 30.0 26.0 30.1 28.2
Alcohol 71.2 73.1 66.2 77.7 79.7 72.3 64.4 67.0 61.1 72.2 71.8 66.7 70.3 74.1 65.9
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 13.1 Lifetime prevalence of drug use in NWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 322 386 438 152 170 205 180 216 233 126 145 159 206 241 279
Any illegal drug* 10.6 14.6 16.6b 12.7 17.4 18.0 8.5 11.5 15.2 13.3 21.1 24.3b 8.6 9.6 11.3
Cannabis 9.3 13.0 16.1b 11.9 16.7 17.6 6.6 9.0 14.6b 10.7 18.9 23.2b 8.2 8.5 11.3
Heroin 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.4 0.0
Methadone 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.0
Other opiates† 1.2 7.9 25.2ab 0.0 7.2 24.5ab 2.4 8.8 26.0ab 1.7 4.8 24.7ab 0.8 10.3 25.6ab
Cocaine (including crack) 0.0 1.6 2.7b 0.0 1.6 4.6b 0.0 1.6 0.7 0.0 3.2 4.3b 0.0 0.4 1.6
Crack 0.0 1.3 0.0a 0.0 1.6 0.0 0.0 1.0 0.0 0.0 2.6 0.0 0.0 0.4 0.0
Cocaine powder 0.0 1.6 2.7b 0.0 1.6 4.6b 0.0 1.6 0.7 0.0 3.2 4.3b 0.0 0.4 1.6
Amphetamines 0.3 2.1 2.5b 0.6 3.1 3.5 0.0 1.0 1.5 0.0 2.6 4.5b 0.5 1.8 1.1
Ecstasy 0.3 2.3 3.6b 0.0 2.9 5.2b 0.6 1.6 1.9 0.6 4.7 7.5b 0.0 0.5 0.9
LSD 0.3 1.3 2.7b 0.6 2.1 4.1b 0.0 0.4 1.1 0.0 1.9 3.2 0.5 0.8 2.3
Magic mushrooms 1.5 3.0 4.2 2.0 3.9 6.4 1.1 2.0 1.8 2.2 3.6 5.9 1.0 2.6 2.9
Solvents 0.7 2.0 0.9 0.0 2.3 1.2 1.4 1.6 0.6 1.0 4.1 2.1 0.4 0.4 0.0
Poppers 0.9 2.7 1.3 1.2 3.6 2.2 0.6 1.6 0.3 1.3 5.5 2.1 0.5 0.5 0.7
Sedatives and tranquillisers ** 11.6 11.1 ** 9.4 8.3 ** 14.0 14.1 ** 5.3 2.8 ** 16.4 16.9
Anti-depressants ** 9.9 7.4 ** 7.4 4.1 ** 12.7 10.9 ** 7.1 4.3 ** 12.0 9.6
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 58.2 56.1 52.6 61.1 58.0 55.9 55.3 53.9 49.1 48.3 54.8 52.3 66.0 57.1 52.7b
Alcohol 86.0 90.0 91.4b 90.8 89.9 93.3 81.0 90.1 89.5b 88.3 89.3 91.0 84.2 90.6 91.7b
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
Drug use in Ireland and Northern Ireland 2010/11: Drug Prevalence Survey: Regional Drug Task Force (Ireland) and Health and Social Care Trust (Northern Ireland) Results
76 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB)
Table 13.2 Last year prevalence of drug use in NWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 322 386 438 152 170 205 180 216 233 126 145 159 206 241 279
Any illegal drug* 2.6 3.0 2.8 4.2 3.8 4.4 0.9 2.1 1.1 4.8 6.8 5.8 0.8 0.0 0.7
Cannabis 2.2 3.0 2.8 3.4 3.8 4.4 0.9 2.1 1.1 3.9 6.8 5.8 0.8 0.0 0.7
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.0 2.6 19.1ab 0.0 2.5 19.6ab 0.0 2.7 18.5ab 0.0 1.6 20.6ab 0.0 3.4 18.0ab
Cocaine (including crack) 0.0 0.3 0.3 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.5
Crack 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.3 0.3 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.5
Amphetamines 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.4 0.3 0.0 0.8 0.0 0.0 0.0 0.6 0.0 1.0 0.7 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 6.1 4.0 ** 5.9 2.4 ** 6.3 5.7 ** 3.0 0.7 ** 8.5 6.3
Anti-depressants ** 5.3 3.1 ** 4.3 1.3 ** 6.4 4.9 ** 4.1 2.9 ** 6.2 3.2
New Psychoactive Substances *** *** 1.5 *** *** 2.6 *** *** 0.4 *** *** 3.0 *** *** 0.50
Tobacco 32.8 32.4 32.2 33.6 34.9 33.3 32.0 29.6 31.1 34.1 39.7 40.7 31.8 26.7 26.4
Alcohol 77.0 78.8 82.2 82.0 80.0 83.4 71.9 77.4 80.9 78.1 80.5 86.3 76.2 77.4 79.4
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 13.3 Last month prevalence of drug use in NWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 322 386 438 152 170 205 180 216 233 126 145 159 206 241 279
Any illegal drug* 0.2 0.3 1.0 0.0 0.0 1.0 0.5 0.6 1.1 0.0 0.7 2.6 0.4 0.0 0.0
Cannabis 0.2 0.3 1.0 0.0 0.0 1.0 0.5 0.6 1.1 0.0 0.7 2.6 0.4 0.0 0.0
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.0 0.4 8.7ab 0.0 0.5 6.9ab 0.0 0.4 10.6ab 0.0 0.0 7.6ab 0.0 0.8 9.5ab
Cocaine (including crack) 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Crack 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 4.5 2.6 ** 3.6 1.4 ** 5.5 3.8 ** 1.6 0.0 ** 6.7 4.4
Anti-depressants ** 3.6 3.1 ** 3.8 1.3 ** 3.4 4.9 ** 1.8 2.9 ** 5.0 3.2
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 28.5 28.1 28.9 28.9 30.0 31.1 28.1 26.0 26.7 29.2 34.9 35.0 28.0 22.8 24.7
Alcohol 67.6 65.1 67.0 74.8 68.8 74.0 60.3 61.1 59.7 70.1 70.6 70.8 65.7 60.9 64.4
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 14.1 Lifetime prevalence of drug use in NRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 521 438 543 226 198 218 295 285 325 216 198 216 305 285 327
Any illegal drug* 29.5 32.2 34.6 40.3 40.1 45.8 19.6 24.3 24.9 39.1 44.3 40.4 20.4 21.2 29.0 b
Cannabis 26.9 28.8 30.2 35.2 37.1 40.5 19.1 20.7 21.6 34.1 40.3 35.3 19.9 18.4 25.6
Heroin 0.9 1.5 1.5 1.2 1.4 2.2 0.7 1.5 1.0 0.5 1.3 1.4 1.4 1.6 1.7
Methadone 1.0 1.0 0.7 1.2 0.4 1.2 0.8 1.5 0.2 1.4 0.8 0.5 0.7 1.1 0.8
Other opiates† 8.4 3.9 40.3 6.7 4.8 34.9 10.0 3.0 44.8 7.8 1.4 38.0 9.0 6.1 42.3
Cocaine (including crack) 5.2 11.0 11.9 8.1 15.1 18.1 b 2.5 6.9 6.8 7.6 15.9 17.5 b 2.9 6.4 6.9 b
Crack 0.6 0.5 1.0 1.2 0.5 1.6 0.0 0.5 0.5 0.5 0.6 1.3 0.7 0.5 0.7
Cocaine powder 5.0 10.7 11.6 7.7 15.1 17.5 b 2.5 6.4 6.8 7.6 15.4 16.8 b 2.6 6.4 6.9 b
Amphetamines 3.8 5.5 5.8 6.0 7.1 9.7 1.7 4.0 2.7 5.5 8.1 7.7 2.2 3.2 4.27
Ecstasy 6.5 11.2 11.3 10.0 16.6 17.2 3.2 5.9 6.4 12.0 18.2 17.7 1.2 4.8 5.6 b
LSD 4.2 6.3 7.4 6.0 9.3 9.6 2.5 3.3 5.5 6.3 8.1 9.9 2.3 4.6 5.25
Magic mushrooms 5.2 11.4 9.1 8.2 17.0 14.9 2.3 5.9 4.3 6.8 16.3 12.3 3.5 6.9 6.2
Solvents 3.5 1.0 2.8 4.5 0.5 4.5 a 2.5 1.4 1.3 6.7 1.5 4.4 0.3 0.5 1.3
Poppers 4.0 5.7 6.3 6.1 8.0 9.1 2.0 3.5 3.9 6.8 8.6 9.3 1.3 3.1 3.6
Sedatives and tranquillisers ** 11.3 14.2 ** 8.6 15.9 ** 14.0 12.8 ** 6.6 10.0 ** 15.6 18.0
Anti-depressants ** 9.6 10.1 ** 5.3 10.3 ** 14.0 9.9 ** 7.8 6.3 ** 10.3 13.5
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 62.5 55.4 60.3 61.8 61.1 62.1 63.1 49.8 58.8 56.6 49.6 56.8 68.1 60.7 63.5
Alcohol 93.5 91.0 89.4 94.8 93.8 92.0 92.3 88.2 87.2 96.5 89.4 84.5 b 90.7 92.4 93.7
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 14.2 Last year prevalence of drug use in NRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 521 438 543 226 198 218 295 285 325 216 198 216 305 285 327
Any illegal drug* 8.4 12.8 10.5 13.3 17.6 17.9 3.9 8.0 4.5 14.2 20.8 16.8 2.9 5.5 4.8
Cannabis 7.7 11.9 9.4 12.2 17.6 15.9 3.4 6.3 4.2 12.6 18.9 15.6 2.9 5.5 3.9
Heroin 0.2 0.4 0.1 0.0 0.5 0.2 0.5 0.3 0.0 0.5 0.5 0.0 0.0 0.2 0.27
Methadone 0.4 0.8 0.5 0.3 0.0 1.2 0.5 1.5 0.0a 0.5 0.8 0.5 0.3 0.7 0.6
Other opiates† 0.7 1.2 27.9 1.1 1.4 22.8 0.3 0.9 32.1 1.1 0.4 27.6 a 0.3 1.9 28.2
Cocaine (including crack) 1.7 3.3 2.6 2.8 5.8 5.4 0.8 0.8 0.3 3.6 5.7 4.4 0.0 1.1 1.0
Crack 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0
Cocaine powder 1.7 3.0 2.4 2.7 5.8 4.9 0.8 0.3 0.3 3.6 5.1 3.9 0.0 1.1 1.0
Amphetamines 0.3 1.2 0.2a 0.6 1.7 0.5 0.0 0.6 0.0 0.5 2.1 0.3a 0.0 0.2 0.2
Ecstasy 1.6 2.9 1.3 2.7 4.7 2.1 0.5 1.1 0.7 3.2 5.3 1.8 0.0 0.7 0.9
LSD 0.0 0.3 0.4 0.0 0.5 0.4 0.0 0.0 0.4 0.0 0.5 0.8 0.0 0.0 0.0
Magic mushrooms 0.9 1.1 0.9 1.6 1.9 1.5 0.3 0.46 0.4 1.6 2.3 1.8 0.3 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.3 1.0 0.1 a 0.6 1.0 0.2 0.0 1.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2
Sedatives and tranquillisers ** 4.1 7.7a ** 3.3 8.7 ** 4.9 6.9 ** 3.1 4.3 ** 4.9 10.8a
Anti-depressants ** 3.8 2.9 ** 2.3 2.7 ** 5.3 3.0 ** 3.3 2.1 ** 4.3 3.6
New Psychoactive Substances *** *** 1.6 *** *** 2.6 *** *** 0.95 *** *** 2.3 *** *** 1.1
Tobacco 42.9 37.2 38.7 40.8 41.2 40.4 44.9 33.2 37.3 47.7 36.0 42.6 38.4 38.2 35.2
Alcohol 88.8 87.9 86.0 92.0 91.9 88.1 85.9 84.0 84.3 91.8 87.5 83.3b 85.9 88.3 88.5
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 14.3 Last month prevalence of drug use in NRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 521 438 543 226 198 218 295 285 325 216 198 216 305 285 327
Any illegal drug* 5.3 8.2 4.6 8.5 13.2 8.6 2.4 3.3 1.3 9.1 13.7 7.3 1.7 3.2 2.2
Cannabis 4.5 7.9 4.5 6.9 12.5 8.6 2.4 3.3 1.1 7.5 13.0 7.3 1.7 3.2 2.1
Heroin 0.2 0.1 0.1 0.0 0.0 0.2 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.2
Methadone 0.4 0.8 0.4 0.3 0.0 0.9 0.5 1.5 0.0a 0.5 0.8 0.3 0.3 0.7 0.6
0.3 0.7 0.6 27.9 1.1 1.4 22.8 0.3 0.9 32.1 1.1 0.4 27.6 a 0.3 1.9 28.2
Other opiates† 0.3 0.2 14.5 0.6 0.5 12.2 0.0 0.0 16.4 0.5 0.0 15.2 0.0 0.5 13.9
Cocaine (including crack) 0.8 1.4 1.1 1.6 2.8 2.2 0.0 0.0 0.1 1.6 2.5 2.1 0.0 0.4 0.1
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.8 1.4 1.1 1.6 2.8 2.2 0.0 0.0 0.1 1.6 2.5 2.1 0.0 0.4 0.1
Amphetamines 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.3 1.0 0.0a 0.6 1.8 0.0 0.0 0.3 0.0 0.5 1.4 0.0 0.0 0.7 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.3 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 2.4 2.1 ** 1.4 1.6 ** 3.3 2.5 ** 1.3 0.3 ** 3.3 3.7
Anti-depressants ** 3.0 2.5 ** 2.3 2.0 ** 3.78 2.8 ** 1.8 2.1 ** 4.1 2.8
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 38.3 34.8 32.8 37.7 38.1 33.5 38.9 31.6 32.3 41.5 33.3 33.8 35.3 36.2 32.0
Alcohol 80.8 78.3 76.1 86.9 85.3 80.7 75.0 71.3 72.4 82.8 76.4 73.4b 78.8 79.9 79.6
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 15.1 Lifetime prevalence of drug use in SERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 440 476 258 169 191 346 271 285 215 184 172 389 256 304
Any illegal drug* 18.5 25.5 25.3b 24.8 32.4 35.8b 12.0 18.2 14.7 27.2 33.7 34.9 11.4 19.1 18.2b
Cannabis 16.8 23.3 24.2b 22.0 29.7 34.2b 11.4 16.6 14.1 25.4 32.3 33.4 9.8 16.3 17.5b
Heroin 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5
Methadone 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5
Other opiates† 1.0 11.9 37.9ab 1.4 11.9 36.0ab 0.6 11.9 39.8ab 1.2 8.6 36.8ab 0.9 14.5 38.7ab
Cocaine (including crack) 2.5 6.7 5.5b 3.5 10.1 9.2b 1.5 3.3 1.9 4.2 10.1 9.1 1.1 4.2 2.9
Crack 0.3 0.5 0.2 0.7 0.6 0.5 0.0 0.5 0.0 0.0 0.5 0.0 0.6 0.5 0.4
Cocaine powder 2.3 6.5 5.5b 3.1 9.5 9.2b 1.5 3.3 1.9 4.2 10.1 9.1 0.8 3.7 2.9
Amphetamines 4.4 6.9 5.8 5.6 8.0 9.6 3.2 5.7 2.0 7.4 10.8 9.6 2.0 3.9 3.0
Ecstasy 4.3 6.5 6.4 6.5 8.7 11.1 2.1 4.2 1.6 9.3 10.7 11.7 0.2 3.2 2.5b
LSD 4.6 4.1 3.9 7.2 6.0 6.7 1.9 2.2 1.2 8.5 3.8 5.0 1.4 4.4 3.1
Magic mushrooms 5.7 6.3 6.8 9.5 8.9 11.5 1.8 3.6 2.0 9.3 7.8 9.5 2.7 5.1 4.8
Solvents 1.1 3.1 1.6 1.9 2.7 1.9 0.3 3.5 1.3 2.0 5.7 2.3 0.4 1.0 1.1
Poppers 3.3 4.5 5.5 4.8 6.4 9.8 1.7 2.5 1.2 6.6 7.6 9.9 0.5 2.1 2.3b
Sedatives and tranquillisers ** 13.3 12.7 ** 9.8 12.7 ** 16.9 12.6 ** 6.6 11.6 ** 18.5 13.5
Anti-depressants ** 10.3 7.5 ** 6.9 4.7 ** 13.9 10.4 ** 8.8 3.5 ** 11.5 10.5
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 60.6 59.4 56.6 65.7 60.2 64.6 55.2 58.5 48.6 64.5 61.2 54.2 57.4 57.9 58.3
Alcohol 89.5 90.5 91.1 89.8 91.4 95.8b 89.1 89.6 86.4 90.0 91.1 88.5 89.0 90.1 93.0
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 15.2 Last year prevalence of drug use in SERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 440 476 258 169 191 346 271 285 215 184 172 389 256 304
Any illegal drug* 6.9 7.9 5.9 9.4 11.1 10.3 4.3 4.5 1.6 13.8 14.9 9.9 1.3 2.4 3.1
Cannabis 5.8 5.1 4.1 7.9 7.4 7.1 3.6 2.6 1.0 11.2 9.9 6.5 1.3 1.4 2.3
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0
Other opiates† 0.4 4.4 27.8ab 0.3 3.9 26.0ab 0.6 4.9 29.7ab 0.6 3.4 27.8ab 0.3 5.1 27.9ab
Cocaine (including crack) 1.7 2.4 1.5 2.5 3.4 2.7 1.0 1.4 0.4 3.9 4.2 3.7 0.0 1.1 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 1.7 2.4 1.5 2.5 3.4 2.7 1.0 1.4 0.4 3.9 4.2 3.7 0.0 1.1 0.0
Amphetamines 0.9 0.6 0.9 1.0 0.7 1.6 0.8 0.5 0.2 2.0 1.3 2.1 0.0 0.0 0.0
Ecstasy 1.3 1.9 0.6 2.5 2.9 0.8 0.0 0.9 0.3 2.8 4.4 1.2 0.0 0.0 0.1
LSD 0.3 0.1 0.4 0.5 0.0 0.8 0.0 0.3 0.0 0.6 0.3 0.9 0.0 0.0 0.0
Magic mushrooms 0.8 0.7 0.4 1.5 0.6 0.8 0.0 0.8 0.0 1.7 0.8 0.9 0.0 0.5 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.7 0.8 0.5 1.0 1.6 1.0 0.5 0.0 0.0 1.6 1.8 0.3 0.0 0.0 0.6
Sedatives and tranquillisers ** 5.6 5.4 ** 5.0 6.8 ** 6.3 4.1 ** 3.3 4.7 ** 7.4 6.0
Anti-depressants ** 3.9 4.0 ** 2.3 3.0 ** 5.5 5.0 ** 2.5 1.1 ** 4.9 6.1
New Psychoactive Substances *** *** 3.9 *** *** 6.1 *** *** 1.7 *** *** 8.6 *** *** 0.0
Tobacco 38.1 35.0 32.8 38.8 34.9 37.7 37.4 35.1 27.8b 49.0 44.7 32.9b 29.2 27.5 32.7
Alcohol 83.7 83.2 87.3 84.7 84.6 91.9b 82.6 81.8 82.7 85.6 88.1 87.1 82.1 79.4 87.4a
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 15.3 Last month prevalence of drug use in SERDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 440 476 258 169 191 346 271 285 215 184 172 389 256 304
Any illegal drug* 3.1 3.6 3.0 4.5 5.0 5.6 1.8 2.2 0.4 7.0 6.9 5.3 0.0 1.1 1.3
Cannabis 2.1 2.8 2.2 2.5 4.3 4.0 1.8 1.2 0.4 4.7 5.0 4.3 0.0 1.1 0.7
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.1 2.8 12.5ab 0.0 3.3 11.2ab 0.3 2.4 13.9ab 0.3 2.1 10.5ab 0.0 3.4 14.0ab
Cocaine (including crack) 0.0 0.9 0.6 0.0 1.3 1.1 0.0 0.5 0.0 0.0 2.1 1.3 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.0 0.9 0.6 0.0 1.3 1.1 0.0 0.5 0.0 0.0 2.1 1.3 0.0 0.0 0.0
Amphetamines 0.2 0.6 0.0 0.0 0.7 0.0 0.5 0.5 0.0a 0.5 1.3 0.0 0.0 0.0 0.0
Ecstasy 1.3 0.3 0.0b 2.5 0.7 0.0b 0.0 0.0 0.0 2.8 0.8 0.0b 0.0 0.0 0.0
LSD 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.3 0.0 0.4 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6
Sedatives and tranquillisers ** 4.1 3.0 ** 4.0 3.9 ** 4.2 2.1 ** 1.8 1.9 ** 5.9 3.8
Anti-depressants ** 2.4 3.9 ** 1.4 3.0 ** 3.6 4.8 ** 0.8 0.9 ** 3.7 6.1
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 32.4 31.7 28.2 33.4 32.3 32.5 31.3 31.0 23.9 39.8 39.2 26.7 26.3 25.8 29.2
Alcohol 74.1 72.6 66.4b 77.4 76.9 73.4 70.6 68.1 59.3b 73.1 75.8 65.1 74.8 70.1 67.3
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 16.1 Lifetime prevalence of drug use in SWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 689 732 264 290 329 340 399 403 297 315 303 307 374 429
Any illegal drug* 24.0 25.6 36.3ab 31.5 31.3 46.7ab 16.9 19.7 25.2 b 29.8 30.9 46.4 ab 16.5 19.9 26.2 b
Cannabis 23.2 24.0 33.4ab 30.2 29.6 43.2ab 16.5 18.2 22.9 28.3 28.1 43.4 ab 16.5 19.5 23.5
Heroin 1.8 0.4 1.3 2.4 0.6 2.1 1.2 0.3 0.5 2.6 0.2 1.5 0.78 0.7 1.2
Methadone 1.2 0.3 1.0 1.1 0.3 1.8 1.2 0.3 0.3 1.9 0.2 0.8 0.3 0.3 1.2
Other opiates† 6.0 4.1 37.8 3.4 1.7 36.9 8.4 6.5 38.8 5.4 3.8 37.0 6.8 4.3 39.7
Cocaine (including crack) 5.0 3.8 9.6 ab 6.7 4.7 12.9ab 3.3 3.0 6.1 7.3 6.2 13.5 ab 1.9 1.4 5.7 a
Crack 0.4 0.6 1.5 0.5 0.8 2.6 0.3 0.4 0.3 0.7 0.8 1.7 0.0 0.3 1.2
Cocaine powder 4.7 3.6 9.4ab 6.4 4.2 12.6 ab 3.3 3.0 6.1 6.9 5.7 13.5 ab 1.9 1.4 5.4 a
Amphetamines 5.1 2.1 7.4a 6.7 2.9 9.7a 3.7 1.2 5.0 a 8.2 1.8 10.3 a 1.2 2.3 4.5 b
Ecstasy 5.9 4.1 10.4 ab 6.8 4.5 15.1ab 5.1 3.6 5.4 10.2 6.0 14.8 a 0.3 2.0 6.1 ab
LSD 4.9 1.7 7.0a 7.6 2.7 10.6a 2.3 0.8 3.3 a 6.9 1.8 9.3 a 2.3 1.6 4.8
Magic mushrooms 5.6 5.5 9.6b 8.8 6.7 12.6 2.5 4.2 6.4 8.0 7.3 12.9 2.5 3.4 6.3 b
Solvents 1.6 1.9 5.2ab 1.8 2.6 8.4ab 1.4 1.2 1.9 2.8 3.1 7.1 b 0.0 0.7 3.4 ab
Poppers 3.0 1.9 5.9ab 4.5 1.8 9.6ab 1.5 1.9 2.0 4.5 3.1 8.5 a 1.0 0.5 3.3 a
Sedatives and tranquillisers ** 8.8 17.6a ** 6.5 17.8a ** 11.2 17.4 a ** 6.8 12.6 a ** 11.0 22.6 a
Anti-depressants ** 9.8 13.6 ** 5.3 11.0a ** 14.5 16.4 ** 8.9 7.9 ** 10.8 19.3 a
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 63.8 56.3 60.7 66.8 54.2 66.3a 60.9 58.5 54.7 62.0 56.4 58.0 66.0 56.2 63.3
Alcohol 91.2 90.9 92.0 93.9 92.9 94.1 88.6 88.9 89.8 92.5 92.5 93.2 89.5 89.2 90.8
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 16.2 Last year prevalence of drug use in SWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 689 732 264 290 329 340 399 403 297 315 303 307 374 429
Any illegal drug* 7.5 7.4 11.1 11.0 10.1 14.4 4.2 4.6 7.7 10.4 10.1 19.3 ab 3.8 4.4 3.0
Cannabis 7.3 6.7 8.7 10.7 8.9 11.6 4.2 4.4 5.6 10. 8.8 14.9 3.8 4.4 2.6
Heroin 0.4 0.0 0.4 0.5 0.0 0.6 0.3 0.0 0.3 0.7 0.0 0.3 0.0 0.00 0.6
Methadone 1.0 0.2 0.6 1.1 0.3 1.0 0.9 0.0 0.2 1.6 0.0 0.5 0.3 0.3 0.7
Other opiates† 1.5 1.4 25.9 1.3 1.1 25.7 1.7 1.8 26.1 1.4 1.5 27.4a 1.6 1.4 24.5
Cocaine (including crack) 1.5 0.8 2.9 a 2.1 1.0 4.2 a 0.8 0.6 1.5 2.1 1.3 4.7 0.7 0.3 1.0
Crack 0.2 0.0 0.4 0.0 0.0 0.6 0.3 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.5
Cocaine powder 1.5 0.8 2.9 a 2.1 1.0 4.2 a 0.8 0.6 1.5 2.1 1.3 4.7 0.7 0.3 1.0
Amphetamines 0.6 0.0 0.8 a 0.9 0.0 0.5 0.3 0.0 1.2 1.1 0.0 1.1 0.0 0.0 0.5
Ecstasy 1.3 0.5 0.7 1.3 0.0 0.5 1.3 1.0 0.6 2.3 1.0 1.0 0.0 0.0 0.1
LSD 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1
Magic mushrooms 0.3 0.2 1.3 0.5 0.5 1.7 0.2 0.0 0.9 0.4 0.5 2.2 0.3 0.0 0.5
Solvents 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5
Poppers 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0
Sedatives and tranquillisers ** 3.9 8.9a ** 2.3 8.1 a ** 5.6 9.7 a ** 2.5 6.3 ** 5.4 11.4 a
Anti-depressants ** 5.2 6.6 ** 2.3 5.2 ** 8.1 8.2 ** 5.3 3.4 ** 5.1 9.8 a
New Psychoactive Substances *** *** 5.8 *** *** 8.8 *** *** 2.7 *** *** 10.4 *** *** 1.4
Tobacco 43.8 38.0 36.9b 47.6 37.1 38.3 b 40.1 38.8 35.4 45.5 43.6 42.3 41.6 31.9 31.6 b
Alcohol 86.0 87.2 86.8 88.0 89.3 88.6 84.0 84.9 84.8 88.2 90.3 89.2 83.1 83.8 84.4
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 16.3 Last month prevalence of drug use in SWRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 604 689 732 264 290 329 340 399 403 297 315 303 307 374 429
Any illegal drug* 4.3 2.0 5.6a 6.9 2.5 8.8 a 1.8 1.4 2.1 6.4 2.3 8.9 a 1.7 1.6 2.3
Cannabis 3.9 1.8 4.5a 6.1 2.5 7.5 a 1.8 1.0 1.3 5.6 2.0 6.8 a 1.7 1.6 2.3
Heroin 0.2 0.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5
Methadone 0.6 0.2 0.6 0.3 0.3 1.0 0.9 0.0 0.3 0.8 0.0 0.5 0.3 0.3 0.7
Other opiates† 0.6 0.9 15.4 0.4 0.6 14.2 0.8 1.3 16.6 0.0 1.1 17.5 1.3 0.8 13.3
Cocaine (including crack) 0.6 0.3 1.4 1.3 0.0 1.8 a 0.0 0.6 0.9 1.1 0.6 2.1 0.0 0.0 0.6
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.6 0.3 1.4 1.3 0.0 1.8 a 0.0 0.6 0.9 1.1 0.6 2.1 0.0 0.0 0.6
Amphetamines 0.2 0.0 0.3 0.5 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5
Ecstasy 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1
LSD 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1
Magic mushrooms 0.2 0.0 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5
Solvents 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5
Poppers 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 2.5 3.8 ** 1.7 3.7 ** 3.5 3.8 ** 1.9 1.0 ** 3.2 6.4
Anti-depressants ** 3.6 5.8 ** 2.0 4.1 ** 5.1 7.5 ** 3.5 2.2 ** 3.6 9.3 a
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 39.4 33.6 32.7 b 42.1 32.4 34.9 36.8 34.8 30.4 41.3 36.3 36.5 36.9 30.6 28.9
Alcohol 73.5 77.4 71.4 77.1 81.2 77.7 70.0 73.5 64.8 a 72.2 76.0 71.8 75.1 78.9 71.1a
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 17.1 Lifetime prevalence of drug use in SRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 746 682 733 335 302 328 411 380 405 299 239 289 447 443 444
Any illegal drug* 12.1 16.3 24.2ab 14.2 19.8 32.1ab 10.1 12.7 16.6b 18.2 22.1 36.1ab 7.1 11.6 15.3b
Cannabis 11.6 15.0 23.3ab 13.6 17.9 31.0ab 9.5 12.0 15.8b 17.1 20.1 35.1ab 6.9 10.8 14.5b
Heroin 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1
Methadone 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0
Other opiates† 0.8 5.2 46.0ab 0.6 4.2 42.8ab 1.0 6.2 49.3ab 1.2 2.5 50.2ab 0.4 7.3 42.9ab
Cocaine (including crack) 1.9 3.1 4.9b 2.2 4.9 7.6b 1.5 1.2 2.1 2.8 5.3 5.8 1.0 1.3 4.1ab
Crack 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5
Cocaine powder 1.9 3.1 4.9b 2.2 4.9 7.6b 1.5 1.2 2.1 2.8 5.3 5.8 1.0 1.3 4.1ab
Amphetamines 1.8 2.6 2.9 2.3 4.2 4.2 1.3 1.0 1.7 3.0 4.6 3.9 0.8 1.0 2.2
Ecstasy 2.8 3.5 5.7b 3.9 4.9 9.0b 1.7 2.0 2.5 5.6 5.9 8.5 0.4 1.4 3.6ab
LSD 1.2 1.2 2.8 1.2 1.6 4.5b 1.1 0.8 1.1 1.8 1.7 3.0 0.6 0.7 2.7ab
Magic mushrooms 2.9 3.5 4.9 3.1 4.9 7.2b 2.6 2.0 2.7 4.6 5.6 6.8 1.4 1.7 3.5
Solvents 1.1 1.1 1.3 1.7 1.6 1.6 0.6 0.5 1.0 2.2 2.0 2.4 0.2 0.3 0.6
Poppers 1.3 2.8 2.3 1.9 3.9 3.8 0.7 1.7 0.9 2.9 4.9 2.5 0.0 1.1 2.2b
Sedatives and tranquillisers ** 9.7 11.5 ** 8.5 7.8 ** 10.9 15.2 ** 3.7 7.5 ** 14.6 14.6
Anti-depressants ** 6.8 9.9 ** 6.0 7.5 ** 7.7 12.1 ** 4.9 5.2 ** 8.4 13.4a
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 54.7 54.7 57.1 53.2 51.8 61.0 56.2 57.7 53.2 51.9 51.9 57.4 57.0 56.9 56.8
Alcohol 91.2 87.2 90.2 93.3 88.6 92.9 89.1 85.7 87.4 93.2 89.1 90.0 89.5 85.7 90.3a
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 17.2 Last year prevalence of drug use in SRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 746 682 733 335 302 328 411 380 405 299 239 289 447 443 444
Any illegal drug* 4.7 4.9 6.1 5.5 7.4 8.9 4.0 2.4 3.2 8.7 9.5 10.8 1.4 1.3 2.4
Cannabis 4.4 4.6 5.5 4.8 6.9 7.9 4.0 2.2 3.2 7.9 8.7 10.0 1.4 1.3 2.1
Heroin 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0
Methadone 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0
Other opiates† 0.3 1.7 35.2ab 0.6 1.1 29.9ab 0.0 2.3 40.4ab 0.3 0.0 39.8ab 0.3 3.1 31.6ab
Cocaine (including crack) 0.7 1.1 1.0 1.0 1.8 1.7 0.4 0.5 0.4 1.2 2.5 1.7 0.3 0.0 0.5
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.7 1.1 1.0 1.0 1.8 1.7 0.4 0.5 0.4 1.2 2.5 1.7 0.3 0.0 0.5
Amphetamines 0.4 0.2 0.3 0.8 0.5 0.1 0.0 0.0 0.5 0.9 0.5 0.7 0.0 0.0 0.0
Ecstasy 0.9 0.6 0.4 1.5 1.2 0.7 0.4 0.0 0.2 2.0 1.1 1.0 0.0 0.3 0.0
LSD 0.3 0.0 0.3 0.7 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.3
Magic mushrooms 0.3 0.7 0.4 0.3 1.4 0.9 0.4 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.5
Solvents 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0
Poppers 0.2 0.2 0.2 0.3 0.5 0.2 0.0 0.0 0.2 0.3 0.5 0.2 0.0 0.0 0.2
Sedatives and tranquillisers ** 4.2 4.9 ** 4.0 2.9 ** 4.4 6.9 ** 1.8 2.8 ** 6.2 6.5
Anti-depressants ** 3.7 5.3 ** 4.1 4.4 ** 3.2 6.3 ** 2.4 3.1 ** 4.7 7.1
New Psychoactive Substances *** *** 3.6 *** *** 5.4 *** *** 1.9 *** *** 7.3 *** *** 0.9
Tobacco 34.7 30.1 31.9 32.0 26.6 36.6a 37.5 33.7 27.3b 40.0 32.8 40.6 30.2 27.9 25.3
Alcohol 85.1 81.4 84.5 88.0 84.8 87.1 82.1 77.8 82.0 88.2 82.3 84.9 82.5 80.6 84.2
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 17.3 Last month prevalence of drug use in SRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 746 682 733 335 302 328 411 380 405 299 239 289 447 443 444
Any illegal drug* 2.1 2.0 2.9 1.9 3.7 4.4 2.3 0.2 1.6 4.1 3.5 4.3 0.4 0.7 1.9b
Cannabis 2.1 2.0 2.9 1.9 3.7 4.2 2.3 0.2 1.6 4.1 3.5 4.1 0.4 0.7 1.9b
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other opiates† 0.2 0.5 18.9ab 0.3 0.3 13.7ab 0.0 0.7 24.0ab 0.3 0.0 19.5ab 0.0 0.9 18.4ab
Cocaine (including crack) 0.4 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.4 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.2 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0
LSD 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0
Poppers 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 2.8 2.8 ** 2.6 1.9 ** 3.0 3.6 ** 1.0 1.2 ** 4.3 4.0
Anti-depressants ** 2.8 4.4 ** 3.1 3.2 ** 2.5 5.5a ** 2.0 2.3 ** 3.5 6.0
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 31.4 27.2 27.2 28.3 25.0 31.9 34.6 29.5 22.5ab 35.4 29.7 33.6 28.0 25.2 22.3
Alcohol 75.3 69.7 72.6 79.0 76.6 76.9 71.6 62.6 68.3 78.3 68.7 73.4 72.8 70.6 72.0
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 18.1 Lifetime prevalence of drug use in WRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 484 543 492 204 214 211 280 329 281 200 216 200 284 327 292
Any illegal drug* 12.5 20.4 23.8b 16.3 25.2 30.9b 8.6 17.3 16.6b 15.6 28.7 32.7b 9.9 15.0 17.1
Cannabis 12.0 18.4 23.0b 15.8 22.9 29.2b 8.1 15.5 16.6b 14.6 25.9 30.8b 9.9 13.5 17.1
Heroin 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.0 0.0 0.0
Methadone 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Other opiates† 1.1 4.1 50.9ab 0.4 3.3 41.1ab 1.8 4.6 60.9ab 0.9 3.2 48.4ab 1.3 4.6 52.8ab
Cocaine (including crack) 1.7 3.1 5.5b 2.1 2.8 8.4ab 1.2 3.3 2.6 2.2 6.5 6.5 1.2 0.9 4.8ab
Crack 0.2 0.4 0.1 0.0 0.5 0.2 0.3 0.3 0.0 0.3 0.9 0.0 0.0 0.0 0.2
Cocaine powder 1.5 3.0 5.5b 2.1 2.3 8.4 0.9 3.3 2.6 1.9 6.0 6.5b 1.2 0.9 4.8ab
Amphetamines 1.4 2.6 2.6 2.2 2.8 3.9 0.5 2.4 1.3 2.0 4.6 4.0 0.9 1.2 1.6
Ecstasy 1.8 3.9 3.7 2.2 3.7 5.1 1.4 4.0 2.3 2.5 7.9 5.7 1.2 1.2 2.2
LSD 1.2 2.0 2.2 1.8 2.3 4.3 0.7 1.8 0.1 1.3 3.2 1.8 1.2 1.2 2.6
Magic mushrooms 2.0 3.1 4.1 2.8 2.8 6.7 1.2 3.3 1.5 2.0 5.6 3.8 2.0 1.5 4.3
Solvents 0.4 1.5 1.9b 0.8 2.8 2.3 0.0 0.6 1.5 0.9 1.9 3.1 0.0 1.2 1.0
Poppers 1.3 2.6 2.5 2.1 2.8 2.4 0.5 2.4 2.6 1.9 5.6 5.7 0.9 0.6 0.2
Sedatives and tranquillisers ** 10.1 9.0 ** 10.8 6.1 ** 9.7 12.0 ** 6.9 8.7 ** 12.2 9.2
Anti-depressants ** 10.7 10.5 ** 8.4 8.0 ** 12.2 13.1 ** 9.3 10.3 ** 11.6 10.6
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 60.8 62.6 56.9 64.7 66.4 57.3 56.7 60.2 56.6 53.5 60.2 48.2a 66.9 64.2 63.4
Alcohol 88.1 89.7 91.1 90.1 91.6 91.2 86.0 88.5 91.1 89.3 91.2 91.2 87.1 88.7 91.1
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 18.2 Last year prevalence of drug use in WRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 484 543 492 204 214 211 280 329 281 200 216 200 284 327 292
Any illegal drug* 2.9 4.2 5.1 3.5 5.1 7.9 2.2 3.7 2.3 3.4 7.9 8.0 2.4 1.8 3.0
Cannabis 2.0 3.9 4.9b 2.8 4.7 7.4b 1.2 3.3 2.3 1.5 6.9 7.6b 2.4 1.8 2.8
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Other opiates† 0.4 1.1 37.5ab 0.0 0.9 26.4ab 0.9 1.2 48.7ab 0.6 0.9 36.8ab 0.3 1.2 38.0ab
Cocaine (including crack) 0.7 1.5 0.8 1.3 0.9 0.8 0.0 1.8 0.7 0.8 3.2 1.4 0.5 0.3 0.3
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.7 1.5 0.8 1.3 0.9 0.8 0.0 1.8 0.7 0.8 3.2 1.4 0.5 0.3 0.3
Amphetamines 0.3 0.4 0.5 0.6 0.5 0.3 0.0 0.3 0.7 0.0 0.5 1.2 0.5 0.3 0.0
Ecstasy 0.3 0.7 0.4 0.0 0.9 0.4 0.5 0.6 0.4 0.6 1.9 0.5 0.0 0.0 0.3
LSD 0.0 0.4 0.1 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.2
Magic mushrooms 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.3 0.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 4.8 5.2 ** 6.5 3.2 ** 3.7 7.1 ** 2.3 5.3 ** 6.4 5.1
Anti-depressants ** 5.9 3.3 ** 6.1 4.0 ** 5.8 2.7 ** 5.1 2.3 ** 6.4 4.1
New Psychoactive Substances *** *** 2.6 *** *** 3.7 *** *** 1.4 *** *** 4.1 *** *** 1.4
Tobacco 35.9 37.6 28.2ab 36.5 35.5 31.9 35.2 38.9 24.5ab 37.7 40.7 30.9a 34.4 35.5 26.2a
Alcohol 77.1 81.2 85.2b 76.5 84.1 86.8b 77.8 79.3 83.6 78.2 85.7 87.7b 76.3 78.3 83.3
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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Table 18.3 Last month prevalence of drug use in WRDTF, 2002/03, 2006/07 and 2010/11
All Adults Males Females Young Adults (15-34yrs) Older Adults (35-64yrs)
02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11 02/3 06/7 10/11
Total sample (unweighted) 484 543 492 204 214 211 280 329 281 200 216 200 284 327 292
Any illegal drug* 1.9 1.3 1.7 2.1 2.3 2.8 1.7 0.6 0.5 2.0 2.8 1.5 1.9 0.3 1.8
Cannabis 1.3 1.3 1.5 1.4 2.3 2.8 1.2 0.6 0.3 0.6 2.8 1.2 1.9 0.3 1.8
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Other opiates† 0.0 0.4 17.6ab 0.0 0.5 13.4ab 0.0 0.3 21.9ab 0.0 0.5 20.2ab 0.0 0.3 15.7ab
Cocaine (including crack) 0.4 0.4 0.1 0.7 0.5 0.0 0.0 0.3 0.3 0.8 0.9 0.3 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine powder 0.4 0.4 0.1 0.7 0.5 0.0 0.0 0.3 0.3 0.8 0.9 0.3 0.0 0.0 0.0
Amphetamines 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0
Ecstasy 0.3 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.9 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sedatives and tranquillisers ** 3.9 1.9 ** 5.6 1.5 ** 2.7 2.3 ** 1.9 0.5 ** 5.2 2.9
Anti-depressants ** 5.0 2.3a ** 4.7 2.5 ** 5.2 2.1 ** 4.6 1.3 ** 5.2 3.1
New Psychoactive Substances *** *** *** *** *** *** *** *** *** *** *** *** *** *** ***
Tobacco 31.5 32.2 23.0 30.5 32.2 26.2 32.5 32.2 19.8ab 32.5 33.8 23.9a 30.7 31.2 22.3ab
Alcohol 67.0 69.4 70.3 70.2 75.2 76.8 63.7 65.7 63.6 66.7 70.4 73.8 67.3 68.8 67.6
a Significant change (p<.05) between 2006/7 and 2010/11. Statistical significance does not imply that the change is of practical importance.
b Significant change (p<.05) between 2002/3 and 2010/11. Statistical significance does not imply that the change is of practical importance.
* Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents
** In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about Sedatives/tranquillisers and Anti-depressants separately.
** * In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in the last 12 months only.
† Tests for statistical significance between the prevalence of Other Opiates are not reported. As a result of measurement changes in 2006/7 and 2010/11, the Other Opiates category is not comparable between the surveys. The measurement 
of Other opiates in Ireland in 2002/3 included 9 drugs: Opium, Temgesic®, Diconal® (dipanone & cyclizine), Napps, MSTs® (morphine), Pethidine, DF118®, (Dihydrocodeine), buprenorphine and morphine. In 2006/7 the category ‘Other 
opiates’ was extended to be consistent with Northern Ireland and included: Codeine and dihydrocodeine (Feminax ®, Kapake ®, Diffs, Dikes, Peach), fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and 
buprehnorphine (Subutex®). In 2010/11 the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief®, Migraleve®, Nurofen Plus®, codeine phosphate, Panadeine®, paracetamol/caffeine/codeine 
and doxylamine, Paracodin®, Paramol®, Solpadeine®, Solpadol®, Syndol®, Tylex®, Uniflu Plus®,Veganin Plus®.
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